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PREFACE 
 
 
In this thesis is described a molecular approach to diagnosis and control of 
pathogenic trypanosomes. Recent developments in genome-wide 
molecular techniques are providing useful advances for fine-scale 
genotyping in various taxa. An attempt has been made to evaluate existing 
molecular tools and to address the need for multi-locus fine-scale 
genotyping approach for molecular marker-assisted analysis. This tool has 
been used to uncover cryptic genetic variation of trypanosome strains, to 
infer phylogenetic relationships and to characterise specific trypanosome 
phenotypic traits, including the role of differential DNA methylation in 
modulating human serum response properties of trypanosomes 
 
Objectives and outline of the thesis 
 
Three severe epidemics of African trypanosomosis over the last century 
jolted scientists and clinicians into (i) active screening (using 
epidemiological and microbiological data) to identify cases, (ii) surveillance 
to monitor disease prevalence and, (iii) the application of effective 
treatments against clinical cases of trypanosomosis. With the success of 
these measures, the disease had practically disappeared between 1960 
and 1965. However, it reappeared in endemic form interspersed by periods 
of epidemic episodes in several foci following a relaxation of the control 
measures over the last thirty years. Unfortunately, appropriate effective 
therapies are now severely limited due mainly to the increasing problem of 
parasite resistance to available drugs, in addition to high frequency of 
severe adverse effects of the drugs, and the long duration and high cost of 
treatments. Furthermore, there is the need for a robust fine-scale diagnostic 
system for epidemiological follow-up. It is important to identify human-
infective isolates in the field to determine the relevance of animal reservoirs 
and the prevalence of human-infective trypanosomes in tsetse flies.  
Therefore, it is evident that controlling trypanosomosis requires innovative 
diagnostic assay development strategies, as well as new approaches and 
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targets for developing effective drugs and a possible vaccine. Whole-
genome methods are changing the scope of genetic and genomic analysis 
of T. brucei towards the discovery of these lead molecules. A careful 
analysis of the genetic make-up based on signature profiling of individuals 
or populations may provide such powerful tools.  
 
This thesis describes the results of genome analyses of pathogenic 
trypanosomes, with special emphasis on T. brucei. The aims were to 
develop and evaluate molecular marker systems for generating sensitive 
tools for molecular typing of strains, taxonomy and analysis of the 
relationships between genetic variations and their consequent functional 
effects, to enhance our understanding of important traits. The data 
presented herein have added to knowledge on such parasite parameters as 
allelic genetic differences, population structure, and molecular basis of 
human serum resistance/sensitivity of pathogenic trypanosomes. 
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1.1. Summary 
 
There have been tremendous advances in our knowledge of trypanosome 
pathobiology yet many aspects remain unclear. Currently, the genome of 
Trypanosome brucei is being sequenced and, with other genome-wide 
analysis methods including microarrays, may provide novel insights for 
better understanding of the parasite, facilitating the development of 
effective controls. An important new challenge investigators face is how to 
utilise these tools to study a parasite that possesses many genetic 
peculiarities. This review summarises our current understanding of African 
trypanosome genetics and links the impact of genome analysis to the 
prospects for developing possible vaccine targets and new tools for 
rationale drug design and specific diagnostics.  
 
 
1.2. Introduction 
 
The tsetse fly-transmitted trypanosomes are unicellular protozoan parasites 
that cause acute to chronic debilitating disease called sleeping sickness in 
humans and nagana in cattle. Molecular epidemiology and genetic analysis 
have confirmed the classification of Trypanosoma brucei into human-
infective subspecies - T. b. gambiense and T. b. rhodesiense, and T. b. 
brucei that is non-infective to humans because the subspecies is lysed by 
normal human serum. There are about 500,000 cases of human disease in 
sub-saharan Africa (WHO, 2001), while the animal disease contributes to 
severely limit livestock production in a third of the continent.  
 
The fight against African trypanosomosis has relied heavily on 
chemotherapy and vector control strategies, and although therapy and 
prophylaxis have been most widely applied, their effectiveness remain 
unsatisfactory (reviewed by Keiser et al., 2001; Anene et al., 2001). Initial 
anti-trypanosomal drugs were dominated by salts of three compounds: 
diamine, phenanthridine and phenanthridine-aromatic amide; all were beset 
by their inability to cross the blood-brain barrier in sufficient quantity to 
Chapter 1 
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prevent relapses of late-stage cases of sleeping sickness in humans. This 
situation was markedly improved following the introduction of Melarsoprol 
but severe adverse effects frequently occur (Kuzoe, 1993; WHO, 1998). No 
less remarkable, however, is the versatility shown by the parasites in their 
ability to develop refractoriness to the treatment of the disease with these 
drugs. In the past 35 years, cymelarsan, a trivalent water-soluble analogue 
of the arsenical melarsoprol, and D, L-α-difluoromethyl-ornithine (DFMO) 
(Eflornithine®) are the only new trypanocides commercially made available 
for veterinary and human use. Unfortunately, they are also toxic to humans, 
and trypanosomes are showing increasing resistance to these drugs. 
Moreover, DFMO, which is the newest trypanocide, appears to be 
ineffective against T. b. rhodesiense and thus can be used in humans only 
for treatment of the disease caused by T. b. gambiense (Bacchi et al., 
1980). Even then, the drug is less efficient in children than in adults (Milford 
et al., 1993). Short-term measures such as chemical modification of 
existing compounds (Werbovetz et al., 1996) or combination therapy 
(Jennings, 1993) could have significant impact on disease control in the 
immediate future.  
 
The need for additional targets and new, less-toxic therapeutics is widely 
acknowledged (WHO, 2001). There is consensus that vaccination will 
provide the most effective means for the control of trypanosomosis, but no 
vaccine is available. In addition, sensitive molecular tools are also required 
for fine-scale identification and more detailed characterisation of all T. 
brucei subspecies, and for epidemiological investigations of African 
trypanosomosis. Such specific diagnostic tool will also provide necessary 
adjunct to the effective use of any new drug or vaccine products. Recent 
developments towards developing specific markers through fine-scale 
trypanosome genome analysis (Agbo et al., 2001; Agbo et al., 2002; Agbo 
et al., In press) indicate that specific molecular diagnosis of T. brucei 
subspecies is feasible. There are high expectations that genomics will offer 
new leads to rationale vaccine design and accelerate the discovery of novel 
drug targets, as well as the development of practical and robust diagnostic 
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assays. This review describes the latest genomics-based technologies and 
discusses their potential contribution to the control of trypanosomosis 
caused by T. brucei. 
 
1.3. Genomics and target discovery for vaccine and drug 
development 
 
1.3.1 Trypanosome genetics 
Traditionally, the search for novel genes required for survival or virulence of 
any organism was based on several genetic methods involving genetic 
crosses, gene knockouts and induced mutations of the genome, followed 
by screening for the relevant phenotype. In trypanosomes, these 
approaches have been hampered by the inability to generate sufficient 
number of progeny clones from genetic crosses and the lack of a fine 
genetic map. These have affected the ability to determine precisely 
statistical significance of segregating phenotypes in relation to the number 
of loci or alleles determining the trait of interest (Gibson and Stevens, 1999; 
MacLeod et al., 1999; Tait et al., 2002). 
 
1.3.2. Trypanosome genome sequencing 
There is now a significant investment in sequencing the genome of T. 
brucei (http://www.tigr.org/tdb/e2k1/tba1/;http://www.sanger.ac.uk/ Projects/ 
T_brucei). According to these databases, at the current rate of progress, it 
is estimated that the full genomic sequence of this parasite will be available 
during the early part of 2004 at the latest. The challenge then will be to 
convert this sequence information to the functions of the full gene 
complement of this organism and to assess their potential value as targets 
for integrated control tools. Already, the extensive genome sequence 
information available in public databases is such that any known T. brucei 
gene can be identified (at >90% chance) by searching these databases, 
using a variety of criteria built into the search tools. 
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Two complementary approaches are being followed in sequencing the 
trypanosome genome: genomic DNA sequencing, and EST (expressed 
sequence tag, or expressed gene) sequencing. Trypanosome genomic 
sequence data reveal that genes are tightly packed on chromosomes (El-
Sayed et al., 2000) and appear to be unidirectional over long regions, which 
could permit better design of future experimental research. Initial data 
emerging from the T. brucei ‘shot-gun’ genome-sequencing project indicate 
that the overall sequence organisation of chromosomes is distinct from that 
of other higher eukaryotic organisms. There are, however, a number of 
similarities with those of the other lower eukaryotes, particularly the 
protozoan parasites (Lanzer et al., 1993; Ravel et al., 1996). Several genes 
encoding housekeeping proteins, enzymes and structural proteins are 
arranged in tandem repeats, making the sequencing difficult because of 
ambiguity in distinguishing big DNA clones containing repetitive DNA 
clusters that may have originated from different chromosomes. In addition, 
size differences have been observed between chromosome homologues 
within a single strain of T. brucei, which are primarily due to differences in 
the number of repeat units contained within the repetitive elements on the 
different chromosome homologues, particularly those found at the telomeric 
ends. Given that only a few specific genes are known in T. brucei, it can be 
speculated that many targets will remain undiscovered among the genes of 
unknown function, underscoring the importance of starting functional 
characterisation of the genome of this parasite, using the available 
sequence data as the starting point.  
 
One of the most intriguing observations from a majority of genome 
sequencing projects completed so far is that a significant proportion (at 
least 40%) of genes identified have unknown functions. In other words, 
these genes have been identified solely by sequence determination 
combined with the fact that they either are homologous to other genes 
identified in other organisms, but whose functions remain unknown or have 
open reading frames which potentially encode functional proteins. Such 
genes will need to be characterised by genetic or biochemical analysis. 
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Expressed sequence tag (EST) analysis provides a rapid means of gene 
discovery and comparative data on expression levels. An example of the 
power of EST sequencing is provided by the efforts to sequence 
approximately 4500 randomly selected cDNAs from T. brucei, a process 
that successfully identified more than 1000 unique gene transcripts (El-
Sayed et al., 1995; El-Sayed and Donelson 1997; Djikeng et al., 1998). 
Prior to this effort, there were only a handful of T. brucei genes in public 
databases. Thus, EST sequencing rapidly identified a large number of 
candidate genes for further investigations. About 10-15% of these ESTs are 
similar to a known gene of at least one other organism, and about 50% are 
novel (El-Sayed et al., 2000; see: www.ncbi.nlm.gov/dbEST/index.html). In 
addition, EST analysis offers the possibility of identifying the complete open 
reading frame (ORF) by re-constructing an overlapping consensus 
sequence from multiple ESTs. Fully sequenced ESTs can also be used to 
identify alternatively spliced messages and gene families consisting of 
related genes. In addition, an extensive comparative EST analysis of T. 
brucei and several other protozoan parasites might reveal interesting 
evolutionary or functional trends among the taxa.  
 
While EST sequencing provides a rapid means of gene discovery and a 
range of markers for gene-based sequence tagged site (STS) mapping, it is 
rather biased in that the ESTs originate from cDNAs synthesised from 
mRNA present in a synchronous population of trypanosomes of a particular 
life-cycle stage. A majority of the ESTs was generated from the 
bloodstream forms of the parasite, a very small number from procyclic 
culture forms and none from the infective metacyclic forms (El-Sayed et al., 
1995; El-Sayed and Donelson 1997; Djikeng et al., 1998). This urges for an 
investigation of the EST content of either a mixture of trypanosomes of all 
life-cycle stages, or ideally, but more labour intensive, all life-cycle stages 
individually.  Considering the size of T. brucei genome, it can be estimated 
that a substantial number of gene transcripts are not represented among 
the ESTs currently available in the public domain databases. These 
represent approximately 1000 unique gene transcripts, from the 6000 
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genes indirectly estimated to be present in T. brucei  (Djikeng et al., 1998). 
However, even after all the possible ESTs of T. brucei would have been 
described, there will still be a significant proportion that encodes proteins of 
either unknown nature or function. Among these are likely to be the genes 
that are specific to this parasite because they are essential to its parasitic 
lifestyle. These genes or their products might be the best candidates for 
drug and/or vaccine design precisely because they are likely to be highly 
directed to phenotypic or disease processes unique to the parasite, but 
would have to be highly expressible and/or accessible to the immune 
system. Furthermore, since these genes probably have no human 
counterpart these vaccines and drugs may be highly specific for the 
parasites expressing less or no adverse effects to humans. 
 
1.3.3. Trypanosoma genome variability 
Variations at multiple genetic loci have been analysed for novel allelic 
differences among T. brucei subspecies using restriction fragment length 
polymorphism (RFLP), amplified fragment length polymorphism (AFLP) and 
minisatellite marker analysis system (Agbo et al., 2002; MacLeod et al., 
2000; Hide et al., 1994). The AFLP technique has also been applied to 
identify a number of polymorphic markers among parental lines of T. brucei 
and for the construction of a genetic map (Tait et al., 2002; see: 
http://www.gla.ac.uk/ibls/II/cmrt). The genetic analysis of significant trait(s) 
requires that linkage analysis be performed using molecular markers (in a 
dense genetic map) that co-segregate with the traits in the progeny of a 
cross. Such markers might be relevant for the identification of targets for 
the development of drugs and/or vaccines.  
 
To date, there has been a paucity of published data on the analysis of the 
inheritance of specific trypanosome traits, except a preliminary analysis of 
resistance to lysis by human serum (Gibson and Mizen, 1997). It is now 
known that human serum resistance of T. b. gambiense and some T. b. 
rhodesiense strains involve a complex of genes, possibly from multiple loci 
and alleles. This could confound classical genetic approaches to the 
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analyses and urges for global genome-wide investigations to identify the 
genes involved. Also, the functional complexity of trypanosomes far 
exceeds that which may be indicated by the genome data of the single 
clone currently being sequenced, mainly due to their immense genome 
plasticity and alternative splicing that result in extensive polycistronic pre-
mRNAs. Therefore, forging a link among the genomic sequences of the 
three trypanosomatids - T. brucei, T. cruzi and Leishmania spp - would 
broaden the list of target candidates that can then be rapidly validated by 
other means. The gene categories generated by this approach enable such 
a pre-selection of target candidates on a whole-genome scale; in other 
words, targets can be defined according to the characteristics of specific 
phenotypic trait(s) for possible broad-spectrum applications. Comparative 
analysis of genomes of such closely-related organisms may generate 
testable hypothesis of genes that might be responsible for differences in 
tropism and pathologies between parasite strains or species. Genomic 
regions that are different among T. brucei variants, for example, can be 
rapidly identified and evaluated for relevance for the development of drugs 
and/or vaccines. Such comparative studies are already gaining appeal as 
templates in homology modelling and molecular dynamics study, to 
elucidate the functional importance and therapeutic potential of target 
enzymes in trypanosomes (Hide et al., 1990; Stevens and Tibayrenc, 1995; 
De Greef et al., 1989). 
 
1.4. Genomics and diagnostic assay development 
 
Success of vaccination may depend upon highly reliable diagnosis of 
parasites, which may be difficult, especially in case of closely-related 
subspecies. However, genomics will also unravel the genome differences 
underlying subspecies differences that can be used for proper diagnosis. 
The development of subspecies-specific markers for molecular diagnosis 
will be discussed first. 
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1.4.1. Genetic markers and molecular epidemiology 
Single nucleotide polymorphisms (SNPs) are densely spaced 
polymorphism throughout the genome (see http://snp.cshl.org), with 
efficient analysis platforms, which promise to allow disease association 
studies even without carefully defined family or pedigree studies. The SNPs 
are expected to be the mainstay of efforts not only in mapping of disease 
associations but also in attempting to identify the genetic determinants of 
the different reactions to different drugs or compounds. Many methods 
used in the recent past employed a subset of SNPs, namely those detected 
by the appearance or disappearance of restriction sites.  
 
Restriction endonuclease-based genome analysis methods have been 
used to search for markers that may be used to simultaneously differentiate 
T. brucei subspecies (Agbo et al., 2001; Agbo et al., 2002; Hide et al., 
1994; Hide et al., 1990; Stevens and Tibayrenc, 1995; Agbo et al., In 
press). Single nucleotide polymorphisms (SNPs) that are identified as 
candidate markers can be cloned and converted into PCR-based 
sequence-tagged sites, and the diagnostic value of each one can 
subsequently be evaluated in larger population studies, to validate an 
association of gene with specific parasite traits. The recent development of 
a finer-scale multi-endonuclease-based genotyping approach, which 
simultaneously accesses multiple independent allelic sites within the 
genome, offers a tool for expanding the number of identifiable single 
nucleotide and restriction fragment polymorphisms (Agbo et al., In press). 
These tools will also increase the chance of detection of subtle variations in 
restriction patterns, and help to establish the parameters of any future 
large-scale efforts to accumulate SNPs in T. brucei. However, 
bioinformatics will provide a key link to the underlying genes and the 
interpretation of any associations these may have to relevant phenotypes. 
 
One approach to the development of specific assays for T. brucei 
subspecies is the identification of genetic markers linked to traits specific to 
the respective subspecies. These could correspond to genes that are 
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specific to a subspecies, and could thus be used for identification on the 
basis of the trait encoded by the gene. An approach that exploited 
differential screening of cDNA libraries using radioactive cDNA from human 
serum-sensitive or resistant clones of T. b. rhodesiense led to the 
identification of the serum-resistant-associated (SRA) gene transcript (De 
Greef et al., 1989). The gene appears to be present only in most T. brucei 
rhodesiense strains and undetectable in the serum-sensitive T. brucei 
brucei (Rifkin et al., 1994). A recently developed PCR assay based on the 
SRA gene appears to be specific for the identification of human-infective T. 
b. rhodesiense and could serve as a useful tool for studies on molecular 
epidemiology of the disease caused by this subspecies (Welburn et al., 
2001; Gibson et al., 2002). The value of the SRA gene for the study of 
human serum resistance will be enhanced by the identification of specific 
ligands in normal human serum with which the protein product of this gene 
interacts to cause the effect, but no signal peptide for the gene has been 
identified. Based on such ligands, in vitro assays can be designed whereby 
compound libraries are screened for small molecules that competitively 
displace the putative ligand. This offers a basis for developing T. b. 
rhodesiense-specific drug and/or vaccine targets.  
 
1.5. Genomics and identification of drug and vaccine targets 
 
1.5.1. Defining gene function 
With the genome sequencing initiatives providing putative targets in 
profusion, some notion of function beyond what can be discerned from 
homology is crucial to the decision to continue with a putative target. 
Knowing when and where a gene is expressed can be an important input to 
this process. It is apparent from the genomes whose sequences have been 
completed that it is usually possible to assign functions to, at best, 60% of 
the genes identified in a particular organism. In addition to categorising 
genes solely by sequence-based comparisons, selection of putative targets 
can be more precisely addressed through direct studies of gene 
expression, at either the mRNA or protein level. Trypanosomes rely heavily 
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on gene regulation at the post-transcriptional or post-translational levels. 
Thus, the level of complexity resulting from co- or post-translational 
modification events can only be dissected and understood through 
qualitative and quantitative studies of gene expression at the level of the 
functional proteins themselves. This urges for proteomics investigations of 
the parasite genome, a subject that is outside the scope of this review.  
 
Recent studies have begun to generalise the notion of an intimate 
correlation between RNA-triggered silencing and gene activity (Ngo et al., 
1998; Wirtz et al., 1999; LaCount et al., 2000; Wang et al., 2000; Drozdz et 
al., 2002). Due to its hostile environment with dangerous opportunities for 
unwanted gene expression, trypanosomes have a vehement response to 
dsRNA (Ngo et al., 1998; Drozdz et al., 2002). This may pose an immense 
challenge to putative drug delivery machineries. Recently, Ullu et al. (2002) 
discussed how this association has begun to answer a number of questions 
relating to mechanisms of gene silencing in trypanosomes. Procedures 
based on silencing of gene expression could be a valuable tool for 
functional genomics studies in trypanosomes, providing valuable 
information about gene function even in cases where only a partial loss-of-
function is generated. This might allow the identification of candidate 
targets for drug development and vaccine design. On the other hand, the 
assessment of differential gene expression based on DNA methylation has 
so far not been explored in T. brucei. Trypanosome genome data so far 
indicate that the genome is composed of relatively small number of genes 
and a large fraction of repetitive DNA. From detailed knowledge of 
methylation processes in other taxa (reviewed by Martienssen and 
Richards, 1995; Martienssen, 1998), it is tempting to speculate that most of 
these repetitive sequences are more heavily methylated relative to 
functional genes. It is therefore, foreseeable that T. brucei genes unique to 
a subspecies or trait can be enriched-for by the exclusion of repeat 
sequences in genomic shotgun libraries.  
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1.5.2. Microarrays (transcriptome profiling) 
The strength of microarray technologies lies in their ability to follow 
genome-wide gene expression patterns to identify several hundreds of 
genes that may be involved in specific phenotypic traits in an organism 
(Schena et al., 1995). One important factor in determining the value of 
microarray is the selection of DNA hybridisation targets. In a pilot study, 
inserts from a T. brucei genomic library were arrayed randomly to generate 
‘shotgun’ microarrays (El-Sayed and Donelson, 1997).  To measure 
variation in expression of genes in the bloodstream and procylic (insect 
vector) stages of the parasite, the arrays were probed with differentially 
labelled cDNAs prepared from total RNA isolated from parasites at defined 
developmental stages. While many clones displayed constitutive levels of 
expression in both stages of the parasite, a substantial number of test 
clones showed differential gene expression.  
 
A major limitation of transcriptome analysis in trypanosomes is, in addition 
to those associated with this approach in general, the level of gene 
regulation at the mRNA level. If what is known about resistance genes in 
other taxa is anything to go by, then transcriptome profiling used to isolate 
more highly expressed genes on the basis of their gene product or patterns 
of expression would not be useful for isolating trypanosome resistance 
genes, e.g. human serum or drug resistance genes. Almost all the 
resistance genes isolated so far from eukaryotes are expressed at low 
levels and are not greatly induced upon infection. Furthermore, in 
trypanosomes, extensive co- and post-transcriptional modification events 
occur, e.g. due to alternative splicing, which result in a diversity of protein 
products from a single open reading frame. In addition, telomeric 
sequences tend to be under-represented in standard genomic libraries, a 
situation that would, for example, limit the value of DNA microarrays for the 
study of antigenic variation in these parasites. Therefore, a concerted effort 
to clone telomeric sequences via other means has been proposed 
(Rudenko, 2000).   
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Following the identification of several potentially useful targets for rationale 
drug or vaccine design, their downstream development into ‘leads’ could be 
greatly facilitated if efficient technologies for mode-of-action studies were 
available. For example, exploring drug-induced alterations in gene 
expression by microarray may provide insight into the induction of genes 
known to encode pathways affected by a potential drug target. The results 
should, in principle, provide possible correlation between changes in gene 
expression and the mode of action of the drug. However, the uses of 
microarray analysis need not be limited to gene expression. For example, 
oligonucleotide arrays can be used for the rapid screening of SNPs and 
thus for exploring subspecies variation. 
 
1.6. Vaccine targets 
 
The development of a broad-spectrum vaccine against trypanosomes 
meets formidable obstacles primarily because of the biology of this parasite 
and immune responses exhibited by the hosts in the course of infection. 
Immune responses to the VSG (the most abundant surface antigen of the 
parasite) are not protective because of the vast repertoire of 
immunologically distinct variants. Furthermore, outcome of the disease in 
an individual host is dependent on its genetic background and that of 
parasite strains responsible for the infection. Although the possibility of anti-
disease vaccine for trypanosomosis has been suggested (Authie, 1994), it 
can be inferred that developing a protective broad-ranging anti-
trypanosome vaccine using conventional vaccine systems currently seems 
unfeasible. The unique aspects of the biochemistry of trypanosomes make 
rationale vaccine design an attractive approach, but targets must be 
selected carefully.  
 
Trypanosome genomics has had a major impact on identification of 
potentially useful targets, including some enzymes, transporters and 
metabolites that may be unique to the parasites (reviewed by Keiser et al., 
2001; Barrett et al., 1999), and their potential for disease prevention or 
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therapeutics is being pursued. For example, reverse genetics tool based on 
RNAi has been used to study the possible therapeutic value of the 
conserved glycolipid (glycosylphosphatidylinositol, GPI) anchor, which 
attaches the VSGs to the cell membrane (Bohme and Cross, 2001). It turns 
out that the high conservation of the VSG GPI signal sequence is not 
necessary for efficient expression and GPI attachment, suggesting that the 
GPI anchor alone might not be a high-value vaccine target. Similarly, many 
surface molecules, including some that might be expected to be major 
structural components of the coat, can be mutated or completely eliminated 
without altering the morphology or growth rate of trypanosomes in culture, 
reviewed by Landfear and Ignatushchenko, 2001). Although this may 
suggest that the GPI molecules might not be the first choice for vaccine 
development, they may offer unique genetic options for identifying genes 
involved in the GPI pathway. Other key invariant surface glycoproteins, 
transporters and receptor complexes have been identified (Seyfang and 
Duszenko, 1993; Borst et al., 1998; Pays and Nolan, 1998), but only a few 
have been tested. For example, the VSG molecules themselves contain 
structurally conserved C-termini (Carrington et al., 1991; Carrington and 
Boothroyd, 1996), but these are so few and are generally so small as to be 
immunologically insignificant. Also, the flagellar pocket, a membrane 
invagination around the base of the flagellum harbours a number of 
invariant receptor molecules that could be targets for vaccine design (da 
Cunha et al., 1989; Engman et al., 1989; Paindovoine et al., 1992; Nozaki 
et al., 1996). Although some of these molecules are distributed over the 
entire surface of the cell, they are inaccessible to the host immune 
response. On the other hand, analogues to myristate, the only fatty acid 
component of the glycolipid anchor, appeared to have trypanocidal activity 
in vitro (Doering et al., 1994), but bioavailability of active compounds in the 
cell will need to be enhanced for sustained activity in vivo.  
 
A pragmatic model would be to ‘traffic’ toxic vaccine molecules into these 
invariant target ligands. For example, RNA aptamers have been exclusively 
expressed in the flagellar pocket (Homann and Goringer, 2001), thus 
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making the approach attractive for rationale vaccine design. Another 
possibility could be an agent interacting with the 35 nucleotide sequences 
at the extreme 5’ termini of all mRNAs in trypanosomes but not in 
mammalian host mRNA. From these studies, knowledge has also been 
gained on how inhibitory a compound needs to be in order to be an 
effective trypanocide. The ability to generate such genetically manipulated 
parasites can also provide insight into whether specific proteins are targets 
of existing drugs, or effective ligands for a possible vaccine.  
 
1.7. Conclusion 
 
There is an enormity of problems to consider and large hurdles to cross in 
the development tools for a trypanosome vaccine or new therapeutics. 
These include the enormity of different possible antigenic specificity's to 
cover the requirement for durable specific immune response and the 
immense cost and long-term requirement for development of most 
vaccines. It is our opinion that the next phase of genomic technologies will 
accelerate the pace at which lead targets can be identified and validated.  
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2.1. Abstract 
 
We have evaluated whether sequence polymorphisms in the rRNA 
intergenic spacer region can be used to study the relatedness of two 
subspecies within the Trypanosoma brucei. Thirteen T. brucei isolates 
made up of 6 T. b. brucei and 7 T. b. gambiense, were analysed using a 
restriction fragment length polymorphism (RFLP). By PCR-based restriction 
mapping of the ITS1-5.8S-ITS2 ribosomal repeat unit, we found a 
fingerprint pattern that separately identifies each of the two sub-species 
analysed, with unique restriction fragments observed in all but one of the T. 
b. gambiense  ‘human’ isolates. Interestingly, the restriction profile for a 
virulent, group 2 T. b. gambiense ‘human’ isolate, revealed an unusual 
RFLP pattern different from the profile of other ‘human’ isolates. 
Sequencing data from 4 representatives of each of the two subspecies 
indicated that the intergenic spacer region had a conserved ITS-1, and a 
variable 5.8S with unique transversions, insertions or deletions. The ITS-2 
regions contained a single repeated element at similar positions in all 
isolates examined, but not in two of the ‘human’ isolates. A unique 4 bp 
{C3A} sequence was found within the 5.8S region of ‘human’ T. b 
gambiense isolates. Phylogenetic analysis of the data suggests that their 
common ancestor was an animal pathogen, and that ‘human’ pathogenicity 
might have evolved secondarily. Our data show that cryptic species within 
T. brucei group can be distinguished by differences in the PCR-RFLP 
profile of the rDNA repeat.  
 
2.2. Index Descriptors and Abbreviations 
  
Trypanosoma brucei subgenus; differentiation sequence; RFLP, restriction 
fragment length polymorphism; rRNA, ribosomal RNA; tRNA, transfer RNA; 
5.8S ribosomal repeat; ITS1, first internal transcribed spacer; ITS2, second 
internal transcribed spacer; PCR, polymerase chain reaction; EDTA, 
ethylene di-amine tetra-acetic acid. 
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2.3. Introduction 
 
Trypanosoma brucei is a unicellular, obligate parasite that is transmitted by 
tsetse flies. The disease trypanosomosis (Kassai et al., 1988) is generally 
an acute to chronic and debilitating one, designated  'nagana' in cattle and 
'sleeping sickness' in humans. Infectivity for humans distinguishes T. b. 
gambiense and T. b. rhodesiense from T. b. brucei, which does not infect 
humans. It is generally thought that differences between T. b. gambiense 
and T. b. rhodesiense stem from adaptation of T. brucei to two different 
ecosystems in West Africa, where the main host is man, and East Africa, 
where man is only an incidental host (Gibson, 1986). Trypanosoma b. 
gambiense and T. b. rhodesiense have animal reservoirs, which constitute 
sources of infection for the tsetse fly vector (Uilenberg, 1998; Njagu et al., 
1999).  
 
Genetic exchange in T. brucei has been demonstrated in the laboratory 
(Jenni et al., 1986; Gibson, 1989), and crosses between human-infective 
and non-human infective sub-species have shown that the trait for human 
infectivity is heritable (Gibson, 1989; Gibson and Mizen, 1997). The ability 
to distinguish human infective from non-human infective isolates of T. 
brucei has important implications for studies of the transmission dynamics 
and anthropo-zoonotic potential of this parasite. Current parasitological 
classification of T. brucei into sub-species is problematic due to lack of 
stable characteristics that distinguish human infective from non-human 
infective trypanosomes. Both subspecies show uniformity in microscopic 
appearance, although there are variations in clinical outcome of the 
diseases they cause. Resistance to lysis by factors in human serum is one 
of the main distinguishing phenotypes, which indicate that the differences in 
disease syndrome result from complex interactions between the host and 
the parasite.  
 
Over the past two decades, most investigators have focused on either the 
detection of trypanosome infections or definition of species rather than 
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subspecies. These studies have been based upon the comparison of 
isoenzymes  (Gibson et al., 1980; Betshcart et al., 1983; Tait et al., 1984; 
Richner et al., 1989), molecular analysis of the genomic or mitochondrial 
DNA by RFLP and PCR-RAPD or on the use of microsatellite and 
minisatellite DNA probes (Kukla et al., 1987; Waitumbi and Murphy, 1993; 
Majiwa et al., 1994; Masake et al., 1997; Donelson and Artama, 1998; 
Morlais et al., 1998; Biteau et al., 2000). Several studies have been 
conducted to identify molecular differences between isolates of T. brucei 
subspecies that are human infective and those that are non-human 
infective, using Southern blot hybridisation analysis with repetitive 
sequences (Gibson et al., 1985a; Paindovoine et al., 1986; Hide et al., 
1990, 1998), chromosome analysis (Brun and Jenni, 1987), isoenzyme 
analysis (Paindovoine, 1989; Mathieu-Daude and Tibayrenc, 1994) or 
frequency comparisons (Gibson et al., 1985b). Most of the previous studies 
have focused on intra-specific characterisation of T. b. brucei and T. b. 
rhodesiense stocks, with few reports on T. b. gambiense characterisation. 
Hide et al. (1990) reported genotypic differences between the West African 
T. b. gambiense and the East African T. b. rhodesiense isolates. The data 
suggested that the geographic location alone is insufficient to account for 
the differences observed.  
 
For developing practical diagnostic and epidemiological markers for 
characterising T. brucei into subspecies in the West Coast of Africa where 
T. b. gambiense is prevalent, it is desirable to have a direct rapid method. A 
PCR-based method, which could be applied directly to the typing of clinical 
or field samples to identify a particular ‘human’ or animal isolate affords 
such a simple and rapid technique. The intergenic spacer separating the 
18S and 28S rRNA genes is involved in the processing of pre-RNA (Young 
and Steitz, 1978) and may contain coding sequences for tRNA (Morgan et 
al., 1977; Young et al., 1979; Bacot and Reeves, 1991). The region is 
otherwise considered to be largely non-functional and under minimal 
selective pressure. Therefore, it is likely to contain sequence variations 
from which taxonomically useful information might be obtained. We have 
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evaluated whether PCR-based restriction fragment length polymorphism 
(PCR-RFLP) and sequence analyses of the internal transcribed spacers 
(ITS-1, ITS-2) and the intervening 5.8S region, could be used to identify 
and discriminate among T. b. gambiense and T. b. brucei isolates. Here we 
report on putative subspecies-specific markers that could be useful in the 
identification and characterisation of these subspecies of T. brucei. 
 
 
2.4. Materials and Methods 
 
2.4.1. Trypanosome isolates 
Sources of the parasite isolates used in the study are listed in Table 1. 
Isolates were derived directly from their host of origin and had been 
identified previously as belonging to either of the two subspecies (Rickman 
and Robson, 1970). The T. b. gambiense isolates were those known to 
belong to either group 1 or 2 (Gibson, 1986). Three of the T. b. brucei 
isolates (STIB 215, B8/18 clone B, KP2 clone 7) have repeatedly been 
shown to be sensitive to lysis by human serum. After preliminary expansion 
and cloning of all isolates in laboratory rodents, genomic DNA was isolated 
from the trypanosomes essentially as described by Van der Ploeg et al. 
(1982). 
 
2.4.2. PCR primer design and DNA amplification 
T. brucei 18S, 5.8S and 28S rDNA sequence data (AJ009141, AJ009142, 
D89527, M12676, U22315, U22316, U22317, U22318, U22319, U22320 
and U75507) were retrieved from GenBank, and aligned using MegaAlign 
(DNASTAR Inc., 1993). Based on consensus sequences in the 5' and 3' 
ends of the 18S and 28S primers, designated ED1-F (CAC CGC CCG TCG 
TTG TTT C) and ED1-R (TTC GCT CGC CGC TGA CTG A), were 
designed. A search for homology to known DNA sequences of other 
organisms was made using the BLAST program (Altschul et al., 1990). The 
ITS1, ITS2 and intervening 5.8S and flanking sequences at the 5' and 3' 
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ends of the 18S and 28S sequences, respectively, were amplified using the 
18S-F and 28S-R primer pair.  
 
The PCR contained 100ng each of ED1-F and ED1-R, 2.5mM dNTP's, 
1xPCR buffer, 2mM MgCl2, 1.25U AmpliTaq Gold (Perkin Elmer, Applied 
Biosystems, Nieuwerkerk a/d IJssel, The Netherlands) and 10ng genomic 
DNA in 50 µl. The reaction profile consisted of 10 min at 95°C to activate 
Taq polymerase, followed by 35 cycles of 95°C for 1 min, 56 °C for 30 s, 
72°C for 2 min, and a 10 min final extension at 72°C. Five µl of PCR 
product was electrophoresed in a 1.5% agarose gel (Ophaero Pronarose 
D-1, Burgos, Spain) with 1xTris-borate-EDTA (TBE) buffer containing 1µg 
of Ethidium bromide.  
 
2.4.3. Sequencing of purified PCR products  
The PCR products were separately purified using Boehringer High Pure 
PCR products purification kit (Roche Molecular Biochemicals, Mannheim, 
Germany). These were sequenced with both PCR primers, using an ABI 
Prism dye terminator cycle sequencing kit (Applied Biosystems, Foster 
City, Calif., USA). To facilitate the sequencing protocol, we utilised the 
internal primers, ITS1-F-INT (ATG GAA TGC GTA TCT CTC TAT) and 
28S-R-INT (GGC GCC AAA ATA CAT GCG T). The relative positions of 
the primers in the T. brucei rRNA gene are indicated in Fig. 1. Sequences 
obtained from 4 representative isolates for each of the two subspecies 
(Table 1), were edited using Lasergene (DNASTAR Inc., 1993) and then 
aligned using Clustal V (Higgins et al., 1991). The alignment was improved 
using SeqMan™II (DNASTAR Inc., 1993). Phylogenetic analysis was 
performed using MegAlign™(DNASTAR Inc., 1993). 
 
2.4.4. PCR-RFLP 
A 10µl sample of one set of PCR products was digested with the restriction 
enzymes DdeI, HhaI, AluI and MseI for 3h at 37°C. The digests were 
analysed by electrophoresis in 3% MetaPhor gel with 1xTBE buffer 
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containing 1 µg Ethidium bromide. The 100 bp ladder (MBI Fermentas, 
Vilnius, Lithuania) was used as DNA size marker. 
 
 
 
Table 1. Trypanosome isolates used in these studies 
 
Isolate Origin Year Original host 
Trypanosoma brucei  brucei 
1. WaTat Uganda 1982 Deer 
2. H3 * Luangwa valley, Zambia 1974 Lion 
3. STIB215 * Serengeti, Tanzania 1971 Lion 
4. B8/18 * Nsukka, Nigeria 1962 Pig 
5. KP2, clone 7 * Côte d’Ivoire 1982 Fly (G. palpalis) 
6. 1902 (sindo) Kenya 1971 Waterbuck 
T.  brucei  gambiense    
7. A006 Fontem, Cameroon 1988 Human 
8. Boula Bouenze, Congo 1989 Human 
9. 1898 D.R. Congo 1974 Human 
10. Dal972 * Daloa, Côte d’Ivoire 1978 Human 
11. Suzena * Yambio, Sudan 1982 Human 
12. NW2 * Uganda 1992 Human 
T.  brucei  gambiense, virulent group 2 
13. TH2 (78E) * Koudougou,  
Côte d’Ivoire 
1978 Human 
   
* Isolates sequenced 
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2.5. Results  
 
2.5.1. RFLP of T. brucei rDNA ITS1-5.8S-ITS2 region 
The ribosomal ITS1-5.8S-ITS2 region, 1282 - 1295 bp, was amplified using 
ED1-F and ED1-R. Agarose gel electrophoresis of the PCR products 
showed that a single amplimer, with insignificant length variation, was 
obtained for each isolate. The PCR products obtained using genomic DNA 
from T. brucei isolates, the 6 of animal origin and 7 of human origin, were 
subjected to endonuclease digestion in order to search for polymorphic 
restriction enzyme sites that could allow the discrimination of the isolates. 
The DdeI, HhaI, AluI and MseI restriction fragments migrated as 8 - 10 
electrophoretic bands. Approximately 380 bp DdeI and 350 bp HhaI 
fragments (Fig. 2A), 350 bp AluI and 230 bp MseI fragments (Fig. 2B) were 
present in all the ‘human’ isolates tested, except in the Group 2 virulent T. 
b. gambiense, and were absent in all animal isolates.  
 
2.5.2. Analysis of the ITS1, 5.8S and ITS2 region 
DNA sequencing of the internal transcribed spacer (ITS1 and ITS2) and the 
5.8S rRNA gene was performed directly on the PCR products. The 
sequences were assembled to form the complete sequence of the region 
and the respective sequences ranged from 1282 - 1295 bp. The results 
confirmed preliminary analysis of PCR amplimer patterns obtained by 
agarose gel electrophoresis, that all ‘human’ and animal isolates studied 
possessed similar domain lengths. Much of the sequences of the T. b. 
brucei and T. b. gambiense were alignable, except for a unique {C3A} 
insertion, in the 5.8S region of the T. b. gambiense isolates, at sequence 
position 562 - 565 (Fig. 3), and several insertions, deletions and 
transversions at different positions of the 5.8S and ITS2 (see full sequence 
data). The end points of the 5.8S rRNA gene were determined by 
comparative alignment. The sequence is approximately 170 bp in length 
and identical in all 6 T. b. brucei and 7 T. b. gambiense isolates, except for 
a 4 bp deletion/insertion sequence at the central portion of the region. The 
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ITS2 of the T. b. brucei and T. b. gambiense isolates revealed considerable 
sequence variability in an area between the 3’ end of the 5.8S rRNA gene 
and the central region.  
 
 
 
    ED1-F                 5.8S-R1       5.8S-F1             28S-R.INT   
   
ITS-1 
 
ITS-2
  5.8S   28S 18S 
 ED1-R 
 
 
 
  5.8S-F2   5.8S-R2
 
344 bp   624 bp 
170 bp 
IVII 
V
III
I
   1295 bp
 
 
 
 
 
 
Fig. 1. Representative scheme of amplification of the ITS1, 5.8S and ITS2 
repeat region (of isolate TH2). Arrows indicate the relative location and 
direction of the primers used for the amplification and sequencing of the 
respective ITS regions. The bars represent the amplification products. The 
sequenced region, subdivided into 5 regions, is indicated as I - V. 
  
 
 
 
Five different regions with respect to rRNA gene identity can be 
distinguished (Fig. 1). Region I contains 126 bp of the 3' end of the 18S 
rDNA (46.2% G + C) which was strictly conserved between the subspecies. 
Region II corresponds to 344 bp of ITS1 (37% G + C) while Region III (170 
bp in length, 60.7% G + C) corresponds to the 5.8S rRNA coding 
sequence. A unique 4 bp {C3A} sequence was found within the 5.8S region 
of human-infective T. b gambiense isolates at sequence positions 562-566. 
ITS2 covers region IV (605 bp, 41% G + C) and consists of one central 
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repeat element in the four animal and one of the ‘human’ isolates (ranging 
from 89 - 99 bp). The ‘human’ isolate, Suzena, was found to contain two 
repeat elements in the region (61 and 89 bp), while no repeats were found 
in Dal 972 and TH2. Region V covers a 72 bp sequence at the 5' end of 
28S rRNA gene. Phylogenetic analysis classified the isolates into either of 
two subspecies, with branches leading to the T. b. brucei subspecies 
relatively longer than those leading to the T. b. gambiense subspecies (Fig. 
5A).  
 
 
 A B
 Hha IDde I Mse I Alu I 
 
1 3   5 7 9 11 13 1  3   5    7  9  11  13 
M Animal Human Animal Human
500 bp
200 bp
180 bp
350 bp
1  3    9  11 13 1   3   5   7 9 11 13
HumanAnimal Human 
5 7 
Animal M 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. PCR-RFLP analysis of 6 animal and 7 human isolates reveals a 
clearly differentiating pattern between the two groups. (A) PCR products 
amplified with primers ED1-F and ED1-R, and digested with DdeI and HhaI. 
(B) PCR products digested with AluI and MseI. ‘M’ is 100 bp ladder (New 
England Biolabs). Details on DNA samples (1 - 13) are as listed in Table 1. 
Arrows indicate polymorphic bands. 
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     .b.
 
 
 
 
 
 
 
Isolate B - 651 584 
T  g - NW2 TCATTTCATTG ATCTTTGAACGCAAACGGC 
T.b. g -  Dal972 TCATTTCATTG ATCTTTGAACGCAAACGGC 
T.b. b -  B8/18 TCATTTCATTG ATCTTTGAACGCAAACGGC 
T.b. g -  TH2 TCATTTCATTG ATCTTTGAACGCAAACGGC 
T.b. g -  Suzena TCATTTCATTG ATCTTTGAACGCAAACGGC 
T.b. b -  KP2 TCATTTCATTG ATCTTTGAACGCAAACGGC 
T.b. b -    STIB215 TCATTTCATTG ATCTTTGAACGCAAACGGC 
CCCA
CCCA
 - - - - 
CCCA
CCCA
 - - - - 
 - - - - 
 
Fig. 3. Alignment region showing unique {C3A} sequence in the 5.8S region 
of animal isolates. T. b. b - Trypanosoma brucei brucei; T. b. g - T. b. 
gambiense. The numbers in bold on top of the aligned sequences indicate 
the relative position of the regions. 
 
 
2.6. Discussion 
 
A relatively simple and rapid typing method based on PCR-RFLP patterns 
has been used to assess the relatedness, and to differentiate, between T. 
b. brucei and T. b. gambiense. The data presented demonstrate that the 
ITS spacers and the intervening 5.8S of T. brucei contain sufficient 
nucleotide sequence polymorphisms and intraspecific conservation which 
could be used for discriminating between T. b. brucei and T. b. gambiense. 
This is especially useful in view of the close phenotypic similarity of these 
two subspecies.  
 
RFLP genotyping with some restriction enzymes segregated the 13 stocks 
into three groups: in group 1, the RFLP patterns of 5 out of the 6 T. b. 
brucei stocks isolated from different animal species in different regions of 
Africa were highly similar. The patterns of three T. b. brucei isolates 
(WaTat, H3 and STIB215) showed much closer similarity to each other than  
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to other isolates. In addition, the RFLP pattern of isolate 1902 isolated from 
a Waterbuck (in Kenya) was different from those of other animal isolates. 
This observation suggests that the isolate might be a unique strain within 
the East African sub-region. In the second group, the RFLP profiles of 6 out 
of the 7 T. b. gambiense isolated from humans from different countries and 
geographic regions of East, West and Central Africa gave a within-group 
homogeneity (Fig. 2). Thus the intraspecific variations observed when 
compared to the overall levels of variation indicate that the 'animal' and 
'human' genotype might be conserved across different geographical 
regions.  
 
The third group consisted of the TH2 isolate, a Group 2 (virulent) T. b. 
gambiense strain whose RFLP profiles were different from those of the 
other two groups, but more closely-related to those of T. b. brucei (Fig. 2). 
The TH2 isolate shared most of the bands common to the ‘human’ and 
animal isolates and had only one unique AluI fragment of about 440 bp 
(Fig. 2). Although the frequency of genetic exchange between T. b. brucei 
and T. b. gambiense may be variable or low, our data suggests that the 
virulent Group T. b. gambiense TH2 isolate might be a unique human-
infective strain resulting from natural genetic exchange within the T. brucei 
subspecies. This agrees with the suggestion of Gibson and Stevens (1999) 
that this isolate might be a hybrid. In strict taxonomic terms therefore, a re-
classification of the isolate as a separate subspecies is needed. The 
polymorphisms detected in the T. brucei isolates may be valuable markers 
for epidemiological studies. The RFLP data showed that the isolates having 
different outbreak history and isolated over decades apart (Table 1) have 
identical genomic fingerprints. This observation gives support to their 
epidemiological relatedness and suggests low plasticity of the analysed 
non-transcribed spacer region of rRNA gene. In line with generally held 
view, this may suggest the clonal expansion of one parental strain that had 
adapted to different climatic or bio-environments. Apparently, RFLP and 
genetic information derived from ITS1, 5.8S and ITS2 region can be used 
to differentiate these closely-related organisms.  
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The nucleotide sequence of the ITS1-5.8S-ITS2 allowed the assignment of 
an isolate with certainty to one of the two subspecies. Ribosomal gene 
clusters are located on different chromosomes; therefore, each unique 
sequence represents an allele of the genomic region. Overall, there was a 
high degree of sequence conservation among the isolates, but interesting 
variations occur both within and between the subspecies, depending on 
whether the isolate was human infective or non-human infective (Fig. 3). 
The general organisation of the entire region was not strictly typical in 
comparison with what has been observed in most of the other eukaryotic 
organisms. Repeated sequence elements were absent in two of the 8 
sequenced PCR products. Generally, there is a high degree of sequence 
conservation between the repeats, but variation occurs both within and 
between subspecies (Fig. 4).  
 
930 940 950 960 970 980 990
TGTATATACAGAGAGTCTGTGGCGGTTGGGACATGTGTATAAATATATATGTATATGTGTGTGTTC
TGTATATACAGAGAGTCTGTGGCGGTTGGGACATGTGTATAAATATATATGTATATGT GTGTGTT CNW2 (915-1011)     H
TGTATATACAGAGAGTCTGTGGCGGTTGGGACATGTGTATAAATATATATGTATATGTGTGTGTT CDal972 (914-1010)  H
TGTAT AGAGAGTCTGTGGCGGTTGG ATGTGTATAAATATATATGTATATGTGTGTGTT CB8/18 (912-1009)   A
TGTAT CAGAGAGTCTGTGGCGGTTGGGACATGTGTATAAATATATATGTATATGTGTGTGTT CTH2 (917-1013)     H
TGTATATACAGAGAGTCTGTGGCGGTTGGGACATGTGTATAAATATATATGTATATGTGTGTGTT CSuzena (914-1010)  H
TGTATATACAGAGAGTCTG CGGTTGGGACATGTGTATAAATATATATGTATATGTGTGTGTT CKP2 (913-1009)     A
TGTATATACAGAGAGTCTGTGGCGGTTGGGACATGTGTATAAATATATATGTATATGTGTGTGTTCSTIB215 (910-1006) A
TGTATATACAGAGAGTCTGTGGCGGTTGGGACATGTGTATAAATATATATGTATATGTGTGTGTTCH3 (906-1002)      A
1000 1010 1020 1030
CGCTGTGGAGATTTTATA- TCTTACGGAGA- GTGT
CGCTGTGGAGATTTTATA- TCTTACGGAGA- GTGTNW2 (915-1011)  
CGCTGTGGAGATTTTATA- TCTTACGGAGA- GTGTDal972 (914-1010)
CGCTGTGGAGATTTTATA- TCTTACGGAGA GTB8/18 (912-1009)
CGCTGTGGAGATTT AT CTTACGGAGA- GTGTTH2 (917-1013)
CGCTGTGGAGATTTTATA- TCTTACGGAGA- GTGTSuzena (914-1010)
CGCTGTGGAGATTTTATA- TCTTACGGAGA- GTGTKP2 (913-1009)
C TGTGGAGATTTTATA- TCTTACGGAGA- GTGTSTIB215 (910-1006)
CGCTGTGGAGATTTTATA- TCTTACGGAGA- GTGTH3 (906-1002)
97
97
98
97
97
97
97
97
ACAC CAC
ACA
TAG
CGT
- AT
C
T
C
 
Fig. 4. Comparison of the sequences of the repeat element in the ITS2 of 4 
animal and 4 human isolates: T. b. brucei - H3, STIB215, B8/18 and KP2; 
T. b. gambiense - Dal972, Suzena, NW2 and TH2. Animal-infective isolates 
are depicted as 'A' and human-infective isolates as 'H'. Base mismatches 
are shown in bold. The numbers to the right of the figure indicate length of 
each repeat. Consensus sequence is shown on the top. 
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The identical nature of the repeat elements among the isolates suggests 
that this repeating unit may represent an original sequence, which might 
also have an important function. However, the function, if any, of this repeat 
remains to be determined. Repeat units have been identified in non-
transcribed spacer regions of nematodes (Kane and Rollinson, 1994), 
Drosophila melanogaster (Kohorn and Rae, 1982) and also in Xenopus 
(Moss, 1983), where they have been shown to influence the levels of 
transcription (Bushy and Reeder, 1983; Grimaldi and Nocera, 1988). To the 
best of our knowledge, there has not been any report of such repeat 
elements in trypanosomes. Region V contains 72 bp of 28S rRNA 
sequence. The length of region I - V for the isolates correlates well with the 
approximately 1300 bp length of the PCR fragments amplified with primers 
ED1-F and ED1-R flanking this region. However, intraspecific variation of 
the rRNA gene complex is believed to be far less than interspecific variation 
due in part to concerted evolution (Hillis and Dixon, 1991). We found that 
differences in the sequences of the non-transcribed spacer region between 
the two subspecies far exceeded variation within a subspecies. The results, 
although preliminary due to the relatively small number of isolates 
examined, indicate that the T. b. brucei and T. b. gambiense subspecies 
can be distinguished by differences in the size and number of DNA 
fragments after digestion of their ITS/5.8S region with specific restriction 
endonucleases. The presence of virtually identical long spacers among the 
isolates suggests that the approach of utilising differences in spacer lengths 
might be of little value in further discrimination of these subspecies. 
Determining the differences between the two closely-related subspecies 
within T. brucei might help determine how pathogenicity evolved.  
 
Cluster analysis and dendograms of the ribosomal repeat unit (Fig. 5A) 
shows a more homogeneous T. b. gambiense clade, which descended 
from an older and more heterogeneous T. b. brucei line. Branches leading 
to the T. b. brucei isolates were relatively much longer, suggesting a faster 
rate of sequence evolution in the T. b. brucei subspecies. Furthermore, it 
suggests that the common ancestor was an animal pathogen, and that 
human pathogenicity might have evolved secondarily.  
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The phylogram, which depicts the differences in the ITS1, 5.8S and ITS2 
regions between these isolates, shows the heterogeneity between the 
subspecies. 
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Fig. 5. Phylogenetic analysis of the ITS1-5.8S-ITS2 rDNA sequences 
showing the relationship between 4 T. b. brucei (H3, STIB215, B8/18 and 
KP2) and 4 T. b. gambiense (Dal972, Suzena, NW2 and TH2) isolates (Fig. 
5A). In Fig. 5B, the phylogram is re-presented to include two outgroup 
species - T. congolense (Savannah-type IL1180) and T. vivax, which gives 
an inter-species yardstick with which to measure intra-species divergence. 
Sequences of the outgroup species were retrieved from the GenBank, with 
accession numbers U22315 and U22316, respectively. 
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To measure intra-species divergence, two outgroup species, Trypanosoma 
congolense and Trypanosoma vivax, were compared by nearest-neighbour 
joining method. The result showed that a neighbour-joining tree of the same 
region was clustered less tightly in these outgroups species, than with T. b. 
brucei and T. b. gambiense (Fig. 5B). Further phylogenetic analysis should 
concentrate on non-rDNA as they are likely to yield more phylogenetically 
meaningful data. It would be interesting to evaluate how these results will 
correlate in T. b. rhodesiense typing. However, it should be noted that T. b. 
gambiense is a more ancient human pathogen, supported in part by the 
observation that (like T. b. brucei in animals) it causes a chronic disease in 
man. Genetic background of the infected individual plays a major role as 
well in the outcome of infection. We conclude that this direct PCR-based 
typing approach may offer a simple and rapid typing technique for routine 
T. brucei diagnostic and epidemiological studies. 
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3.1. Summary 
 
Genetic analysis of Trypanosoma spp depends on the detection of variation 
between strains. We have used the amplified fragment length 
polymorphism (AFLP) technique to develop a convenient and reliable 
method for genetic characterisation of Trypanosome (sub)species. AFLP 
accesses multiple independent sites within the genome and would allow a 
better definition of the relatedness of different Trypanosome (sub)species. 
Nine isolates (three from each T. brucei subspecies) were tested with 40 
AFLP primer combinations to identify the most appropriate pairs of 
restriction endonucleases and selective primers. Primers based on the 
recognition sequences of EcoRI and BglII were chosen and used to 
analyse thirty-one T. brucei isolates. Similarity levels calculated with the 
Pearson correlation coefficient ranged from 15 to 98%, and clusters were 
determined using the unweighted pair-group method using arithmetic 
averages (UPGMA). At the intraspecific level, AFLP fingerprints were 
grouped by numerical analysis in two main clusters, allowing a clear 
separation of T. b. gambiense (cluster I) from T. b. brucei and T. b. 
rhodesiense isolates (cluster II). Interspecies evaluation of this customised 
approach produced heterogeneous AFLP patterns, with unique genetic 
markers, except for T. evansi and T. equiperdum, which showed identical 
patterns and clustered together.  
 
 
3.2. Introduction 
 
Trypanosoma brucei is a unicellular, protozoan parasite that is transmitted 
by tsetse flies. It consists of three subspecies - T. b. brucei, T. b. 
gambiense and T. b. rhodesiense that are indistinguishable by conventional 
morphological, biochemical and antigenic criteria but differ by their 
geographical distribution and host specificity (Gibson et al., 1980; Gibson, 
1985). The disease, trypanosomosis (Kassai, 1988), is generally an acute 
to chronic, debilitating disease. T. b. brucei, the cause of 'nagana' in cattle 
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does not cause disease in humans because this subspecies is lysed by 
normal human serum. T. b. gambiense and T. b. rhodesiense are resistant 
to normal human serum, although T. b. rhodesiense can revert to a human 
serum sensitive phenotype (Hawking, 1973; Hawking, 1977). There is a 
resurgence of sleeping sickness and increasing incidence of drug 
resistance (Murray et al., 2000), thus the need for high-resolution analytical 
tools that will facilitate the typing of T. brucei isolates on routine basis 
increases. Moreover, the ability to differentiate between human-infective 
and human non-infective isolates has important implications for studies of 
the transmission dynamics and anthropo-zoonotic potential of this parasite.  
 
As an initial step towards an appropriate strategy for management the 
disease, the genetic diversity of the parasite's populations must be 
assessed. Genetic markers have been used to study the diversity of 
trypanosome populations. These have included isoenzyme studies (Gibson 
et al., 1980, Tait et al., 1984; 1985, Richner et al., 1989; Godfrey et al., 
1990; Stevens and Godfrey, 1992), randomly amplified polymorphic DNA 
data (Mathieu-Daude et al., 1995; Kukla et al., 1987; Waitumbi and 
Murphy, 1993), microsatellite and minisatellite DNA analysis (Donelson and 
Artama, 1998; Morlais et al., 1998; MacLeod et al., 2000; Biteau et al., 
2000) and restriction fragment length polymorphism, RFLP (Hide et al., 
1994; Agbo et al., 2001). However, the identification of the characteristics 
specific to a subspecies is not yet supported by the discriminatory power of 
conventional diagnostic methods. Furthermore, many of the genetic typing 
assays have drawbacks in that they may require a relatively large amount 
of high-quality DNA or, as with RAPD technique, may be difficult to 
reproduce between laboratories (Jones et al., 1997; Perez et al., 1998). 
Many markers, especially isoenzymes, can evolve too fast for use as 
epidemiological markers, so that results can be misinterpreted (Hide, 
1999). Furthermore, in the majority of these methods, only a very limited 
part of the genome is covered through highly specific molecular targeting of 
one or more repetitive DNA elements. To avoid possible bias arising from 
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the use of such methods, the population structure should be inferred from 
neutral markers that distribute randomly throughout the genome.  
 
We have used the amplified fragment length polymorphism (AFLP) 
technique, a PCR-based fingerprinting method, to investigate the genetic 
diversity of T. brucei isolates, and tested the technique for trypanosome 
genotyping in general. The technique has already been frequently used for 
linkage analysis in plant genetics, and has also been applied for high 
resolution fingerprinting of plant, bacterial and fungal genomes (Vos et al., 
1995; Folkerstma et al., 1996; Lin et al., 1996). Moreover, it has been 
applied to the analysis of population diversity in potato cysts and root-knot 
nematodes (Folkerstma et al., 1996; Semblat et al., 2000). There are two 
main advantages (Dijkshoorn et al., 1996, Janssen et al., 1996, Lin et al., 
1996) of this technique in characterising microbial populations: there is an 
extensive coverage of the genome under study (Janssen et al., 1996) and 
the complexity of the AFLP fingerprint can be advantageously managed by 
adding selective primers during PCR amplifications (Vos et al., 1995), and 
by varying the choice of restriction enzyme pairs. These features make the 
technique better suited for revealing higher levels of genetic variation than 
isoenzyme and RFLP analysis. In addition, the reproducibility is reported to 
be high (Vos et al., 1985), while the requirement for only small amounts of 
DNA makes it highly suitable for genotyping isolates on a large scale or for 
isolation of binary specific markers. A recent review by Masiga et al. (2000) 
highlighted the value of this technique to parasite genetic studies. The 
objective of this study was to ascertain the usefulness of the AFLP 
technique in assessing the genetic diversity of trypanosome strains at the 
species or subspecies level, and as a tool to study potential relationships of 
various trypanosome (sub)species.  
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3.3. Materials and Methods 
 
3.3.1. Trypanosome materials 
The 31 isolates used were directly derived from different hosts between 
1968 and 1993, and have been characterised on the basis of their 
response to normal human serum, as well as on host and geographical 
origins (Gibson, W.C., Personal Communication). The geographical origin, 
year of isolation and source of strain are described in Table 1. Genomic 
DNA was isolated from the purified pellets by standard method (Van der 
Ploeg et al., 1982).  
 
3.3.2. AFLP reactions 
AFLP markers were assayed as previously described by Vos et. al. (1995), 
with the following modifications: 50 - 300 ng DNA was digested in a total 
volume of 20 µl using 10 U each of eight combinations of enzymes 
(EcoRI/MseI, BglII/HpaII, HindIII/HpaII, EcoRI/HindIII, EcoRI/BglII, 
EcoRI/BamHI, BglII/HindIII and BglII/BamHI). All restriction enzymes were 
from New England Biolabs or Roche Molecular Biochemicals. The 
digestion mixture was incubated at 37ºC for 4 h followed by the addition of 
10 X ligation buffer [20 mM Tris-HCl, 60 mM KCl, 1 mM EDTA, 5 mM 
dithiothreitol, 50 % glycerol (v/v), pH 7.5 (4ºC), DNA ligase (1 U)] and 10 
pmol (or 100 pmol for 4-bp recognising endonucleases) of respective 
adapters (Table 2) and incubation at 15ºC for 16 h.  
 
In a series of preliminary experiments, PCR amplification conditions were 
optimised (data not shown). Based on these results, the final optimised 
reaction conditions for pre-selective PCR included 2.5 mM dNTP's, 2 mM 
MgCl2, 1X PCR buffer (100 mM Tris-HCl, pH 8.3, 500 mM KCl, 1.5 mM 
MgCl2, 0.01 % (w/v) gelatin), 5 pM of each pre-selective primer (Table 1), 
1.25 U AmpliTaq® DNA polymerase (Perkin-Elmer, Maarssen, The 
Netherlands) and four microlitres of 1:2-diluted ligation product. The 
optimised thermal cycling conditions were 2 min at 95°C, followed by 20 
cycles of 95ºC for 30 s, 56ºC for 30 s and 72ºC for 1 min. The PCR product 
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was diluted 20-fold and 4 µl of the dilution was used for the selective 
amplification reaction, using primer combinations with a selective 
nucleotide at the 3' end of one or both primers. The cycling conditions were 
as for the pre-selective amplification, except for a final extension at 60ºC 
for 30 min. The final products were diluted four-fold, and 1 µl, together with 
a Genescan-500 internal standard (PE Applied Biosystems, Maarssen, The 
Netherlands), was analysed on a 7.3% denaturing sequencing gel by using 
an ABI 373A automated DNA sequencer. Gels were routinely prepared by 
using the ABI protocols and were electrophoresed for 5 h. Forty primer 
combinations were evaluated using all 9 possible +1/+0 or +1/+1 primer 
combinations for each pair of enzymes (with selective nucleotide only on 3' 
end of the upstream primer, or on both primers, respectively) (Table 2). The 
T. brucei isolates were analysed using three selected restriction 
endonuclease combinations, with the set of selective primers, viz: 
Eco+A/Bgl+0, Eco+A/Bgl+T and Eco+0/Hind+A. 
 
3.3.3. Data Analysis 
After electrophoresis, AFLP data were collected with the GenScan software 
(PE Applied Biosystems, Maarssen, The Netherlands). Densitometric 
values were transferred to the GelCampar v4.1 software (Applied Maths, 
Kortrijk, Belgium), and gels were normalised by using the internal size 
standard that was added to each lane. Levels of similarity between banding 
patterns were calculated with the Pearson correlation product-moment 
coefficient (Pearson, 1926). The unweighted pair group method using 
average linkage (UPGMA) was used to cluster the patterns (Vauterin and 
Vauterin, 1992). 
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3.4. Results 
 
3.4.1. Selection of AFLP enzymes and primers 
AFLP genetic markers were assessed for their usefulness in characterising 
molecular diversity among T. brucei subspecies. Nine T. brucei isolates 
were first analysed to determine the optimal AFLP conditions. Restriction 
digestion and adapter ligation were performed in alternate steps, followed 
by pre-selective and selective PCR amplification. Nine sets of restriction 
enzyme combinations were tested (Table 3). The banding patterns 
obtained using EcoRI and MseI restriction enzymes (with A + T-rich 
recognition sequences) for example, contained more bands than 
fingerprints generated with BamHI and HpaII (with G + C-rich recognition 
sequences). 
 
Overall, fingerprints with the pair of 6-bp/4-bp recognising endonuclease 
combinations (EcoRI/MseI, BglII/HpaII and HindIII/HpaII) gave unevenly 
distributed, non-scorable banding patterns or monomorphic profiles of 
mostly small-sized (<150 bp) fragments (Table 3). Thus, we did not find the 
sets of 6-bp/4-bp recognising endonuclease combinations suitable for 
useful AFLP fingerprinting of T. brucei. Two sets of restriction enzyme 
combinations (EcoRI/BglII and EcoRI/HindIII) were selected based on their 
reproducibility, even distribution of bands along the gel, number of 
polymorphic bands and polymorphism detected within and between 
subspecies. The EcoRI/BglII combination (with A selective nucleotide at the 
3' end of EcoRI primer) gave the best polymorphic, evenly distributed 
profiles, and was chosen for further analysis. To evaluate for the 
reproducibility of our results, the AFLP analyses procedure was repeated 
three times with the 9 test isolates, starting from DNA digestion.
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Isolate Origin Year Host
Trypanosoma brucei brucei :
1.     Lump266 Kiboko, Kenya 1969 Fly, G. pallidipes
2.     PTAG130 Daloa, Ivory Coast 1985 Pig
3.     KP2, clone 7 Kouassi-Perita, Ivory Coast 1982 Fly (G. palpalis)
4.     B8/18 Nsukka, Nigeria 1962 Pig
5.     SW3/87 Democratic Rep. of Congo 1987 Pig
6.     LVBG3N Lambwevalley, Kenya 1980 Cow
7.     M249 Matuga, Kenya 1981 Sheep
8.     H3 Luangwavalley, Zambia 1974 Lion
9.     STIB215 Serengeti,Tanzania 1971 Lion
10.   1902 (sindo) Kenya 1971 Waterbuck
11.   AnTat2/2 Nigeria 1970 Fly, G. morsitans
12.   AnTat17/1 Democratic Rep. of Congo 1978 Sheep
13.   J10 Zambia 1973 N.A.
T.  b. gambiense, group 1:
14.  ITMAP1843 Bouenza, Congo 1975 Human
15.  A006 Fontem, Cameroon 1988 Human
16.  Font-1 Fontem, Cameroon 1993 Human
17.  PT16 Côte d’Ivoire 1992 Human
18.  PT312 Côte d’Ivoire 1992 Human
19. Mabia Bouenza, Congo 1989 Human
20.  NW2 Uganda 1992 Human
21. Suzena Yambio, Sudan 1982 Human
22.  1829 (Aljo) Badundu, D.R. Congo 1970 Human
23.  1898 Democratic Rep. of Congo 1974 Human
24.  Dal972 Daloa, Ivory Coast 1978 Human
T.  b. gambiense, group 2:
25.  TB26 Bouenza, Congo 1983 Pig
Trypanosoma brucei rhodesiense :
26.  TRPZ320 Zambia 1983 Fly, G. pallidipes
27. Gambella II Illubabor, Ethiipia 1968 Human
28.  058 Luangwavalley, Zambia 1975 Human
29.  LVH56 Lambwevalley 1978 Human
30.  LVH108 Lambwevalley 1980 Human
31.  AnTat25.1* Rwanda 1971 Human
T. evansi/ T. equiperdum:
AnTat3.1 (T. ev) South America 1969 Capybara
RoTat1.2 (T. ev) Indonesia 1982 Water buffalo
AnTat4.1 (T.eq) N.A unknown N.A
STIB818 (T. eq) Beijing, China 1979 Horse
T. congolense:
C49 (savannah)
Gam2 (savannah) The Gambia 1977 Cow
IL3900 (riverine/forest) Burkina Faso 1982 Dog
ANR3 (riverine/forest) The Gambia 1988 Fly
K45.1 (Kilifi) Kenya 1982 Cow
WG5 (Kilifi) Kenya 1980 Goat
T. simiae:
TsØ2 Kenya N.A Bushbuck
Ken2 The Gambia 1988 Fly
* Isolate was adapted-sensitive to normal human serum
Table 1. Trypanosome isolates used in this study
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Table 2. Adapters and PCR primer core sequences used in this study. 
EcoR I
H indIII
BglII
MfeI
XbaI
MseI
HpaII
(C/CGG )
5'-CTC GTA GAC TGC GTA CC 5'- 6-FAM- GAC TGC GTA CCA ATT C
3'-CAT CTG  ACG  CAT GGT TAA
5'-CTC GTA GAC TGC GTA CC 5'- 6-FAM- GAC TGC GTA CCA GCT T
3'-CTG  ACG  CAT GGT CGA
5'-CGG  ACT AG A GTA CAC TGT C 5'-6-FAM- GAG  TAC ACT GTC GAT CT
3'-C TGA TCT  CAT GTG  ACA GCT AG
5'-AAT TCC CAA GAG  CTC TCC AGT AC       5’-6-FAM- GAG  AGC TCT TGG  AAT TG
3'-G  GTT CTC GAG  AGG  TCA TGA T
5'-GTC GTA GAC TGC G TA CG 5'- 6-FAM- GAC TGC GTA CGC TAG  A
3'-CTG  ACG  CAT GCG  ATC
5'-GAC GAT GAG  TCC TGA G 5'-GAT GAG  TCC TGA GTA A
3'-CTA CTC AGG  ACT CAT
5'-GAC GAT GAG  TCC TGA T 5'-GAT GAG  TCC TGA TCG  G
3'-CTA CTC AGG  ACT AGC
                 Adapter Prim er core sequence 
 
 
 
 
3.4.2. AFLP analysis of Trypanosoma brucei 
The 31 T. brucei stocks comprising 13 animal-infective and 18 human-
infective isolates were subjected to AFLP analysis. The AFLP profiles were 
found to be strikingly similar, especially for the T. b. gambiense isolates 
and SW3/87 (Fig. 1 A, lanes 19 to 31), in spite of their distant geographical 
origins and time of isolation. After normalisation of data, the similarity levels 
between individual fingerprints, calculated by Pearson correlation product-
moment coefficient, ranged from 60 - 96%. The fingerprint pattern showed 
a relatively high degree of heterogeneity of the T. b. brucei and T. b. 
rhodesiense subspecies, while the T. b. gambiense isolates showed rather 
homogeneous patterns (Fig. 1A). 
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Table 3. Primer combinations that were evaluated by AFLP. 
Fingerprints were scored (+ to ++++), based on relative total number of 
bands and uniformity of size distribution from 35 - 500 bp. The 
combinations shown in bold were selected for further analyses. ‘O’ is AFLP 
primer without any selective nucleotide; ‘A’ or ‘T’ indicate primer with the 
respective selective nucleotide. 
 
 
Enzyme                               BamHI EcoRI                       HindIII                     HpaII                            MseI
Base     O        A         T        O        A            T    O      A         T          T      TC      A       G      T        C  AT 
. BglII O          - +           +         - ++++         ++         - ++         +         +         +         - - - - -
A          - +           +         +        +++          +         +          +          +        ++ +         - - - - -
T          - +           +         +        +++          +         +          +          +       ++ +         - - - - -
. EcoRI O         - +           +                                         - +++ ++ - - -*        -*       -*        -*       -*
A          - +           +                                         - + +          - - -*        -*       -*        -*       -* 
T          - +           +                                         - +         +          - - -*        -*       -*        -*       -*
. HindIII O         - - - - - - - - - -
A          - - - ++ +        - - - - -
T          - - - ++ +        - - - - -
. BamHI O                                            - +            +          - - - - - - - - - -
A                                            +          +       +          - - - - - - - - - -
T                                            +          +       +          - - - - - - - - - -
 
* Very weak bands. 
-* Not scored because most bands were relatively very small (<150 bp) and 
faint. 
- Not studied. 
 
 
 
3.4.3 Cluster analysis 
The use of Pearson coefficient (Pearson, 1926) for the calculation of inter-
strain correlations allowed a rapid classification of analysed isolates into 2 
main clusters, I and II (Fig. 1 A). The T. b. gambiense isolates (Cluster I) 
were maximally separated from T. b. brucei and T. b. rhodesiense, both 
residing in Cluster II. Cluster I isolates were further subdivided into sub-
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clusters, denoted as P and Q, while cluster II has R and S subclusters (Fig. 
1 A). Numerical analysis of the AFLP profiles showed that the T. b. 
gambiense cluster was joined with the T. b. brucei/T. b. rhodesiense cluster 
at a Pearson correlation level of 60%. Similarity level among the T. b. 
gambiense isolates (Cluster I) ranged from 92 to 96%, indicating a highly 
identical set of isolates. Despite the overall homogeneity of this cluster, our 
numerical data showed a further subdivision in which T. b. gambiense 
isolates from West and Central Africa were homogeneously distributed into 
2 subclusters, designated as P and Q (Fig. 1 A). The first is composed of 
two Congo stocks from the same focus isolated from humans over a 14-
year period, and all the five isolates from West Africa (CÔte d'Ivoire and 
Cameroon). The second subcluster contains two Democratic Republic 
(D.R) of Congo stocks, isolated 14 years apart, and one isolate each from 
Congo, Sudan and Uganda. Interestingly, visual inspection of the 
normalised band patterns revealed two T. b. gambiense-specific marker 
bands, M1 and M2 (Fig. 1 A). One 'T. b. brucei' stock (SW3/87), a pig 
isolate from Congo, was 'outgrouped' into cluster I. This implies that this 
particular isolate is closer to T. b. gambiense than it is to T. b. brucei/T. b. 
rhodesiense in Cluster II, which raises the issue of whether it is indeed a T. 
b. brucei. Given that it has the T. b. gambiense-specific bands M1 and M2, 
one is led to the conclusion that this isolate might in fact be a T. b. 
gambiense. 
 
Two main clusters result comprising of isolates in the Trypanozoon family 
(T. brucei, T. evansi, T. equiperdum) (Cluster I), and those belonging to 
Nannomonas (T. congolense) and Pycnomonas (T. simiae) subgenera. 
Symbols P, Q and R classify species belonging to subgenera 
Nannomonas, Pycnomonas and Trypanozoon, respectively. Within Cluster 
II, the T. b. brucei and T. b. rhodesiense isolates were subdivided into two 
different sub-clusters, designated R and S. The Cluster II dendogram 
showed longer branch lengths of sub-clusters, with a similarity level of 60 to 
80%. This indicates higher diversity among the isolates, compared to the 
92 to 96% similarity level of Cluster I isolates.  
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Overall, highly identical fingerprints were obtained from the 12 T. b. 
gambiense isolates, while T. b. brucei and T. b. rhodesiense isolates 
showed more genetic diversity than T. b. gambiense. 
 
3.4.4. Interspecies analysis 
To evaluate the applicability of the technique for interspecies analysis, 
AFLP data obtained from two independent isolates each of T. congolense 
(kilifi, riverine/forest and savannah), T. evansi and T. equiperdum were 
similarly analysed. The fingerprint patterns were compared to those of 
randomly selected T. brucei isolates (Fig. 1 B). The dendogram of the 19 
populations, based on AFLP analysis using the UPMGA program, resulted 
in 2 main clusters, in which the Trypanozoon (Trypanosoma brucei ssp, T. 
evansi and T. equiperdum) isolates were maximally separated from the 
Nannomonas (T. congolense) and Pycnomonas (T. simiae) at a similarity 
level of 15%. The similarity level between individual fingerprints of each 
pair of (sub)species, calculated by Pearson coefficient, ranged from 15 to 
95%, indicating an overall high level of genetic heterogeneity among the 
subgenera (Fig. 1 B). The Trypanozoon isolates (Cluster I) were further 
divided into two subclusters comprising (i) the T. b. gambiense (PT16 and 
Mabia), and SW3/87, a 'T. b. brucei' which had been included to evaluate if 
its clustering position would also be different in an interspecies analysis. 
Both are distinct from other Trypanozoon isolates; subcluster II comprised 
all the other members of Trypanozoon subgenus (T. b. brucei, T. b. 
rhodesiense, T. evansi and T. equiperdum). The Kenyan T. b. brucei 
isolate from cow (LVBG3N) is out-grouped from other members of this 
subcluster, showing a more distant relationship. The T. b. rhodesiense 
isolates (Gambella-2 and 058) are more closely-related to the T. 
evansi/T.equiperdum clade, both of which are separated at a similarity level 
of 73%. Interestingly, KP2, clone 7, a tsetse fly isolate from CÔte d'Ivoire is 
on the same T. evansi/T. equiperdum clade. Overall, the two subclusters 
show a genetic similarity level of about 68%, which is a significant level of 
diversity within the Trypanozoon subgenus. 
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Within Cluster II, heterogeneous fingerprint patterns were obtained, except 
for T. evansi and T. equiperdum, which shared highly similar AFLP patterns 
and a high level of genetic homogeneity of 95 - 98% (Fig. 1 B). 
Furthermore, in the interspecies analysis, there was a higher degree of 
homogeneity between the fingerprint patterns of each of the analysed pair 
of isolates than in the intraspecific analysis (Fig. 1 B). For instance, the 
fingerprint patterns of IL3900 and ANR3, both T. congolense 
(riverine/forest) isolates, were quite similar (Fig. 1 B, lanes 1 and 2). Taken 
together, the data indicate that there exists remarkable diversity within the 
genomes of Trypanozoon isolates. 
 
 
 
 
Fig. 1. (A) Numerical analysis of normalised AFLP bands patterns 
generated from T. b. brucei, B (n = 13), T. b. gambiense, G (n = 12) and T. 
b. rhodesiense, R (n = 6), using primer combination EcoRI+A/BglII+0. The 
dendogram was constructed using the unweighted pair-group method using 
arithmetic averages, UPGMA. Correlation levels were expressed as 
percentage values using the Pearson coefficient. M1 and M2 denote 
subspecies-specific AFLP marker bands differentiating T. b. brucei from T. 
b. gambiense/T. b. rhodesiense. (B) Comparative dendogram based on 
AFLP band patterns from interspecies analysis of Trypanosoma 
congolense - Tc/kil (kilifi), Tc/WA (riverine/forest) and Tc/sav (savannah), T. 
simiae (Ts), T. evansi (Tev) and T. equiperdum (Teq) strains. Their 
fingerprints were compared to the patterns generated from two isolates 
each of T. b. gambiense (TB26 and Mabia) and T. b. rhodesiense 
(Gambella-2 and 058), and three T. b. brucei isolates (KP2, clone 7, 
LVBG3N and SW3/87). Similarities between pairs were calculated by 
Pearson correlation coefficient. Fingerprints were generated with 
Eco+A/Bgl+0 primer combinations. Isolates grouped in P, Q and R belong 
to the subgenus Nannomonas, Pycnomonas and Trypanozoon, 
respectively. 
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Fig. 1 A 
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3.5. Discussion 
 
Accurate measurement of genetic relationships requires a marker system 
that provides an unbiased estimate of total genomic variance and is 
sufficiently abundant to minimise errors due to sampling variance (Spooner 
et al., 1996). We looked for a genotyping method suitable for trypanosome 
(sub)species for several reasons. The limitations of previously described 
methods based on single genetic locus have been highlighted above. 
Karyotypes of Trypanosoma brucei isolates, for example, are known to be 
highly plastic (Gibson, 1991), with unusual chromosomal size 
polymorphisms between isolates (Melville et al., 1998). Therefore, any 
genotyping technique based on a single genetic locus may provide 
inadequate results. The AFLP method is an extremely useful and reliable 
technique for detecting polymorphisms and its reproducibility is reported to 
be very high (Vos et al., 1995). The appropriate choice of restriction 
enzymes and, the number and base composition of selective bases, 
determine the usefulness and applicability of this technique in genetic 
diversity studies. In theory, each 6-bp recognising endonuclease cleaves 
every 46 (1096) bp in the genome. Since trypanosome genome is relatively 
small, the addition of only one selective nucleotide should yield scorable 
banding patterns. In our hands, the use of a pair of 6-bp recognising 
endonucleases (EcoRI/BglII), with ‘A’ selective nucleotide at the 3' end of 
the BglII primer was sufficient to generate useful fingerprints for 
trypanosome (sub)species genotyping. We propose this combination as the 
standard set with which to characterise trypanosomes to the (sub)species 
level.  
 
In this study, we identified optimal AFLP conditions for Trypanosome 
(sub)species fingerprinting. The restriction endonucleases that were used 
to genotype other species did not produce satisfactory AFLP patterns: 
trypanosome genomic DNA was not adequately digested with BamHI, HhaI 
digestion resulted in monomorphic fragments, while EcoRI and MseI 
combination resulted in too many small fragments. Restriction 
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endonucleases EcoRI combined with another 6-bp-cutting endonuclease 
BglII resulted in reproducible, evenly distributed and the most informative 
band patterns. The resolution of different selective primers tested varied, 
but EcoRI + A selective nucleotide combined with BglII primer with no 
selective base produced the best patterns. Genetically related strains 
produced homologous patterns and grouped together, whereas unrelated 
strains separated on the dendogram.  
 
In certain eukaryotic systems especially plants, polysaccharides are often 
co-precipitated with DNA (Rether et al., 1993), and extraction steps with 
organic solvents (such as phenol, chloroform) may fail to strip all sugars 
completely. With the high glycoprotein content in trypanosome surface coat 
(the Variable Surface Glycoproteins, VSG) this may lead to partial or poor 
DNA digestion, which is an important step in the AFLP technique. To 
improve the chances of complete enzyme restriction, we opted for 
restriction digestion of genomic DNA followed by ligation in two separate 
steps. This produced better and more consistent results compared to 
digestion and ligation in one reaction (data not shown). To obtain 
reproducible fingerprints, a standardised protocol for AFLP analysis and 
computer-based analysis was required. Since a pre-amplification step 
could preferentially enrich heterosite fragments following adapter ligation 
(Vos et al., 1995), we chose the two-step PCR amplification procedure: a 
pre-selective reaction (without any selective nucleotide on primer), followed 
by selective amplification reaction.  
 
As in previous studies with RAPD and single-locus analyses (Mathieu-
Daude et al., 1995; Hide et al., 1998; Biteau et al., 2000; MacLeod et al., 
2000; Agbo et al., 2001), our data correlated the close genetic relatedness 
among the three T. brucei subspecies. In our analysis, therefore, we aimed 
to group the isolates rather than distinguish them, crucial for bio-diversity 
surveys or epidemiological research. The Pearson correlation coefficient 
(Pearson, 1926) suggest that individual T. b. brucei and T. b. rhodesiense 
isolates from various foci may be quite distinct while the dendogram data 
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indicate that isolates from the same region are similar (Fig. 1 A). Some of 
the T. b. brucei and T. b. gambiense isolates used in this study have also 
been examined, using RFLP, for variations in their ITS/5.8S rDNA region 
(Agbo et al., 2001), who proposed two distinct evolutionary lines of 
descent. Interestingly, in these current studies, each of the main clusters of 
isolates revealed by numerical analysis of AFLP variations corresponded to 
the respective evolutionary line of the organism. It should be noted that 
AFLP is independent of ITS/5.8S rDNA sequence analysis because the 
nucleotide positions analysed by AFLP are distributed over the whole 
genome. Therefore, the two T. b. gambiense-specific AFLP fragments that 
we detected (Fig. 1 A) appear to additional reliable and specific markers for 
the characterisation of T. b. gambiense stocks. Clustering analysis showed 
that variations were more pronounced among T. b. brucei/T. b. rhodesiense 
subspecies (cluster II), which suggests a slightly different level of genetic 
heterogeneity between the two lines.  
 
For T. brucei genotyping, our data indicate that human-infective T. b. 
gambiense form a distinct homogeneous group separate from T. b. brucei 
and T. b. rhodesiense isolates, which cluster together. This agrees with 
earlier reports that T. b. gambiense is a homogeneous group of isolates 
with high levels of similarity (Biteau et al., 2000). The low level of molecular 
variation among the T. b. gambiense isolates may be explained by two 
hypothesis: (i) the introduction of human-infective trypanosomes to West 
and Central Africa (the ecozone for T. b. gambiense) was more recent and, 
most probably, only a few strains were introduced, and; (ii) the cumulative 
effects adopted for the control of the disease. The control of Gambian 
sleeping sickness relies on case identification, principally using the card 
agglutination test (Magnus et al., 1978), and chemotherapy of a largely 
asymptomatic human reservoir. On the other hand, T. b. rhodesiense, the 
cause of Rhodesian sleeping sickness is zoonotic, with reservoirs in wild 
animals and domestic livestock (Welburn et al., 2001). Combined with the 
acuteness of the disease, its control demands a more aggressive 
approach. These have included large-scale tsetse control operations, aerial 
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spraying and aggressive medical interventions. These measures may have 
accumulated to induce more mutational pressure on T. b. rhodesiense, 
resulting in an increased level of genetic diversity within the subspecies. 
 
As an interspecies yardstick with which to measure intra-specific 
divergence among T. brucei subspecies, two isolates each from 
Nannomonas (T. congolense) and Pycnomonas (T. simiae) subgenera 
were similarly analysed, and their fingerprints compared to Trypanozoon 
(T. brucei) patterns. As shown in Fig. 1 B, the different isolates within each 
subgenus have similar but distinct fingerprint patterns, except for T. evansi 
and T. equiperdum, whose fingerprint patterns were closely identical. This 
obvious close relationship between the two ‘species’ is in agreement with 
earlier reports (Gibson et al., 1980; Lun et al., 1992; Zhang et al., 1994; 
Brun et al., 1998; Biteau et al., 2000). However, a clear correlation was 
found between AFLP polymorphisms and trypanosome species. The 
specific bands present in each of the analysed species allowed us to 
separate the strains effectively. On the basis of the pronounced differences 
in their dendograms, different subtypes of T. congolense (kilifi, 
riverine/forest and savannah) could be considered as separate subspecies. 
Sequence information based on rRNA genes has been used to 
characterise and to infer the phylogenetic relationship among Trypanozoon, 
Pycnomonas and Nannomonas trypanosome parasites (Stevens et al., 
1999; Urakawa and Majiwa, 2001; Gibson et al., 2001). Our data and the 
previous reports have corroborated the close genetic relatedness between 
T. b. brucei and T. b. rhodesiense. In addition, our results did show the 
existence of micro-heterogeneity among isolates of these subspecies. 
Overall, our data show that there does exist more genetic diversity within 
and between the subgenera than was previously reported.  
 
The AFLP method has a higher multiplex ratio (= number of loci 
simultaneously analysed per experiment) than single sequence repeats 
(SSRs). As it simultaneously accesses multiple independent sites within the 
entire genome, it provides a more valuable tool for overall evaluation of the 
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phylogenetic relatedness of trypanosome strains. Our study has 
established the AFLP conditions and primer combinations that permit the 
assessment of genetic diversity of T. brucei subspecies. It further 
demonstrated that the technique could be applied in trypanosome diversity 
studies, with potential use for the isolation of intra- or inter-specific genetic 
markers. The results also show that human infective isolates derived from 
different ecozones may indeed be genetically separate groups. 
Furthermore, they correlate the close phenotypic relatedness between T. b. 
brucei and T. b. rhodesiense. In addition, our data suggest that variation 
between human-infective T. brucei subgenus is beyond only geographical 
origin, since the T. b. rhodesiense seem to be genetically more diverse, 
while the T. b. gambiense are more clonal or genetically more stable over 
time. By this technique, the two subspecies can be unambiguously 
classified by whole-genome fingerprinting. Through the evaluation of large 
number of clearly defined field samples, such AFLP fingerprinting may 
facilitate the identification of polymorphisms linked to parasite factors of 
host tropism, and contribute to the understanding of host-parasite 
interactions at the molecular level. Finally, our data present some further 
markers for defining T. b. gambiense, while the detected polymorphisms of 
trypanosome species may be valuable tools for epidemiological studies.   
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4.1. Abstract 
 
Restriction enzyme-detectable polymorphisms have been used for 
assessing genetic differences and generating informative genetic markers. 
The most detailed fingerprinting analyses have been obtained using the 
AFLP technique, which accesses subsets of polymorphisms at one or two 
restriction sites. To combine increased discriminatory power with stringency 
of PCR amplification, it would be beneficial to access additional 
independent restriction sites per analysis, and to amplify subsets of DNA 
restriction fragments with only one pair of oligonucleotide primers. We have 
now developed a unique approach that permits the simultaneous use of 
four or more endonucleases in combination with one pair of 
adapters/primers, and applied it to genotype 21 trypanosome populations 
to subspecies level. The approach takes advantage of the fact that some 
endonucleases create cohesive ends that are compatible with the overhang 
sites created by other endonucleases. We demonstrate the greater 
resolution of identifiable polymorphic fragments over conventional ligation-
mediated restriction analysis method, and discuss the value of the 
approach as a tool for fine genetic mapping of Trypanosoma brucei. Finally, 
we propose utility of the method for fine characterisation and for identifying 
co-dominant genetic markers in a variety of other taxa. 
 
 
4.2. Introduction 
 
A variety of fingerprinting methods have been developed for accurate 
assessment of genetic diversity, and to address questions regarding 
population structure and genetic relatedness among prokaryotic and 
eukaryotic organisms (see Mueller and Wolfenbarger 1999 for review). The 
ideal genome fingerprinting method should provide an unbiased estimate of 
the total genome variance in the population and must be sufficiently 
sensitive to detect minimal genetic differences and minimise errors due to 
sampling variance. This is particularly relevant for the comparative analysis 
Chapter 4 
 
76  
of genomes of closely related organisms where the relatively limited 
genetic variation between subspecies can only be revealed by the 
enhanced resolution power of the technique employed.  
 
Trypanosome species are unicellular, protozoan parasites that cause 
debilitating disease, collectively called trypanosomosis (Kassai 1988), with 
fatal outcome in man and animals. Trypanosoma brucei consists of three 
subspecies that are indistinguishable by conventional morphological and 
antigenic criteria, but differ in their geographical distribution and host 
specificity (Gibson et al., 1980). For epidemiological identification and 
tracking of the subspecies strains, T. b. gambiense can be distinguished 
from T. b. brucei and T. b. rhodesiense (Hide et al., 1998; Agbo et al., 
2002). However, the distinction between T. b. brucei and T. b. rhodesiense 
has always been more difficult to determine (Godfrey et al., 1990; Hide 
1999; Agbo et al., 2002). Resistance to normal human serum (equivalent to 
human infectivity) is an important trait that distinguishes T. b. gambiense 
and T. b. rhodesiense (which are resistant) from T. b. brucei strains (which 
are sensitive). We found some association between different genetic 
marker loci and resistance in molecular signatures of rDNA regions of 
human- and nonhuman-infective T. brucei isolates (Agbo et al., 2001).  
 
Members of the T. brucei complex possess a remarkably high degree of 
genetic identity and are rich in repetitive DNA, a feature that has also been 
exploited for molecular typing (Hide et al., 1990; Hide et al., 1994). 
However, this approach is cumbersome and technically demanding. A 
recently reported serum-resistance-associated (SRA) gene probe (De 
Greef et al., 1989) adapted as a PCR-based typing system (Welburn et al., 
2001; Gibson et al., 2002) offers hope for a rapid tool for identifying human-
infective T. b. rhodesiense trypanosomes. However, since parasites 
derived from hosts other than humans potentially contain human- as well 
as animal-infective strains, the need for high-resolution distinguishing 
analytical tools that will facilitate the definitive typing of all T. brucei 
subspecies on a routine basis persists. 
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The conventional AFLP method (Vos et al., 1995) has shown most value 
for interspecies genotyping and, to a limited extent, for delineating different 
sets of clonally descended individuals in several plants and fungi (Mueller 
and Wolfenbarger 1999). A review by Masiga et al. (2000) highlighted 
possible value for the conventional AFLP in parasite genetic studies but 
was recently reported to offer low resolution in the genotyping of 
trypanosome subspecies (Agbo et al., 2002), and previously in closely 
related strains in other taxa (Lindstedt et al., 2000). Simons et al. (1997) 
pioneered early attempts at the use of additional endonucleases to 
increase the discriminatory power of AFLP but reported only slight 
improvement in fingerprint patterns compared to the standard protocol. 
Lindstedt and co-workers (2000) generated fragments of DNA with a set of 
three endonucleases followed by adapter ligation and their amplification 
using a cognate set of three primers. Such multiplex PCR with three 
primers is bound to compromise or diminish stringency and robustness of 
the method. More recently, a triple-endonuclease/two-adapter AFLP 
approach was shown to be rapid and robust (Van Der Wurff et al., 2000). 
However, the approach is limited by the fact that only the restriction 
fragments resulting from two endonucleases not interspersed by a specific 
restriction site of the third contribute to the detectable polymorphism. In 
addition, from a conceptual point of view, it can further be argued that since 
the modification entailed a reduction in the number of potentially amplifiable 
fragments, this would limit its value as a finer fingerprinting approach over 
the conventional two-endonuclease method.  
 
We hypothesised that to obtain additional polymorphisms in the genetic 
analysis of complex and closely-related subspecies, it would indeed be 
necessary (i) to simultaneously access multiple independent restriction 
enzyme sites within the genome and (ii) to robustly detect all the resulting 
heterosite restriction fragments. On this basis, the use of four or more 
endonucleases to digest genomic DNA would, in principle, provide 
discrimination at extra sites within the genome, while one pair of adapters 
and cognate primers would allow for stringent PCR. We describe here the
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features of a multiplex-endonuclease/two-adapter genotyping approach 
that combines increased resolution power with stringency in PCR. We 
demonstrate that more amplified restriction fragments are generated than 
with the conventional AFLP method (involving the use of two 
endonucleases with a pair of adapters) in the analysis of genetic 
differences among trypanosome isolates. This approach considerably 
enlarged the number of restriction fragment polymorphisms that was 
detected in trypanosome genotyping.  
 
 
4.3. Materials and Methods 
 
4.3.1. Four-endonuclease, two-adapter genetic fingerprinting 
Sets of four endonucleases in combination two adapters were used to 
evaluate the value of the multiplex-endonuclease, two-adapter method as a 
useful tool for finer DNA amplification fingerprinting. To identify the best set 
of endonucleases, we first evaluated the approach using seven cloned 
‘test’ Trypanosoma brucei isolates belonging to the three subspecies of the 
parasite - T. b brucei, T. b. gambiense and T. b. rhodesiense (Table 1). 
Genomic DNA, isolated essentially as previously described (Heath, 1997), 
was digested using restriction enzyme combinations: (i) BglII, BclI, EcoRI 
and MunI; (ii) BglII, BclI, AcsI and MunI; (iii) BclI, XhoII, AcsI and MunI, 
and; (iv) BglII, XhoII, EcoRI and AcsI, respectively. All enzymes were 
purchased from Roche Molecular Biochemicals (Almere, The Netherlands) 
or Westburg (Leusden, The Netherlands). Since complete digestion of DNA 
is an important step in the restriction analysis technique, 100 ng genomic 
DNA was digested for 4 h with 10 U of each endonuclease, essentially in 
two successive double digestion reactions, with an intermediate 2-propanol 
precipitation step. The digests were precipitated and reconstituted in 10 µl 
distilled water. Ten µl of a buffer containing 660 mM Tris HCl, 50 mM 
MgCl2, 10 mM Dithiothreitol, 10mM ATP, pH7.5, and 20 pM of each BglII 
and MunI adapters (Table 2) were added. One µl (400U) of high 
concentration T4 DNA ligase (New England Biolabs) was added and the 
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mixture incubated for 2 h at 25ºC. Pre-selective amplification was 
performed in a total volume of 20 µl containing 1 U of Taq polymerase 
(Roche Molecular Biochemicals, Almere, The Netherlands), 4 µl of 1:1-
diluted ligation product, 2 µl of 10X PCR buffer (100mM Tris HCl pH 9.0, 50 
mM KCl, 1% triton X-100, 0.1% w/v gelatin), 2.5 mM MgCl2, 200 µM of 
each dNTP and 5 pM of each BglII and MunI primers. The reaction mix was 
incubated for 2 min at 95ºC, and subjected to 20 cycles of PCR (30 s at 
95ºC, 30 s at 56ºC and 2 min at 72ºC). Four µl of 1:20-diluted pre-selective 
products were used as template for selective reaction in a MunI-0/BglII-A 
selective primer combination (with only ‘A’ selective nucleotide in the BglII 
primer). The MunI-0 primer (without any selective nucleotide) was 
fluorescently labelled with FAM (i.e. 6-carboxyfluorescein). The PCR 
program was essentially the same as for pre-selective amplification, except 
that the last cycling step was followed by 30-min incubation at 60ºC. The 
final products were diluted 1:1 with TE, and Genescan-500 internal lane 
standard (PE Applied Biosystems) was added. One µl of the mix was 
resolved in a 7.3% denaturing sequencing gel using a model ABI 373A 
automated DNA sequencer. Gels were routinely prepared by using ABI 
protocols and electrophoresed for 5 h. To assess the reproducibility of the 
approach, two sets of genomic DNA were isolated at separate occasions 
from the 'test' isolates, and processed according to the described protocol. 
 
4.3.2. Data analysis 
The gel patterns were collected with the GenScan software (PE Applied 
Biosystems) and sample files were transferred to the GelCompar v4.1 
software (Applied Maths, Kortrijk, Belgium). Band positions were inferred 
from the signal peaks in the sample files, and used to establish the total 
number of bands in each lane. By computer-assisted analysis, samples 
files were directly scored for presence/absence of signal peaks in the four-
endonuclease and conventional approaches. Gels were normalised by 
using the internal standard that was added to each lane. A coefficient of 
racial likeness was used to create a similarity matrix. Clustering of the 
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patterns was performed with the unweighted pair group method using 
average linkage (UPGMA) (Vauterin and Vauterin 1992).  
 
 
Isolate        Source                                Year of isolation
Trypanosoma brucei brucei
AnTat2/2* Tsetse fly (Glossina morsitans); Nigeria 1970
AnTat17/1* Sheep; Democratic Rep. of Congo 1978
J10* Hyena; Zambia 1973
T. brucei gambiense
LiTat1.3* Human; Cote de Ivoire 1952
PT16* Human; Cote de Ivoire 1992
T. brucei rhodesiense
STIB848* Human; Uganda 1990
AnTat12.1* + Human; Uganda 1971
T. evansi
RoTat1.2 Water buffalo; Indonesia 1982
AnTat3.1 Capybara; South America 1969
T. equiperdum
STIB818 Horse; China 1979
AnTat4.1 Unknown; South America N/A
T. congolense
C49 (savannah) Cow, Kenya 1966
Gam2 (savannah) Cow; The Gambia 1977
IL3900 (riverine/forest) Dog; Burkina Faso 1980
ANR3 (riverine/forest) Fly; The Gambia 1988
K45.1 (kilifi) Cow; Kenya 1982
WG5 (kilifi) Goat; Kenya 1980
T. simiae
Ken2 Fly; The Gambia 1988
TsØ2 Bushbuck; Kenya N/A
* ‘Test’ samples; + Adapted sensitive to normal human serum; N/A - data not available
Table 1 Trypanosome populations used in these studies
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Table 2.  The complementary sets of BglII and MunI adapters and PCR 
primers 
 
Endonuclease Adapter Primer core sequence
BglII 5'-CGG ACT AGA GTA CAC TGT C 5'-GAG TAC ACT GTC GAT CT
(A/GATCT) 3'-C TGA TCT CAT GTG ACA GCT AG
MunI 5'-AAT TC CAA GAG CTC TCC AGT AC       5'-6-FAM-GAG AGC TCT TGG AAT TG
(C/AATTG) 3'- G GTT CTC GAG AGG TCA TGA T
 
 
4.3.3. Computer predictive modelling 
A Monte Carlo simulation program (in QuickBasic language) was used to 
calculate an estimate of the occurrence of the recognition enzyme 
sequences. The program randomly generates a genome of adequate large 
size, to calculate the frequency of the recognition sequences of a set of 
endonucleases, with diverse combinations and permutations. Increasing 
the size of the genome and the number of repetitions was used to enhance 
the precision of the estimate.  
 
 
4.4. Results and Discussion 
 
4.4.1. Principle of the multiplex-endonuclease, 2-adapter genetic 
fingerprinting approach 
The approach evaluated using four-endonucleases in combination with two 
adapters was found to be a robust and reproducible technique capable of 
detecting additional amplifiable fragments to increase the number of 
detectable polymorphisms between genomes. Sets of four different 6 bp-
cutting endonucleases that simultaneously access independent sites were 
used to digest genomic DNA. On average, the restriction site for a '6-bp 
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cutter' enzyme occurs every 4096 (46) bp, assuming a random distribution 
of the four bases in DNA. Assuming a random distribution of four different 
6-bp-recognising ('rare cutting') enzymes (hypothetically A, B, C and D 
combination), the possible number of combinations, P of their respective 
digestion frequency in the genome is (PAB + PCD). If the restriction enzyme 
cleavage sites are independent of one another (i.e. no shared nucleotides 
at similar positions), the cleavage site of each endonuclease would be 
expected to occur approximately every 1024 bp against 2048 bp for a pair 
of 6-bp cutters. In practice, this will not be the case as will be discussed 
later.  
 
The four 'rare cutter' enzymes used (BglII-BclI/EcoRI-MunI) generate sets 
of fragments with 16 possible restriction ends out of which 10 different sets 
are potentially amplifiable (Fig. 1). The endonucleases were chosen such 
that for each pair, the cohesive ends created by one are compatible with 
the overhang sites created by the other restriction enzyme. On this basis, 
only one pair of adapters, BglII and MunI (Table 2) was ligated to allow the 
amplification of the fragments using a pair of cognate primers in PCR. In 
this approach, BglII adapter also ligated to the overhang sites created by 
BclI or XhoII, while MunI adapter also ligated to EcoRI, AcsI or ApoI sites. 
The short adapter ligation step ensured a substantial reduction in the 
amount of time required for preparing the DNA fingerprints. With the BglII, 
BclI, EcoRI and MunI combination, following adapter ligation reaction, 5 
groups of products result  (Fig. 1, A - E). The four 'rare cutter' enzymes 
used (BglII-BclI/EcoRI-MunI) generate sets of fragments with 16 possible 
restriction ends out of which 10 different sets are potentially amplifiable 
(Fig. 1).  
 
The endonucleases were chosen such that for each pair, the cohesive 
ends created by one are compatible with the overhang sites created by the 
other restriction enzyme. On this basis, only one pair of adapters, BglII and 
MunI (Table 2) was ligated to allow the amplification of the fragments using 
a pair of cognate primers in PCR. In this approach, BglII adapter also 
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ligated to the overhang sites created by BclI or XhoII, while MunI adapter 
also ligated to EcoRI, AcsI or ApoI sites. The short adapter ligation step 
ensured a substantial reduction in the amount of time required for preparing 
the DNA fingerprints. With the BglII, BclI, EcoRI and MunI combination, 
following adapter ligation reaction, 5 groups of products result  (Fig. 1, A - 
E). These consist of sets of fragments with (i) BglII or MunI adapters at 
both ends (A, B), (ii) BglII and MunI adapters at the ends of each fragment 
(heterosite) (C), (iii) BglII or MunI adapter at only one end of fragment (D) 
and, (iv) no adapter (E). The PCR was then used to obtain exponential 
amplification of the heterosite products (with different adapters at each 
end). In contrast, DNA fragments with only one adapter undergo linear 
amplification and are rapidly competed out in PCR. The amplification of 
DNA with the same adapter at each end (Fig. 1, A and B) is suppressed 
because self-annealing of inverted repeat adapters inhibits binding of PCR 
primers. The use of only one set of adapters and primers diminishes 
competition during PCR, permitting robust and stringent reaction 
conditions. Repeat of the experiments with samples derived at two 
separate times from the 'test' isolates gave identical AFLP profiles, with the 
same bands and same polymorphisms which indicates high reproducibility 
of the method.  
 
On the other hand, endonucleases that generate blunt end DNA fragments 
may be used in a method of the approach described here, in combination 
with a pair of adapters blunt at one end and cohesive on the other. Such 
adapters may be generated by the action of restriction endonucleases on 
double-stranded ribonucleotides, or generated by the annealing of two 
specifically designed single-stranded oligonucleotides that differ in length 
and that anneal such as to produce a double-stranded ribonucleotide 
having one blunt end and one overhanging or recessive end. 
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Fig. 1. Schematic illustration of the fingerprinting method based on four-
endonucleases with two-adapter. Digestion of genomic DNA with four 
different restriction enzymes generated 16 different restriction products (III). 
Solid lines represent restriction enzyme fragments of DNA. Boxes at the 
ends of DNA fragments represent the respective restriction ends or 
cognate adapter. Following ligation reaction, 6 different groups of products 
result (IV): sets carrying BglII or MunI adapters at both ends (A, B); sets 
with BglII and MunI adapters at the ends of each fragment (heterosite) (C); 
sets with BglII or MunI adapter at only one end of fragment (D), and, sets 
that did not ligate to any adapter (E). For selective PCR amplification, 
MunI-0/Bgl-A selective primer combination was used, with the MunI primer 
fluorescently labelled to enable the detection of fragments. Note that 
irrespective of which of the two cognate primers is labelled, the same 
subset of representation products, comprising the heterosite fragments, is 
exponentially amplified and detected (IV, C). 
 
For Figure 1, see facing page. 
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4.4.2. Comparison of the four- and two-endonuclease data 
The efficiency of the two approaches for generating additional 
polymorphisms for finer genotyping was assessed by directly comparing 
their fingerprint patterns using trypanosome DNA (Fig. 2). Here, we show 
that for all the (sub)species analysed, the four-endonuclease approach 
revealed remarkably more restriction fragments and extra polymorphisms 
compared to the two-enzyme method, indicating that additional restriction 
sites were indeed accessed. However, the increase in the number of 
fingerprint fragments was not linear when compared to the two-
endonuclease approach with BglII and EcoRI. In principle, the pair of 
endonucleases, BglII (A/GATCT) and BclI (T/GATCA) when used together 
to digest the genome would cleave 6-bp palindromic 5’-GATC- sequences if 
an ‘A’ or ‘T’ is present at the 5’ end, respectively. Assuming both restriction 
enzyme sites to be equally distributed in the genome and that all sites are 
cleaved, this would imply twice as much cleavage as with only one of the 
two enzymes, with a cutting frequency of one every 2048 (46/2) bp in the 
genome.  
 
In reality, this is highly unlikely due to several factors. First, the recognition 
sequences of the endonucleases may overlap at certain positions, in which 
case only one of the pair can cleave its site. Taking this into account in the 
simulation studies, a pair of endonucleases that share the same 
nucleotides at two or four positions (e.g. BglII/BclI and BglII/EcoRI), were 
predicted to give approximately the same mean cutting frequency, 2269 bp 
and 2275 bp, respectively. However, in a BglII-BclI-MunI-EcoRI digestion, a 
site for any of the four endonucleases is predicted to occur every 1501 bp. 
Second, there are differential effects of methylation on enzyme sensitivity to 
substrate. For example, while both BglII and BclI recognition sequences 
completely overlap Dam methylase site GATC, methylation does not block 
cleavage with BglII, but it does block cleavage with BclI, so that restriction 
may not occur at all BclI recognition sites. Similarly, EcoRI recognition site 
(G/AATTC) is insensitive to methylation, while the cleavage of MunI 
(C/AATTG) site is completely blocked by Dam-methylation.  
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Thirdly, a common limitation of ligation-mediated restriction analyses is that 
the actual number of amplified fragments is less than that of theoretically 
amplifiable fragments. This phenomenon would be expanded in the four-
endonuclease approach since more restriction fragments are generated 
than with two endonucleases. Finally, liberal assumptions have been made 
that all four restriction enzyme recognition sequences are randomly and 
equally distributed in the genome, and that all restriction sites are cleaved. 
 
4.4.3. Trypanosome species: intra- and inter-species analyses of 
genetic differences 
We previously evaluated the conventional AFLP approach as a tool for 
generating useful markers for finer characterisation of trypanosome isolates 
to subspecies level (Agbo et al., 2002). This approach was limited by the 
fact that only marked size differences based on allelic restriction fragments 
from two endonucleases could be assessed and, as a result, only few 
polymorphic markers were detected. An important issue that arises in the 
context of using genetic markers for classifying individuals relates to the 
number of fragments and markers needed to provide adequate fingerprint 
or clustering. The more restriction sites are accessed in the genome, the 
more informative the resulting representation fragments in finding 
polymorphisms. Such fine genetic differences may be used for correlating 
the underlying structural patterns of diversity in a population of interest and 
to obtain more precise clusters of genotypes. This unique multiplex-
endonuclease method presents a tool for expanding the number of 
derivable fingerprint fragments, in combination with a pair of adapters and 
cognate primers to ensure stringency in PCR amplification. For the inter- 
and intra-species analyses of trypanosome isolates (Table 1), the BglII-
BclI/EcoRI-MunI combination was selected on the basis of its 
reproducibility, even distribution of bands along the gel and number of 
polymorphic bands detected (Fig. 2, A-F).  
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Fig. 2. Demonstration of the higher resolution power of the approach.  
Fingerprints resulting from intra- and inter-species analyses of trypanosome 
isolates demonstrate greater resolution of the four-endonuclease approach. 
A, C and E represent dendograms from the samples analysed with the four-
endonuclease approach (using BglII-BclI/EcoRI-MunI). These are directly 
compared with profiles derived from samples processed with the two 
endonucleases (BglII and EcoRI), viz B, D and F, respectively. A pair of 
adapters and primers (BglII and MunI) was used, respectively to ligate and 
PCR-amplify the resulting digestion products. The total number of bands 
from each tested sample is outlined in bold. (See facing page) 
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The intra-specific analyses of Trypanosoma brucei subspecies with four 
endonucleases (A) resulted in more restriction fragments and extra 
polymorphisms compared to the two-endonuclease method (B). Similarly, 
with the closely related T. evansi and T. equiperdum species (C and D), a 
higher number of fragments resulted with the four-endonuclease approach, 
but less so with the number of identifiable polymorphisms between the 
species. This underscores the close genetic relatedness of the two species, 
being probably pathotypes of the same parental strain. The greater 
discriminatory power of the four-endonuclease approach was best 
demonstrated in the inter-species analyses of T. congolense and T. simiae 
isolates, in which far more polymorphic fragments result (E) than with the 
two-endonuclease approach (F). These results propose that additional sites 
within the genome were indeed accessed in the four-endonuclease 
method. When, for instance, the same region of the genome is accessed in 
both approaches, there is more coverage with the multi-endonuclease 
method so that more polymorphic restriction fragments are accessed and 
detected than with two or three endonucleases.  
 
Nearly all eukaryotes contain non-coding repeat sequences that are under 
minimal evolutionary pressure. Therefore, since DNA polymorphisms may 
be concentrated at these regions, they will be highly informative for DNA 
fingerprinting, genetic mapping and population structure studies. It is thus 
possible that DNA polymorphisms can be overlooked when only a limited 
number of endonucleases have been tested with the conventional AFLP. 
This might explain the success of the four-endonuclease approach over the 
two-endonuclease conventional method and underline the greater inter-
species genetic difference (Fig. 2 E, F) when compared to differences 
within the members of the Trypanozoon subgenus (T. brucei, T. evansi and 
T. equiperdum). The approach described here offers a useful tool for finer 
genome characterisation of T. brucei subspecies, and could be easily 
applied for the genotyping of a variety of taxa.  
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There is currently a great deal of debate regarding the feasibility of 
identifying genetic associations with complex T. brucei human serum 
response phenotype. It is imperative that the molecular tool employed is a 
genome-wide approach that accesses multiple independent sites to permit 
the resolution of fine genetic differences. Large population studies and/or 
detailed pedigree analysis can then be used to determine if observed 
anonymous markers either directly contribute to, or are associated with 
human serum response traits.  
 
For species like trypanosomes that have highly plastic genome composition 
or size, the more completely the genome is accessed, the greater the 
chance of uncovering similarities and/or differences in coding and non-
coding regions. Using this approach, the complexity of genetic fingerprints 
can be advantageously managed for finer genetic analysis by increasing 
the number and/or varying the choice of restriction enzyme pairs. These 
features make the approach better suited for revealing higher levels of 
genetic variation than with previous methods (Vos et al., 1995; Lindstedt et 
al., 2000; Simons et al., 1997; Van der Wurff et al., 2000). For micro-
restriction mapping of T. brucei subspecies, additional endonucleases in 
varying combinations and numbers can now be utilised to directly access 
more genomic regions for genetic markers that may be associated with 
human resistance/sensitivity. 
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5.1 Abstract 
 
Using a novel multilocus DNA marker analysis method, we studied the 
population genetic structure of T. brucei stocks and derived clones isolated 
from animal and rhodesiense sleeping sickness patients during a national 
sleeping sickness control program in Mukono district, Uganda. We then 
performed a cladistic analysis to trace relationships and evolution, using 
stocks and clones recovered from geographically and temporally matched 
hosts, including interstrain comparisons with T. b. gambiense stocks and 
clones. Our results show that while there was close genetic relatedness 
among parasite populations from the same geographical region, 
microheterogeneities exist between different stocks. Data are presented 
that indicate that not every human sleeping sickness focus may be 
associated with a particular human-infective trypanosome strain 
responsible for long-term stability of the reference focus. We provide 
evidence of genetic sub-structuring among type 1 T. b. gambiense stocks, 
which has potentially important implications for molecular epidemiology of 
T. brucei.  
 
 
5.2. Introduction 
 
The species Trypanosoma brucei consists of T. b. brucei (one of the 
causes of nagana in cattle), T. b. rhodesiense, and T. b. gambiense (the 
cause of human sleeping sickness in East and Central-West Africa, 
respectively). Trypanosoma b. brucei is one of the trypanosomes that have 
severely limited livestock productivity in over a third of sub-Saharan Africa. 
It does not cause disease in humans because this subspecies is lysed by 
normal human serum. The disease, collectively called trypanosomosis, has 
re-emerged as a major health threat in sub-saharan Africa, with a 
conservative estimate of about 500,000 current human infections (WHO, 
2001).  
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One of the fundamental tools that is required for a full understanding of the 
epidemiology of trypanosomosis caused by Trypanosoma brucei is a 
reliable method for identifying and tracking strains. The complexity of the 
transmission cycles involved and the comparative dynamics of the 
transmission through parts of these cycles mean that systems for 
generating robust and reliable genetic markers for epidemiological studies 
are needed. It is now well established that T. b. rhodesiense and T. b. 
brucei genomes are more polymorphic than those of T. b. gambiense 
(Hide, 1999; Agbo et al., 2002). However, knowledge of the extent of 
genetic diversity of local parasite populations and the role of this diversity in 
the interactions of the parasite with both the animal and human hosts in 
related and distant populations remain poorly understood. The 
epidemiological analysis undertaken on stocks isolated during a human 
sleeping sickness epidemic in Tororo district of Uganda (Hide et al., 1994), 
as well as other studies MacLeod et al., 1999; MacLeod et al., 2001a; 
2001b) provided unique opportunities to address these issues, because a 
number of parameters that may provide insight into population structure of 
natural populations of trypanosomes, were investigated. 
 
In East Africa, certain geographically-related foci are characterised by 
periods of long-term endemicity interspersed with short epidemic episodes. 
To better understand the causes of these episodes, the molecular 
epidemiology and population structure of T. brucei within Busoga focus 
have been studied (MacLeod et al., 2000; Enyaru et al., 1993; Enyaru et 
al., 1997; Degen et al., 1995). A recently developed PCR system based on 
the serum-resistance-associated (SRA) gene (De Greef et al., 1989) has 
been shown to be specific for the identification of T. b. rhodesiense strains 
(Welburn et al., 2001; Gibson et al., 2002). However, the absence of the 
SRA gene from other T. brucei subspecies, even in the so-called 
rhodesiense-like, virulent or type 2 T. b. gambiense (Gibson, 1986) 
underscores the need for additional genetic markers.  
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We undertook a population-genetic study to evaluate the population 
structure of parasite stocks isolated during endemic and epidemic periods 
within Mukono district in Busoga focus, using a recently described 
multilocus fine genotyping marker system (Agbo et al., In press). An 
attractive feature of the approach is that multiple independent restriction 
enzyme-based polymorphisms can be genotyped in a single reaction and 
scored in a single lane of a gel on an automated sequencer. In this 
analysis, we looked for evidence of the uniqueness of circulating 
genotypes. Furthermore, we traced stock relationships and evolution by 
analysing the extent of genetic polymorphisms among human-infective 
stocks on the one hand, and between human- and animal infective stocks 
on the other hand, from geographically and temporally matched 
populations, within the same and different foci. Our data suggest that this 
approach may offer a valuable tool for fine-scale epidemiological 
investigations of trypanosomosis and diseases caused by other agents. 
 
 
5.3. Materials and Methods 
 
5.3.1. Trypanosome stocks and clones 
The trypanosome populations listed in Table 1 were originally isolated 
between 1990-1992 from pigs (19), cattle (5) and rhodesiense sleeping 
sickness patients (4) during an evaluation of the National Sleeping 
Sickness Control Programmme (NSSCP) in Bulutwe, Mukono district, 
South-Eastern Uganda, a rhodesiense sleeping sickness endemic area. At 
that time 0.7% of villagers, 33.5% of cattle and 52.8% of domestic pigs 
harbored trypanosome infections (Nowak et al., 1992). Human serum 
response properties of the parasites were evaluated earlier (Von 
Dobschuetz, 2002; Mangeni, unpublished data) using the Blood Incubation 
Infectivity Test (BIIT) (Rickman and Robson, 1980) and the Human Serum 
Resistance Test (HSRT) (Jenni and Brun, 1982).  
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A collection of stocks and clones consisting of T. b. brucei (7), T. b. 
gambiense (10) and T. b. rhodesiense (8) derived during epidemic 
episodes from related and disparate locations (Table 2) was also analysed 
to compare the genotypic properties of the various populations, separated 
in space and time. Parasite cloned populations were generated following 
limited passage of cryostabilates in laboratory rodents, according to 
published protocols (Hawking, 1976; Brun et al., 1981). Genomic DNA from 
all samples was extracted according to Heath (1997). The DNA samples 
were screened by PCR for the presence of the serum-resistance-
associated (SRA) and T. b. gambiense-specific glycoprotein (TgsGP) 
genes, exactly as described by Gibson et al. (2002) and Radwanska et al. 
(2002), respectively. 
 
5.3.2. Multiplex-endonuclease analysis 
Multiplex genetic fingerprint patterns were generated for each sample 
according to the principle described by Agbo et al.  (In press), which 
permits the simultaneous assessment of multiple independent polymorphic 
sites per genotyping analysis and ensures PCR stringency through the use 
of only one pair of adapters and primers. Briefly, 200-300 ng of genomic 
DNA was digested for 4 h with 10 U of each restriction enzyme, in 
combinations BglII-BclI-EcoRI-MfeI or BglII-BclI-XhoII-EcoRI-MfeI-AcsI, 
respectively. The digests were precipitated and reconstituted in 10 µl 
distilled water. Ten µl of a buffer containing 660 mM Tris HCl, 50 mM 
MgCl2, 10 mM dithiothreitol, 10mM ATP, pH7.5, and 20 pM of each adapter 
- BglII (5'-CGGACTAGAGTACACTGTC; 5'-GATCGACAGTGTACTCTAGTC) 
and MunI (5'-AATTCCAAGAGCTCTCCAGTAC;  
5'-AGTACTGGAGAGCTCTTG) - were added. One µl (400U) of high 
concentration T4 DNA ligase (New England Biolabs) was added and the 
mixture incubated for 2 h at 25ºC. Pre-selective amplification was 
performed in a total volume of 20 µl containing 1 U of Taq polymerase 
(Roche Molecular Biochemicals, Almere, The Netherlands), 4 µl of 1:1-
diluted ligation product, 2 µl of 10X PCR buffer (100mM Tris HCl pH 9.0, 50 
mM KCl, 1% triton X-100, 0.1% w/v gelatin), 2.5 mM MgCl2, 200 µM of each 
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dNTP and 5 pM of each primer - BglII (5'-GAGTACACTGTCGATCT) and 
MunI (5'-GAGAGCTCTTGGAATTG ). The reaction mixture was incubated 
for 2 min at 95ºC, and subjected to 20 cycles of PCR (30 s at 95ºC, 30 s at 
56ºC and 2 min at 72ºC). Four µl of 1:20-diluted pre-selective products 
were used as template for selective primer combinations BgllI-0/MfeI-A 
(with zero and an ‘A’ selective nucleotide in the BglII and MfeI primers, 
respectively), BgllI-0/MfeI-AA and BgllI-0/MfeI-AT. The PCR program, 
electrophoresis of selective sample products, and data collection and 
analysis were as previously described (Agbo et al., 2002). 
 
 
 
 
 
Table 1. Origins of trypanosome populations isolated during and endemic 
period and identity according to BIIT, HSRT, SRA-PCR and TgsGP19-
PCR. 
a Blood Incubation Infectivity Test (Rickman and Robson, 1970); °Tietjen; 
personal communication; * Mangeni (unpublished data); n.d.: not done. 
b Human Serum Resistance Test (Jenni and Brun, 1982); ** von 
Dobschuetz (2002); The HSRT was performed twice per isolate, except for 
BOT/BU 623/7 and BOT/BU 602/7 where it was tested three and seven 
times, respectively (Rickman and Robson, 1970). The isolates were defined 
as resistant “Res” if they showed continuous growth in the presence of 
human serum for at least 10 days and sensitive “Sens” if they were lysed 
within 3 days. Isolates which showed non-continuous growth but remained 
alive in the presence of human serum for at least 3 days were classified as 
sub resistant “Subres” (Von Debschuetz, 2002). 
c Serum-resistance associated (SRA) gene (present + / not present - ), as 
determined using primers defined by Gibson et al (2002).  
d T. b. gambiense-specific glycoprotein (TgsGP) gene (present + / not 
present -), established using primers defined by Radwanska et al. (2002). 
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Stocks/Clones Origin Isolation
date 
Host BIITa HSRTb SRAc TgsGPd 
    
1. SUS/BU 83/6 Bulutwe Mar. 1992 Pig Sens° Sens** - - 
2. SUS/BU 83/7 Bulutwe Apr. 1992 Pig Sens° Sens** - - 
3. SUS/BU 83/9 Bulutwe Jul. 1992 Pig n.d. Sens** - - 
4. SUS/BU 83/9 Cl.1 Bulutwe Jul. 1992 Pig Subres* Sens** - - 
5. SUS/BU 83/9 Cl.2 Bulutwe Jul. 1992 Pig Sens* Sens** - - 
6. SUS/BU 83/9 Cl.4 Bulutwe Jul. 1992 Pig Subres* Sens** - - 
7. SUS/BU 83/9 Cl.5 Bulutwe Jul. 1992 Pig Subres* Sens** - - 
8. SUS/BU 132/2 Bulutwe Mar. 1991 Pig n.d. Sens** - - 
9. SUS/BU 132/4 Bulutwe Aug. 1991 Pig n.d. Subres** - - 
10. SUS/BU 139/2 Bulutwe Mar. 1991 Pig Res* Subres** - - 
11. SUS/BU 169/4 Bulutwe Aug. 1991 Pig Sens° Subres** - - 
12. SUS/BU 319/7 Bulutwe Apr. 1992 Pig Subres*
/sens° 
Sens** - - 
13. SUS/BU 319/7 Cl.1 Bulutwe Apr. 1992 Pig Sens* Sens** - - 
14. SUS/BU 319/7 Cl.3 Bulutwe Apr. 1992 Pig Subres* Sens** - - 
15. SUS/BU 319/9 Bulutwe Jul. 1992 Pig Sens° Sens** - - 
16. SUS/BU 347/7 Bulutwe Apr. 1992 Pig Res° Res** - - 
17. SUS/BU 373/7 Bulutwe Apr. 1992 Pig Res° Res** - - 
18. SUS/BU 561/3 Bulutwe Jun. 1991 Pig Subres*
/sens° 
Sens** - - 
19. SUS/BU 932/7 Bulutwe Apr. 1992 Pig Subres* Subres** - - 
20. BOT/BU 483/2 Bulutwe Mar. 1991 Cattle Subres* Sens** - - 
21. BOT/BU 492/2 Bulutwe Mar. 1991 Cattle n.d. Sens** - - 
22. BOT/BU 602/7 Bulutwe Apr. 1992 Cattle Subres*
/res° 
Res** - - 
23. BOT/BU 623/7 Bulutwe Apr. 1992 Cattle Res° Subres** - - 
24. BOT/BU 1845/7 Bulutwe Apr. 1992 Cattle Res° Subres** - - 
25. HOM/BU H1 Bulutwe Nov. 1990 Man n.d. Res** + - 
26. HOM/BU H2 Bulutwe Nov. 1990 Man n.d. Res** + - 
27. HOM/BU H5 Bulutwe Apr. 1991 Man n.d. Res** + - 
28. HOM/IG 2602 Kapyanga Feb. 1990 Man Res° Res** + - 
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5.3.3. Phylotyping by multiplex-endonuclease analysis   
Genomic fingerprint patterns were generated in parallel for 13 reference 
populations (i.e. 5 T. b. brucei, 6 T. b. gambiense and 2 T. b. rhodesiense). 
Only fragments ranging from 35-500 bp were analysed from which a 
schematic representation of the fingerprint patterns was constructed. From 
these profiles, identified on the basis of their intensity and individuality, a 
numerical matrix of observations based on the presence (1) and absence 
(0) of bands was built. The data were compared using Pearson correlation 
product moment coefficient (Pearson, 1926), which determined the 
proportion of mismatched bands between samples. Based on the similarity 
matrix a dendrogram was generated using the unweighted pair-group 
method using arithmetic averages (UPGMA).  
 
 
5.4. Results 
 
5.4.1. Trypanosome identity 
The results of the BIIT and HSRT (summarised in Table 1) permitted an 
early classification of the stocks or clones derived during the endemicity 
survey in Mukono district. Trypanosomes positive (resistant) in one of these 
tests are considered putative T. b. rhodesiense. All trypanosome DNAs 
were further screened by PCR for a 1.2-kb SRA fragment, scored as 
present or absent (+ or -) (Table 1), and for a 308-bp TgsGP product (Fig. 
1). The SRA gene fragment was amplified only from endemic trypanosome 
populations of human origin, which are considered genuine T. b. 
rhodesiense. All the samples identified as ‘sub-resistant’ in the HSRT were 
negative for the SRA-specific PCR product. The specific TgsGP19 
fragment was generated from only the T. b. gambiense populations.  
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Table 2. Origin and identity of trypanosome populations derived during 
epidemic outbreaks.  
  
Species       Subspecies Trypanosome 
stocks and 
clones 
Origin Isolation 
year 
Original 
host 
1. T. brucei  brucei AnTat1.8 Uganda 1966 Bushbuck 
2. T.  brucei  brucei AnTat2.2 Nigeria 1970 Tsetse 
3. T.  brucei  brucei AnTat5.2 Gambia 1975 Bovine 
4. T.  brucei  brucei AnTat17.1 D.R. Congo 1978 Sheep 
5. T.  brucei  brucei Ketri2494 Kenya 1980 Tsetse 
6. T.  brucei  brucei J10 Zambia 1973 Hyena 
7. T.  brucei  brucei TSW196 Côte d’Ivoire 1978 Pig 
8. T.  brucei  gambiense AnTat9.1 Cameroon 1976 Man 
9. T.  brucei  gambiense LiTat1.3 Côte d’Ivoire 1952 Man 
10. T.  brucei  gambiense AnTat11.17 D.R. Congo 1974 Man 
11. T.  brucei  gambiense AnTat22.1 Congo/Brazzville 1975 Man 
12. T.  brucei  gambiense JUA Cameroon 1979 Man 
13. T.  brucei  gambiense BAGE D.R. Congo 1995 Man 
14. T.  brucei  gambiense NABE D.R. Congo 1995 Man 
15. T.  brucei  gambiense PAKWE D.R. Congo 1995 Man 
16. T.  brucei  gambiense SEKA D.R. Congo 1995 Man 
17. T.  brucei  gambiense PT312 Côte d’Ivoire 1992 Man 
18. T .brucei rhodesiense 0404 Rwanda 1970 Man 
19. T. brucei rhodesiense STIB847 Uganda (Busoga) 1990 Man 
20. T. brucei rhodesiense STIB848 Uganda (Busoga) 1990 Man 
21. T. brucei rhodesiense STIB849 Uganda (Busoga) 1991 Man 
22. T. brucei rhodesiense STIB850 Uganda (Busoga) 1990 Man 
23. T. brucei rhodesiense STIB851 Uganda (Tororo) 1990 Man 
24. T. brucei rhodesiense STIB882 Uganda 1993 Man 
25. T. brucei rhodesiense STIB883 Uganda 1994 Man 
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Fig. 1. T. b. gambiense-specific TgsGP19-PCR analysis.  
DNA marker (M) is a 100-bp ladder. Sample series A, lanes 1-28 
correspond to DNA from the trypanosomes listed in Table 1 (1-28), while 
lanes labelled 29-53 of series B correspond to samples 1-25 listed in Table 
2. 
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5.4.2. Complexity of T. brucei populations during an endemic period 
According to the composite BglII-BclI-EcoRI-MfeI (four-endonuclease) 
analysis pattern for the samples from Mukono district (Table 1), using BglII-
0/MfeI-A primer combination, the collection consisted of 3 phylogenetic 
Clusters A, B and C (Fig. 2). The pattern analysis of the control samples 
(data not shown), as well as human serum response trait and presence of 
SRA gene product, revealed that each cluster consisted of both T. b. brucei 
and T. b. rhodesiense.  Also, the genetic relatedness and thus the 
distribution of the samples in the dendogram did not seem to correlate with 
serum response properties, and samples with the same serum response 
trait are not necessarily more closely-related than stocks and clones with a 
different trait. For instance, human serum resistant SUS/BU 347/7 and 
SUS/BU 373/7 isolated from pig (by definition putative T. b. rhodesiense) 
share a genetic similarity level of 96%. On the other hand, T. b. 
rhodesiense HOM/BU H1 and HOM/BU H2 from different human hosts, 
which share 96.5% genetic similarity are 93% similar to HOM/BU H5 
(Cluster B). Furthermore, HOM/IG 2602 from human in another village is 
distantly outplaced from other T. b. rhodesiense (to Cluster C). The 
similarity levels between different populations, as determined by numerical 
analysis of fingerprint patterns, were shown to span a continuous range of 
values between 79-98% (Fig. 2), with a dendogram (cophenetic) correlation 
of 88.4%. However, within each cluster, a highly similar genotype pattern 
was obtained. Overall, genotype of T. b. rhodesiense stocks from man 
share specific bands, which are different from other stocks (see Boxes in 
Figures 2 and 3). 
 
Since the identity of populations is highly dependent upon the resolution 
power of the molecular tool employed, the samples were further processed 
using a combination of six endonucleases and a pair of adapters. The 
amplified representation fragments and generated fingerprint data were 
similarly analysed as described for four-endonuclease procedure (Fig. 3). 
The approach consistently generated additional restriction fragments to 
permit for finer genome analysis, however, selection at both fragment ends 
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seemed necessary for generating discrete fragments for further analysis. 
Numerical analysis of 6-endonuclease fingerprint of the Mukono samples 
revealed two distinct clusters (Fig. 3). Cluster I comprised of a group of 7 T. 
b. brucei stocks and clones (which share genetic similarity of more than 
90%) and 4 T. b. rhodesiense stocks which are 77.8%, 78.5, 80% and 85% 
related to other T. b. brucei stocks. Cluster II sub-divided into two 
subclusters comprising 3 T. b. rhodesiense stocks of human origin (A) and 
13 T. b. brucei or T. b. rhodesiense stocks and clones (B), which share a 
correlation coefficient of 75.5%. Both clusters share an overall similarity 
that ranged between 73.5-98%, with a dendogram (cophenetic) correlation 
of 95% (Fig. 3). Overall, comparing the dendograms (Figures 2 and 3), 
analysis with 6 endonucleases revealed less genetic similarity between 
stocks or clones than with 4 enzymes.  
 
5.4.3. Cladistic analysis 
Genetic relatedness of the samples was evaluated on populations isolated 
during periods of low circulating parasitism (endemic) and upsurge in 
disease incidence (epidemic). Fingerprint patterns of the stocks isolated in 
Mukono district, Uganda between 1990-1992 were compared to T. b. 
rhodesiense strains isolated during 1990-1994 epidemic episodes in the 
same Busoga focus. Relationships between the sets of populations inferred 
by numerical analysis of fingerprint data were expressed as percentage 
values of the Pearson correlation product moment coefficient. From the 
dendogram (Fig. 4), the two groups comprising endemic and epidemic 
stocks and clones were clearly separated and showed a percent genetic 
similarity coefficient of 78%. On the basis of percent genetic similarity, the 
dendogram was stratified into three groups. Window I represents a group of 
populations with 79-89% genetic similarity and considered to be ‘closely-
related’. Fingerprints in Window II comprise of stocks or clones that share 
90-95% genetic similarity (‘highly-related’), while Window III displays stocks 
or clones with more than 95% genetic similarity (considered ‘identical’). On 
the basis of this classification, it can be seen that T. brucei populations 
circulating in Mukono district during the endemicity survey were closely-
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related (at 82.8% for most samples, and in the range 79-82.8% for all 
samples). However, these are slightly different from those isolated during 
the epidemic within the same Busoga focus (which are 77.8% related). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. Dendogram from four-endonuclease analysis of 28 Trypanosoma 
brucei populations isolated during endemic period (1990-1992), based on 
similarity relationships, according to composite genomic patterns. Cluster A 
corresponded with T. b. brucei populations, whereas Clusters B and C each 
consisted of T. b. brucei and T. b. rhodesiense populations. 
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Although several of the stocks isolated during the endemic survey were 
identical (clonal), there were major genetic differences within the Mukono 
T. b. rhodesiense and T. b. brucei stocks, respectively. The genotype 
profiles indicate that most endemic stocks were genetically separated at a 
similarity coefficient of 82.8%, and 79% for the stocks - SUS/BU561/3, 
HOM/IG 2602 and BOT/BU 623/7 (Fig. 4). The analysis was then extended 
to include the genotype of T. b. brucei stocks circulating during various 
epidemic periods in disparate geographical regions. From the dendogram 
(Fig. 5), three broad groups result in which the samples isolated during the 
endemic survey are clustered together but share genetic similarity of only 
79%. As expected, the T. b. rhodesiense stocks isolated during the 1990-
1992 epidemic in Busoga were more genetically-related to the T. b. 
rhodesiense stocks from the endemicity survey in Mukono (also within 
Busoga focus) than the disparate epidemic period T. b. brucei populations. 
A genetic correlation coefficient of 77.8% indicates that the genetic 
composition of T. b. brucei populations isolated during the epidemic period 
were remarkably different from those of other T. b. brucei isolated from the 
same focus during endemic periods. 
 
When the Mukono samples were compared to all disparate stocks from 
epidemic episodes, the dendogram correlation showed essentially two 
clusters (Fig. 6). Cluster P comprises of disparate T. b. brucei and T. b. 
gambiense populations derived outside of Busoga focus during epidemic 
periods, while populations from Busoga focus form Cluster Q. Each cluster 
is subgrouped into two subclusters differentiated on the basis of the 
subspecies identity of the samples. Subclusters P1 and P2 comprise of 
disparate T. b. gambiense and T. b. brucei stocks and clones, respectively. 
While the samples comprising the former are genotypically not 
homogeneous, the latter are most heterogeneous. In addition, the T. b. 
gambiense stocks and clones from Cameroon, Congo and Democratic 
Republic of Congo are substructured into 2 groups (including LiTat 1.3 from 
Côte d’Ivoire) that share a genetic relatedness of 86.8%. This may also 
suggest that different genotypes were responsible for the 1995 outbreaks in  
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Democratic Republic (D.R) of Congo. On the other hand, Ketri 2494, 
isolated in Kenya (1980) from tsetse fly, grouped within Cluster Q. It is 
interesting that Ketri 2494 (from Kenya) is sub-clustered in Q-1, while 
AnTat 1.8 also a T. b. brucei isolated from Uganda (a closely-related 
geographical area) did not fall within this group (Fig. 6). This indicates that 
there is close genetic relatedness of Ketri 2494 to the epidemic T. b. 
rhodesiense stocks from Uganda. While the samples within cluster P share 
a coefficient genetic relatedness of only 76.5%, the subgroups comprising 
cluster Q share genetic similarity of 82.5%. Populations within both clusters 
share only 74% genetic relatedness. 
 
 
Fig. 3. Relationship between 28 T. brucei stocks or clones derived during 
endemic period survey between 1990-1992, inferred by numerical analysis 
of fingerprint data generated by six-endonuclease analysis. Subspecies 
identification ‘B’ and ‘R’ represent T. b. brucei and T. b. rhodesiense, 
respectively. 
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As expected, intra-subspecies relatedness of the disparate T. b. brucei 
stocks derived during epidemic episodes was less than for those derived 
during the endemic survey in Mukono district. As in previous clustering 
correlations (Figs. 4 and 5), STIB 883 and now PT312 were classified as 
outliers in the dendogram. Their correlations to other populations were 
64.8% and 59%, respectively, indicating distant genetic relatedness. In 
addition, it shows that the STIB 883 was completely different from other 
stocks circulating during the epidemic in Busoga focus and suggests that 
new parasite strains that upset host-parasite balance may have an 
important role in initiating an epidemic episode.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Assessment of relationship between stocks isolated during endemic 
and epidemic periods in Busoga focus, Uganda. The extent relatedness of 
T. b. brucei (B) and T. b. rhodesiense (R) from epidemic (epi) and endemic 
(end) periods are grouped in Windows I, II and III. (See facing page). 
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5.5. Discussion 
 
Using restriction fragment length polymorphisms-based analysis, Hide et al. 
(1998) found little genetic differences between T. b. brucei populations 
isolated during an endemic period (Busia, Kenya, 1993-1994) and 
populations isolated during an epidemic period (Tororo, Kenya, 1988-
1990), both within Busoga focus. Further, no major differences were found 
between the genotypes of circulating populations in the two regions. In our 
study, we expanded the number of genomic sites accessed per analysis 
using a multiplex set of four or six different endonucleases to genotype 
samples from the same focus in order to evaluate the complexity of 
parasite populations in an area in which trypanosomosis is holoendemic. In 
general, there was congruence between clustering based on fingerprint 
type and parasite subspecies identification of these stocks isolated during 
an endemic survey (Mukono, Uganda, 1990-1992) and during an epidemic 
period (Busoga, Uganda, 1990-1994), but remarkable differences were also 
revealed. As expected, the average genetic correlation coefficient between 
samples in the dendogram was less when six endonucleases were used for 
the analysis than when four were used. In contrast to Hide et al. (1998), we 
found microheterogeneities between genomes of populations from both 
regions.  
 
 
 
 
 
 
 
 
Fig. 5. Dendogram based on fingerprints from four-endonuclease analysis 
of T. b. brucei (B) and T. b. rhodesiense (R) populations isolated during 
endemic and epidemic periods in disparate geographical regions. 
 
 
 
 
  
10
0
90
80
 
G
en
et
ic
 s
im
ila
rit
y 
(%
)
70
Fi
g.
 5
  
 
An
Ta
t1
7/
1
An
Ta
t1
7/
1
SU
S/
BU
 5
61
/3
SU
S/
BU
 5
61
/3
H
O
M
/B
U
 2
60
2
H
O
M
/B
U
 2
60
2
BO
T/
BU
 6
23
/7
BO
T/
BU
 6
23
/7
BO
T/
BU
 6
02
/7
BO
T/
BU
 6
02
/7
SU
S/
BU
 1
32
/2
SU
S/
BU
 1
32
/2
SU
S/
BU
 8
3/
6
SU
S/
BU
 8
3/
6
SU
S/
BU
 8
3/
9
SU
S/
BU
 8
3/
9
SU
S/
BU
 8
3/
9 
C
l. 
2
SU
S/
BU
 8
3/
9 
C
l. 
2
SU
S/
BU
 8
3/
9 
C
l. 
5 
SU
S/
BU
 8
3/
9 
C
l. 
5 
SU
S/
BU
 8
3/
7
SU
S/
BU
 8
3/
7
SU
S/
BU
 8
3/
9 
C
l. 
1
SU
S/
BU
 8
3/
9 
C
l. 
1
SU
S/
BU
 8
3/
9 
C
l. 
4
An
Ta
t 1
.8
SU
S/
BU
 8
3/
9 
C
l. 
4
SU
S/
BU
 3
19
/7
SU
S/
BU
 3
19
/7
SU
S/
BU
 3
19
//7
 C
l. 
3
SU
S/
BU
 3
19
//7
 C
l. 
3
SU
S/
BU
 3
19
/9
SU
S/
BU
 3
19
/9
SU
S/
BU
 3
47
/7
 
SU
S/
BU
 3
47
/7
 
SU
S/
BU
 5
61
/3
SU
S/
BU
 5
61
/3
BO
T/
BU
 4
83
/2
BO
T/
BU
 4
83
/2
BO
T/
BU
 4
94
/2
BO
T/
BU
 4
94
/2
BO
T/
BU
 1
84
5/
7
BO
T/
BU
 1
84
5/
7
SU
S/
BU
 3
19
/7
 C
l. 
1
SU
S/
BU
 3
19
/7
 C
l. 
1
SU
S/
BU
 9
32
/7
SU
S/
BU
 9
32
/7
SU
S/
BU
 1
32
/4
SU
S/
BU
 1
32
/4
SU
S/
BU
 1
39
/2
SU
S/
BU
 1
39
/2
SU
S/
BU
 1
69
/4
SU
S/
BU
 1
69
/4
H
O
M
/B
U
 H
I
H
O
M
/B
U
 H
I
H
O
M
/B
U
 H
2
H
O
M
/B
U
 H
2
H
O
M
/B
U
 H
5
H
O
M
/B
U
 H
5
Ke
tri
 2
49
4
04
04
Ke
tri
 2
49
4
ST
IB
 8
27
ST
IB
 8
27
ST
IB
 8
49
ST
IB
 8
49
ST
IB
 8
82
ST
IB
 8
82
ST
IB
 8
50
ST
IB
 8
50
ST
IB
 8
48
ST
IB
 8
48
ST
IB
 8
51
ST
IB
 8
51
An
Ta
t 2
.2
An
Ta
t 2
.2
TS
W
 1
96
TS
W
 1
96
An
Ta
t 5
.2
An
Ta
t 5
.2
J1
0
J1
0
ST
IB
 8
83
ST
IB
 8
83
B
I III
 II 
B
/R B
/R B
/R
 
BR
R
Chapter 5 
 
118 
In Mukono district at the time of sampling, 0.7% of villagers, 33.5% of cattle 
and 52.8% of pigs were harbouring trypanosome infection (Nowak et al., 
1992), and it was remarkable to find putative T. b. rhodesiense in the pigs, 
as well as in the cattle (Fig. 2). Therefore, besides the acknowledged role 
of cattle as reservoir hosts for T. b. rhodesiense (Welburn et al., 2001; 
Fevre et al., 2001), pigs may also constitute an important consideration in 
targeting human disease control strategies, such as molecular 
epidemiology and chemotherapy.  
 
 
The importance of identifying human-infective strains in the field to 
determine the relevance of animal reservoirs and the prevalence of human-
infective trypanosomes has previously been highlighted (Hide, 1999). The 
use of isoenzyme analysis on parasite populations to characterise stocks of 
T. brucei permitted early attempts to study genetic diversity and population 
dynamics of field strains (Godfrey and Kilgour, 1976; Gibson et al., 1980; 
Tait, 1980). Further isoenzyme studies on populations isolated from the 
same locations at the same time clearly implicated cattle as potential 
reservoirs (Gibson and Gashumba, 1930; Gibson and Wellde, 1985). Its 
application to distinguish populations of T. b. brucei and T. b. rhodesiense 
failed to establish unequivocal criteria for distinction (Tait et al., 1985; 
Godfrey et al., 1990). This may also have been so because of the reliance 
on human response property as a basis for strain characterisation. The 
SRA-PCR offered a good tool for correlating serum response properties of 
samples to BIIT and HSRT results. However, it is interesting to note that 2 
populations isolated from pig (SUS/BU 347, SUS/BU 373/7) and 1 isolated 
from cattle (BOT/BU 602/7) shown to be resistant to lysis to human serum 
in both BIIT and HSRT are negative for the SRA gene fragment detected by 
PCR. This is suggestive of possible variations in the sequence of the SRA 
gene leading to failure to amplify the target during PCR. It may also indicate 
that BIIT and HSRT assays are not sufficient to unequivocally prove 
infectivity to humans (i.e. genuine T. b. rhodesiense) or underscore that the 
SRA gene is not the only genetic factor conferring resistance to normal    
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human serum. The epidemiological significance of such differences among 
trypanosome populations has been previously highlighted (Gibson et al., 
2002). As shown by our data, the use of human infectivity as a basis for the 
characterisation of T. brucei populations especially those from East Africa 
needs to be fully complemented by other fine-scale analysis method, like 
that described in this paper. Using this multi-locus approach, we show that 
finer genetic differences exist among T. brucei stocks derived from the 
same focus during endemic and epidemic periods, which could be 
complemented with phenotypic traits for the characterisation of strains.  
 
Why human and animal trypanosomosis in East Africa occur in cyclical 
periods of epidemics, interspersed with long periods of low-level endemicity 
in only a small number of foci, is unclear. It would be desirable to study the 
nature of these mechanisms in the overall context of possible inter-
subspecies genetic interactions with strains from related and distant 
epidemiological areas and time. Therefore, in a pilot study, we correlated 
genotypes of stocks isolated during an endemic survey from related 
geographical regions and those of disparate stocks from epidemic episodes 
in distant regions. Our data show that T. brucei stocks isolated during 1990-
1994 epidemic in Busoga focus were closely related to stocks isolated 
during a 1990-1992 endemicity survey in Mukono district of Uganda. 
However, our data further suggest that both groups are sufficiently 
heterogeneous to exclude clonality. As expected, the heterogeneity 
coefficient between stocks increased in space and time, and inter-stock 
differences exist on the basis of geographical origin as well as subspecies 
identity. When we compared genotype profiles of the ‘type 1’ T. b. 
gambiense populations, according to the classification of Gibson (1986), 
the dendogram correlations gave evidence of genetic sub-structuring within 
the subspecies (Fig. 6). The ‘type 2’ stocks have mostly been isolated from 
Côte d’Ivoire and, together with the clustering pattern of the fine-scale 
genotyping data, might explain the identity of PT312 as belonging to ‘type 
2’. This is in contrast to previous isoenzyme study which classified the
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same stock as ‘type 1’ (Truc et al., 1997). In addition, STIB 883 and PT312 
were classified as outliers in the dendogram (Fig. 6) and correlate at 
correlate at 64.8% and 59%, respectively, in relation to other populations, 
indicating distant genetic relatedness to other isolates. This also shows that 
STIB 883 was completely different from other stocks isolated during the 
epidemic in Busoga focus. Such observation indicates that new parasite 
strains that upset host-parasite balance may have an important role in 
initiating an epidemic episode. The introduction of such new strains and 
subsequent outbreaks of T. b. rhodesiense might have coincided with 
transhumance movement of cattle.  
 
To summarise, we studied within- and between-stock variations using a fine 
genotyping method to develop an understanding of the levels of variation 
within and between geographical foci and to describe genetic relatedness 
of epidemiologically-defined T. brucei populations. Genome composition of 
the stocks seemed sufficiently stable in space and time, in agreement with 
the findings of Godfrey and Kilgour (1976). However, significant genetic 
differences exist among stocks even from within a disease focus, while T. 
b. brucei and T. b. rhodesiense appear to be sufficiently genetically 
separated to merit their retention as separate subspecies. Taken together, 
the data indicate that considerable genetic differences exist among T. 
brucei populations within the same disease focus. These differences are 
more evident in cladistic analysis of stocks separated in space and time of 
isolation. 
 
 
 
 
Fig. 6. Fingerprint types and relationship between T. b. brucei (B), T. b. 
rhodesiense (R) and T. b. gambiense (G) populations from epidemic (epid) 
or endemic (end) periods in Busoga focus and other disparate locations. 
The two main clusters P and Q are further sub-clustered. 
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6.1. Abstract 
 
Detailed genotyping analyses of Trypanosoma brucei can be used to study 
genetic and phenotypic diversity, in order to identify biological loci 
associated with intrinsic parasite factors. Variations in multilocus genotypes 
based on neutral polymorphisms should be positively correlated with 
variation in virulence and tropism, provided the markers are finely 
distributed and stable enough for such association to exist. We applied 
marker-assisted fine-scale multilocus genotyping analysis as a predictive 
tool for characterising ANTAR series of antigenic variants, to determine the 
correlation between genotype and human serum resistance (HSR) 
phenotypic trait. Then we evaluated for differential DNA methylation based 
on uniqueness of the phenotypic and genetic constitution of genotypes, 
using the ANTAR series and two unique isovat clones that spontaneous 
lost the ability to revert to human serum resistance. The classification 
strategy of combining the genotype information with the human serum 
response trait produced well-differentiated groups of genotypes, indicating 
significant dominant genetic differences among the parasite clones 
examined. The techniques applied to measure genetic relatedness 
demonstrated ability of the multilocus genome analysis data to correlate 
genotypes on the basis of clonal identity of strains, but incongruent on the 
basis of phenotypic attributes. The lack of correlation between methylation-
dependent matrices and HSR suggest that epigenetic regulation of the trait 
is independent of DNA methylation. 
 
 
6.2. Introduction 
 
The tsetse-borne parasites of Trypanosoma brucei cause acute to chronic 
disease in humans and animals, are virtually identical by morphological and 
developmental criteria, but can be distinguished based on their ability to 
resist lysis by human serum (equivalent to human infectivity). Trypanosoma 
b. brucei, one of the causes of 'nagana' in cattle does not infect humans 
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because it is lysed by normal human serum. Trypanosoma b. gambiense 
and T. b. rhodesiense, on the other hand, are resistant to lysis by normal 
human serum (Hawking, 1973). Two important complications arise from this 
method of characterisation. First, in East Africa, isolates from tsetse and 
domestic animals may consist of a mixture of the human infective T. b. 
rhodesiense and non-human infective T. b. brucei. Therefore, parasites 
derived from hosts other than humans potentially contain both subspecies. 
Secondly, T. b. gambiense and T. b. rhodesiense appear to differ in their 
mechanism of resistance to normal human serum, T. b. gambiense being 
constitutively resistant to lysis, whereas in T. b. rhodesiense this 
mechanism is reversible (Hawking, 1977). 
 
There have been great advances in elucidating the molecular basis of 
trypanosome killing by human serum or parasite resistance to lysis. Human 
haptoglobin-related protein has been identified as the human toxin 
responsible for T. b. brucei killing (Rifkin, 1976), corroborated by 
subsequent studies (Rifkin et al., 1994; Tomlinson and Raper, 1996; Raper 
et al., 2001). Other recent studies have shown that a serum-resistance-
associated (SRA) gene transcript, present only in resistant T. b. 
rhodesiense, is responsible for human serum killing of the parasites (De 
Greef et al., 1989; Xong et al., 1998). In this case, an important factor in 
human infectivity was whether or not the SRA was expressed. The gene is 
present in all strains tested so far (Welburn et al., 2001; Gibson et al., 
2002), but absent in T. b. gambiense - a subspecies that is constitutively 
resistant to lysis by human serum. It has been suggested that variable 
expression of SRA might account for the periodic loss of human infectivity 
in T. b. rhodesiense strains. It is therefore, conceivable that the complex 
process of human serum resistance (HSR) may transcend the activity of 
one gene fragment.  
 
The identification of new genome-based tools for the study of genetic 
associations of human serum resistance in trypanosomes will have an 
important input in the overall control strategies of trypanosomosis. In other 
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taxa, a common genome-based approach to study such associations 
between different loci and resistance has been to search for polymorphisms 
between independent sensitive and resistant populations (Cowen et al., 
1999; Huys et al., 2000; Grigg et al., 2001). Although these approaches can 
indicate that different populations differ at a particular locus, they are not 
specific for resistance phenotype unless the resistant population has been 
stably derived from the susceptible population. Genome scan methods 
have been successfully applied to characterise multigene traits relevant for 
animal breeding (Malek et al., 2001a, 2001b). In trypanosomes, other 
molecular characterisation studies were less successful in revealing 
specific resistance markers (Borst and Grivell, 1971; Gibson et al., 1980; 
Tait et al., 1985; Godfrey et al., 1990; Hide et al., 1991; MacLeod et al., 
2000; Agbo et al., 2002).  
 
The goals of this study were twofold: to identify and categorise individual 
human serum sensitive and resistant T. b. rhodesiense clones on the basis 
of their molecular signatures, and to evaluate for possible correlation of 
differential DNA methylation patterns in establishing these traits. Therefore, 
a marker-enrichment strategy involving sets of hexaplex endonuclease-
based genotyping was used to study the correlation between human serum 
resistant phenotypes and genotypes of two different T. b. rhodesiense 
strains. These consisted of (1) sets of ANTAR antigenic variants with 
reversible serum response traits and, (2) a pair of 'mutant' strains that 
spontaneously became constitutively human serum sensitive. Finally, we 
evaluated the correlation of differential DNA methylation and genotypes to 
specific serum response properties. 
 
 
6.3. Materials and Methods 
 
6.3.1. Parasite characterisation and DNA isolation 
Two sets of T. b. rhodesiense clones and strains were used. The first 
consisted of a pair each of AnTat 12.1 and AnTat 25.1 isovat clones, 
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derived from sleeping sickness patients in Rwanda (1971). Each isovat 
couple comprised of a non-rodent-adapted serum resistant (NA/R) clone, 
which after multiple short passages (>40) and subcloning in mice, gave rise 
to a rodent-adapted and serum sensitive (AD/S) clone with the same VAT 
(Fig. 1). The second set consisted of STIB 848 and STIB 884 isolated from 
sleeping sickness patients in Uganda in 1990 and 1993, respectively (J. 
Enyaru, pers. comm.). These strains now appear to be constitutively 
sensitive to normal human serum, as resistant populations could no longer 
be generated in recent repeated attempts by the authors (unpublished 
data). The stable phenotype of the STIB strains presents them as a reliable 
model for fine-scale genomics marker-based characterisation studies.  
 
The procedures for parasite cloning, serotyping and selection of VATs were 
as previously described (Van Meirvenne et al., 1975). Testing for human 
serum resistance or sensitivity and selecting human serum resistant VATs 
(i.e. HSIIT, human serum infectivity inhibition test) were as previously 
described (Van Meirvenne et al., 1976). Trypanosomes were grown in mice 
and rats and pure trypanosome sediments were obtained after separation 
from the blood, according to Lanham and Godfrey (1970). Genomic DNA 
was isolated from trypanosome pellets stored at -80ºC, according to 
standard protocols and further characterised using primers previously 
described for T. b. rhodesiense-specific PCR (Welburn et al., 2001).  
 
6.3.2. Multiplex endonuclease genotyping analysis (MEGA) 
We explored interspecific diversity between subgroups of the 4 ANTAR 
clones using an extension of the recently developed MEGA technique 
(Agbo et al., In press). Briefly, about 200-400 ng of genomic DNA obtained 
from each of the clones was digested respectively, with 10U each of (BglII, 
BclI, XhoII, EcoRI, AcsI and MfeI) endonuclease combination. Restriction 
enzymes were purchased from Roche Molecular Biochemicals (Almere, 
The Netherlands) or New England Biolabs (Westburg, Leusden, The 
Netherlands). The restriction digestions were performed in a final volume of 
20 µl of appropriate buffer, according to the supplier's recommendations. 
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Depending on the optimal temperature of enzyme activity, reactions were 
incubated at 37°C or 50°C, for 6 h. When buffers were compatible, enzyme 
reactions were performed in double digestions. Ligation of 50 pm each of 
BglII and MfeI adapters (Table 1) to the digested fragments was performed 
as previously described (Sambrook et al., 1989). The amplification cascade 
involved two reaction series. For the pre-selective amplification, 4 µl of 
double-diluted ligation products were incubated with 20 pm each of BglII 
and MfeI primers (Table 1), 200 µM dNTPs, PCR buffer and 1.25 U Takara 
exonuclease Taq polymerase, in a final volume of 20 µl.  
 
 PATIENT 
  (blood ) 
Rat ( day  5) 
Mouse  passages
 ( days  3.3.2.2.3)
ITMAS 120372A 
Mouse  passages
 ( days  3.3.4)
Cloning 
AnTat 25. 1 NA/R 
AnTat  25.1 AD/S 
Mouse  passages
 (N = 49) 
A. 
PATIENT
  (blood)
Rat (day 5)
Mouse passages 
 (days 4.3.3.3) 
ITMAS 160372A
Cloning
AnTat 12. 1 NA/R
AnTat 12.1 AD/S
Mouse passages 
 (N = 43)
ITMAS 181278D
     AnTat 12.1
B.
Fig. 1. Simplified pedigree of ANTAR Variable Antigenic Types (VATs) - 
AnTat 25.1 and AnTat 12.1 - derived from two sleeping sickness patients in 
Rwanda (1971). ‘NA/R’ and ‘AD/S’ are ‘Non-adapted resistant’ and 
‘Adapted sensitive’ clones, respectively. 
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The mixture was first incubated at 72°C for 5 min and then 95°C for 30 s, 
followed by 20 cycles consisting of 95°C for 30 s, 56°C for 30 s and 72°C 
for 2 min. The pre-selective amplification products were 1:20-diluted with 
double-distilled water. For the selective amplification phase, 4 µl of the 
diluted samples was mixed with PCR buffer, 20 pm each of BglII+0 and 
fluorescently-labelled MfeI+A, MfeI+AA and MfeI+AT primers, respectively. 
Then 200 µM dNTPs and 1.25 U Takara exonuclease Taq polymerase 
were added. The 20 µl final reaction volume was incubated at 95°C for 2 
min, followed by 20 reaction cycles as for the pre-selective phase, and a 
final elongation phase of 10 min at 72°C. Selective amplification products 
were electrophoresed in 7% polyacrylamide sequencing gels, using ABI 
373 sequencer (Applied Biosystems).  
 
6.3.3. Differential methylation analysis  
Methylation sensitivity data of the restriction enzymes used and the 
relevant references have been published at [http://rebase.neb.com/cgi-
bin/mslist]. Analysis of the differential patterns of DNA methylation from the 
clones and the mutant non-revertant T. b. rhodesiense strains involved a 
modification of the MEGA approach. Three sets of methylation-sensitive 
restriction enzymes FbaI-MflI-MunI-AcsI, FbaI-MflI-XbaI-SpeI and FbaI-MflI-
BstBI-ClaI were used to digest 200-400 ng genomic DNA for 8 h, to ensure 
complete digestion. The hexacutters BclI, and BglII and XhoII in the original 
protocol were replaced with isoschizomers FbaI and MflI, respectively. 
Each endonuclease per set of two enzymes creates cohesive ends that are 
compatible with the overhang sites created by the other. FbaI and MflI do 
not cut when the recognition sequence is Dam methylated whereas BglII 
and XhoII are not impaired. Similarly, MunI (isoschizomer of MfeI) and AcsI 
are inactive in internal Dam methylation, but AcsI cuts hemimethylated 
external adenosine or guanidine, although at a lower rate. XbaI 
(recognising TCTAGA) and SpeI (ACTAGT) are blocked by Dam- and 
m5C-methylation, but cut the hemimethylated sequence, also at a lower 
rate than the unmethylated one. BstBI (recognising TTCGAA) and ClaI 
(ATCGAT) create compatible cohesive 3’ overhang ends and are blocked 
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by m5C-methylation. Subsequent procedures for the MEGA were as 
described above. On the basis of its reproducibility, even distribution of 
bands along the gel and number of polymorphic bands detected, the FbaI-
MflI-MunI-AcsI combination was selected. Details of the sequences and 
combinations of the adapters and primers used are given in Table 1.  
 
 
 
Endonuclease 
combinations 
Adapters Pre-selective PCR 
 primer sets 
Selective primer 
sets: differential 
methylation 
FbaI-MflI-MunI-AcsI BglII/MfeI BglII+0/MfeI+0 BglII+A/MfeI+AA* 
BglII+A/MfeI+AG* 
BglII+T/MfeI+AC* 
BglII+T/MfeI+AT* 
 
Table 1. Combinations of primers and adapters used for analyses. 
Equimolar amounts of cognate oligonucleotides were heated at 99°C for 10 
min and placed on the bench to cool to room to permit annealing of 
adapters: BglII (5'-CGG ACT AGA GTA CAC TGT C; 5'-GAT CGA CAG TGT 
ACT CTA GTC); MfeI (5'-AAT TCC AAG AGC TCT CCA GTA C; 5'-AGT ACT 
GGA GAG CTC TTG) and XbaI (5'-GTC GTA GAC TGC GTA CG; 5'-CTA 
GCG TAC GCA GTC). Core primer sequences (without selective 
nucleotide, i.e. primer+0) were: BglII (5'-GAG TAC ACT GTC GAT CT); MfeI 
(5'-GAG AGC TCT TGG AAT TG) and XbaI (5'-GAC TGC GTA CGC TAG A). 
Symbol * indicates FAM (6-carboxyfluorescein)-labeled primer. The 
endonucleases are completely blocked by Dam DNA methylation. 
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6.3.4. Data processing 
Following conversion of gel files, normalisation of sample files and 
background subtraction, inter-strain polymorphic amplified fragments were 
scored for the presence (1) or absence (0) of specific fragments depicted 
by signal peaks. Internal size marker loaded with every sample permitted 
definitive determinations of fragment sizes. Genetic similarities between 
fingerprint pairs were calculated using the Pearson product-moment 
coefficient, and matrices were clustered using the minimum variance within 
groups proposed by Ward (1963).  
 
 
6.4. Results and Discussion 
 
6.4.1. Strain identification and distribution of genotypes  
The reversibility of the human serum-resistance phenotype in the AnTat 12 
and AnTat 25 strains enabled the development of isogenic clones for 
comparative genotype analysis. In the T. b. rhodesiense ETat series of 
antigenic variants (Van Meirvenne et al., 1976), this character was 
associated with antigenic variation, and cloned isovat populations exist in 
both the normal human serum sensitive and resistant forms. By differential 
hybridisation of the sensitive and resistant ETat clones, De Greef and 
colleagues (1989) identified a transcript of the serum-resistance-associated 
(SRA) gene, present only in the resistant clones.  
 
In this study, we first verified strain identity by using previously described 
primers (Welburn et al., 2001) to amplify the T. b. rhodesiense-
characteristic 743 bp SRA product in all ANTAR and STIB samples (Fig. 2). 
This fragment spans through a 378 bp deletion that encodes the central 
region of an SRA-related VSG N-terminal domain (Welburn et al., 2001). It 
has been shown that for the SRA-dependent parasite gene fragment, the 
important factor in human serum resistance phenotype was whether or not 
the gene was expressed, and that not all T. b. rhodesiense express the 
transcript (Xong et al., 1998). This might explain the positive amplification 
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of the gene in the serum sensitive STIB strains. The ubiquity of the SRA 
gene (Welburn et al., 20001; Gibson et al., 2002) and its association with 
human infectivity is beyond doubt. However, other parasite genetic factors 
are thought to be involved, partly because SRA is absent in T. b. 
gambiense. Even within the T. b. rhodesiense, the gene is not expressed in 
all strains (Rifkin et al., 1994), which raises question on the role of 
epigenetic regulatory processes in the trait. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       2   3   4     M   1
Fig. 2. Specific PCR amplification products based  
on serum-resistance-associated (SRA) gene (De  
Greef et al., 1989). Product set was generated  
using primer combination B537 and B538 (Welburn 
et al., 2001).  
Lane 1 - neg. control (water); 2 - AnTat12.1 NA/R;  
3 - AnTat12.1 AD/S; 4 - AnTat25.1 NA/R;  
5 - AnTat25.1 AD/S; 6 - STIB 884; 7 - STIB 848;  
M - 100 bp marker
5   6   7  M  
 
 
Few previous studies have been undertaken to directly relate the T. brucei 
trait of human infectivity to the molecular signatures of different strains 
(Hide et al., 1991; Hide et al., 1994; Agbo et al., 2001). In other eukaryotic 
organisms, genome scan methods have permitted the identification of 
genomic regions that control phenotypic traits (Malek et al., 2001a, 2001b). 
In this study, we genotyped 4 ANTAR clones using restriction fragments 
generated from 6-endonuclease digestions of genomic DNA and amplified 
with BglII+0 and MfeI+A*, MfeI+AA* or MfeI+AT* primer combinations 
(Table 1). The representative genotypic profiles obtained using optimised 
protocols (Fig. 3) were reproducible in repeat experiments, confirming
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(among other parameters) the complete digestion of genomic DNA. In 
principle, given the enhanced efficiency of detection of amplifiable 
polymorphisms with the multiplex-endonuclease genotyping approach 
(Agbo et al., In press), the genotype patterns would be expected to strongly 
correlate with the phenotypic characters of the analysed test clones. 
However, on the combined dendogram (Fig. 3), there was incongruence 
between human serum response properties and genotypic profiles, 
suggesting limited role for dominance-dependent polymorphisms. 
 
The clustering of fingerprints was performed using the minimum variance 
within groups proposed by Ward (1963), which combines in each step, the 
two clusters whose fusion yields the least increase in the sum of squared 
distances from each individual to the centroid of the cluster to which it 
belongs. Therefore, the variance between groups is maximised while the 
variance within groups is minimised. The lack of correlation between clones 
determined by molecular profiles and human serum resistance suggests 
limited role for human infectivity on phenetic relationships.  
 
So far, the analysis has involved human serum sensitive or resistant 
trypanosome clones that have been reversibly adapted to specific 
phenotypes. It would also be informative to analyse the constitutively 
resistant or sensitive strains, and to compare the clones derived from other 
strains of the same subspecies. In this way, it might be possible to test for 
correlation of human infectivity and molecular patterns, and to determine 
whether these co-evolve in parasite populations. 
 
6.4.2. MEGA and differential DNA methylation patterns 
Sets of methylation-sensitive endonucleases were used to search for DNA 
methylation patterns in genomes of the clones derived from ANTAR clones, 
and from STIB strains that became constitutively human serum sensitive 
(Fig. 4). The restriction endonucleases FbaI and MflI are expected to cut 
less often than other hexacutters, such as BglII and XhoII, because of their 
sensitivity to Dam methylated residues. It should be pointed out that the 
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differences in banding patterns obtained in this analysis are not restriction 
fragment length polymorphisms between normal human serum sensitive 
and resistant trypanosomes, but represent differences in Dam and m5C 
methylated residues.  
 
 
 
 
 
9080 100 
% genetic relatedness 
AnTat25.1 NA/R 
AnTat25.1 AD/S 
AnTat12.1 AD/S
AnTat12.1 NA/R 
AnTat25.1 NA/R 
AnTat25.1 AD/S 
AnTat12.1 AD/S 
AnTat12.1 NA/R 
AnTat12.1 NA/R 
AnTat12.1 AD/S 
AnTat25.1 NA/R 
AnTat25.1 AD/S 
 
 
 
 
 
 
 
I
II
III
Fig. 3. Cophenetic dendogram profiles showing genotypic and human 
serum phenotypic correlates. The selective primer combinations used for 
the amplification of the 6-endonuclease digested products were BglII-
0/MfeI-AT* [I]; BglII-0/MfeI-A* [II]; BglII-0/MfeI-AA* [III]. 
 
 
If differential methylation exists at the sites recognised by the restriction 
enzymes used, and the methylation has a role in human serum response, 
then the fingerprint patterns would be expected to segregate according to 
human serum response status of the trypanosomes. Alternatively, the lack 
of such a correlation would suggest a lack of differential regulation of 
methylation in the different strains at the analysed restriction sites. 
 
To evaluate this hypothesis, we derived similarity matrices from 
methylation-sensitive polymorphisms of 3 sets of endonucleases (see 
Materials and Methods). No correlation was found between these matrices 
and human serum response trait, suggesting a lack of relationship between 
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the components defining genetic relatedness and those that define 
methylation patterns. In fact, AnTat 12.1 NA/R and AD/S, and AnTat25.1 
NA/R and AD/S, that are clonally related, respectively, were not grouped on 
the basis of the analysis of methylation-dependent polymorphisms. 
However, the STIB strains that are less genetically-related displayed more 
similar patterns of methylation-dependent polymorphisms (Fig. 4). These 
results indicate that there is a high degree of heterogeneity in the 
methylation state of specific methylation-sensitive sites among strains. 
Alternatively, it is possible that the two sets of strains may be different in 
other ways possibly unconnected with resistance to human serum. It should 
be pointed out that although this approach can be used to correlate 
methylation-dependent epigenetic regulation of human serum 
responsiveness at the genomic level, the relationship between presence or 
absence of an amplified fragment and its methylated or non-methylated 
state cannot be established by this analysis. 
 
There is currently a great deal of debate regarding the feasibility of 
identifying genetic associations with the human serum response (HSR) trait 
in T. brucei. However, much effort needs to be invested to identify tools 
with the greatest potential value for increasing the level of fine resolution. In 
this study, we have established that genotypic markers and HSR 
phenotypic properties are not directly correlated among T. b. rhodesiense 
clones and strains. We also presented data that propose limited role for 
differential methylation in HSR trait. It would be interesting to evaluate 
differences in DNA methylation patterns in known trypanosome genes 
using this MEGA approach. 
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Fig. 4. Dendogram from differential methylation analysis of T. brucei 
subspecies, using the MEGA approach. Pearson correlation product 
moment coefficient was used to determine the proportion of mismatched 
fragments between samples, and plotted in the dendograms following 
unweighted pair group method using average linkage (UPGMA) analysis. 
Genetic profiles are computer reconstructions and hence, underestimate 
the resolution of the original gel images. The FbaI-MflI-MunI-AcsI restriction 
fragments were amplified using primer combinations BglII-A/MfeI-AC* [A]; 
BglII-A/MfeI-AT* [B], BglII-T/MfeI-AA* [C], and BglII-T/MfeI-AG* [D].  
(See overleaf). 
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7.1. Summary 
 
The pathogenic trypanosomes T. equiperdum, T. evansi as well as T. 
brucei are morphologically identical. In horses, these parasites are 
considered to cause respectively dourine, surra and nagana. Previous 
molecular attempts to differentiate these species were not successful for T. 
evansi and T. equiperdum; only T. b. brucei could be differentiated to a 
certain extent. In this study we analysed ten T. equiperdum, eight T. evansi 
and four T. b. brucei using Random Amplified Polymorphic DNA (RAPD) 
and the fine-scale multiplex-endonuclease genotyping approach (MEGA). 
The results obtained confirm the homogeneity of the T. evansi group 
tested. The T. b. brucei clustered out in a heterogenous group. For T. 
equiperdum the situation is more complex: eight out of ten T. equiperdum 
clustered together with the T. evansi group, while two T. equiperdum 
strains were more related to T. b. brucei. Hence, two hypotheses can be 
formulated: (1) only two T. equiperdum strains are genuine T. equiperdum 
causing dourine; all other T. equiperdum strains actually are T. evansi 
causing surra or (2) T. equiperdum does not exist at all. In that case, 
different clinical outcome of horse infections with T. evansi or T. b. brucei is 
primarily related to the host immune response. 
 
 
7.2. Introduction 
 
Dourine, Surra and Nagana are all lethal diseases in horses caused by 
Trypanosoma equiperdum, T. evansi and T. b. brucei, respectively (Office 
International des Epizooties, OIE list B). They are all members of the 
Trypanozoon subgenus and have morphologically identical bloodstream 
forms. Trypanosoma equiperdum and T. evansi are transmitted 
respectively by sexual contact and by blood sucking flies explaining their 
worldwide distribution, while the dependence on tsetse flies as the vector 
limits T. b. brucei to sub-Saharan Africa (Stephen, 1986). 
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Most research on the genome of pathogenic Salivarian trypanosomes is 
performed on T. b. brucei. The genomes of T. equiperdum and T. evansi 
have not been thoroughly studied and most investigations focus on the 
sequence of variable surface glycoproteins (VSGs) (Baltz et al., 1986; Roth 
et al., 1986; Urakawa et al., 2001), on expression sites (Florent, Raibaud 
and Eisen, 1991), and on the kinetoplast DNA (kDNA) (Riou and Saucier, 
1979; Frasch et al., 1980; Borst, Fase-Fowler and Gibson, 1987; Masiga 
and Gibson, 1990; Ou, Giroud and Baltz, 1991; Lun, Brun and Gibson, 
1992).  
 
Despite numerous attempts, researchers have not been able to differentiate 
T. equiperdum from T. evansi consistently, neither at the serological, nor at 
the molecular level (Baltz, PhD thesis, Université de Bordeaux II, 1982; 
Hide et al., 1990; Lun et al., 1992; Lun, Brun and Gibson, 1992; Biteau et 
al., 2000). Previous studies performed in our laboratory further underlines 
the close relationship between both species (Claes et al., 2002). Only two 
of the ten putative T. equiperdum strains, the BoTat 1.1 (Morocco) and the 
Onderstepoort Veterinary Institute (OVI) strain (South Africa), seem to differ 
from the rest of the T. equiperdum strains in Variable Antigen Repertoire. 
All other T. equiperdum have the same characteristics as T. evansi strains. 
In the present study, we examined the characteristics of several T. 
equiperdum, T. evansi and T. b. brucei populations with two molecular 
techniques, Random Amplified Polymorphic DNA (RAPD) and a recently 
developed multiplex-endonuclease genotyping analysis (MEGA) (Agbo et 
al., In press). 
 
 
7.3. Materials and Methods 
 
7.3.1. Trypanosome populations 
A collection of four T. b. brucei, eight T. evansi and ten T. equiperdum 
populations, derived from strains isolated all over the world, was used in 
this study (Table 1). All populations were kept as cryostabilates in liquid 
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nitrogen. For the T. equiperdum strains, the history is mostly unknown. 
Only the OVI strain from South Africa, was well documented. 
 
7.3.2. Preparation of trypanosome DNA 
Bloodstream form trypanosomes were expanded in mice and rats and were 
purified from the blood by DEAE chromatography (Lanham and Godfrey, 
1970), followed by repeated centrifugation (3 times 20 min., 2000g) and 
sediment washes with Phosphate Buffered Saline Glucose (PSG) (38mM 
Na2HPO4.2H20, 2mM NaHPO4, 80mM glucose). Finally, trypanosome 
pellets were subsequently stored at -80°C. Twenty µl of trypanosome 
pellets (approximately 2 x 107 cells) were resuspended in 200 µl of 
Phosphate Buffered Saline (PBS) and the trypanosome DNA was extracted 
using the QIAamp DNA mini kit (Westburg, Leusden, The Netherlands), 
resulting in pure DNA in 200 µl of Milli-Q water. The typical yield of DNA 
extracted from a 20 µl pellet was 150 ng/µl or 30 µg of total DNA. The 
extracts obtained were diluted in Milli-Q water to a standard concentration 
of 50 ng/µl and stored at -20°C.  
 
7.3.3. Random Amplified Polymorphic DNA (RAPD) 
Ten µl of extracted DNA (50 ng/µl) were mixed with 40 µl of a PCR-mix 
containing: 0.5 U Taq DNA recombinant polymerase (Promega, UK), PCR 
buffer (Promega, UK), 3.0 mM MgCl2 (Promega, UK), 200 µM of each of the 
four dNTPs (Roche, Mannheim, Germany) and 0.5 µM of the 
oligonucleotide 10-mer (Gibco BRL, UK). The different oligonucleotides 
used were (in 5'-3' direction): RAPD 606 CGG TCG GCC A (Ventura et al., 
2001) and RAPD ILO 525 CGG ACG TCG C (Waitumbi and Murphy, 
1993). Amplifications were performed in a Biometra® Trio-block 
thermocycler. Cycling conditions were as follows: denaturation for 4 min. at 
94ºC, followed by 40 amplification cycles of 2 min. denaturation at 94ºC, 2 
min. primer-template annealing at 40ºC and 2 min. polymerisation at 72ºC. 
A final elongation step was carried out for 5 min. at 72°C. Twenty µl of the 
PCR product and ten µl of a 3 kb size marker (MBI Fermentas, Germany) 
were subjected to electrophoresis in a 2 % agarose gel (90 min at 100V). 
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Gels were stained with ethidium bromide (0.5µg/ml) (Sigma, USA) and 
analysed on an Imagemaster Video Detection System (Pharmacia, UK). 
 
 
Table 1. Trypanosome populations used in these studies 
 
Species Clone/strain ITMAS Origin Year  Host 
T. b. brucei AnTat 2.2 100297B Nigeria 1970 Tsetse fly 
T. b. brucei AnTat 5.2 220197 The Gambia 1975 Cattle 
T. b. brucei AnTat 17.1 210596 R. D. Congo 1978 Sheep 
T. b. brucei KETRI 2494 270881 Kenya 1980 Tsetse fly 
T. evansi AnTat 3.1 070799 South America 1969 Capybara 
T. evansi RoTat 1.2 020298 Indonesia 1982 Water 
buffalo 
T. evansi Merzouga 56 120399D Morocco 1998 Camel 
T. evansi Zagora I.17 040399B Morroco 1997 Camel 
T. evansi KETRI 2480 110297 Kenya 1980 Camel 
T. evansi CAN 86 K 140799B Brazil 1986 Dog 
T. evansi Stock 
Colombia 
150799 Colombia 1973 Horse 
T. evansi Stock Vietnam 101298 Vietnam 1998 Water 
buffalo 
T. equiperdum AnTat 4.1 210983A unknown unknown unknown 
T. equiperdum Alfort 241199A unknown unknown unknown 
T. equiperdum SVP 241199B unknown unknown unknown 
T. equiperdum ATCC 30019 020301 France 1903 ? Horse 
T. equiperdum ATCC 30023 280201 France 1903 ? Horse 
T. equiperdum STIB 818 010999 P. R. China 1979 Horse 
T. equiperdum American 220101 unknown unknown unknown 
T. equiperdum Canadian 290101 unknown unknown unknown 
T. equiperdum OVI 241199C South Africa 1975 Horse 
T. equiperdum BoTat 1.1 240982A Morocco 1924 Horse 
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7.3.4. Multiplex-endonuclease fingerprinting method 
A fine-scale genotyping approach involving multiplex endonucleases in 
combination with a pair of cognate adapters was used according to Agbo et 
al  (In press). Briefly, 100-250 ng genomic DNA were digested for 4 h using 
10 U each of BglII, BclI, AcsI and MunI endonucleases in two successive 
double digestion reactions. The final digestion products were precipitated 
and reconstituted in 10 µl distilled water. Ten µl of a buffer containing 660 
mM Tris HCl, 50 mM MgCl2, 10 mM Dithiothreitol, 10mM ATP, pH7.5, and 
20 pM of each BglII (5'-CGGACTAGAGTACACTGTC; 5'-
GATCGACAGTGTACTCTAGTC) and  
MunI (5'-AATTCCAAGAGCTCTCCAGTAC; 5'-AGTACTGGAGAGCTCTTG) 
adapters were added. The BglII adapter also ligated to the overhang sites 
created by BclI, while MunI adapter also ligated to the AcsI site. One µl 
(400U) of T4 DNA ligase (New England Biolabs) was added and the 
mixture incubated for 2 h at 25ºC. Pre-selective amplification was 
performed in a total volume of 20 µl containing 4 µl of 1:1-diluted ligation 
product, 1 U of Taq polymerase (Roche Molecular Biochemicals, Almere, 
The Netherlands), 10X PCR buffer (100mM Tris HCl pH 9.0, 50 mM KCl, 
1% triton X-100, 0.1% w/v gelatin), 2.5 mM MgCl2, 200 µM of each dNTP 
and 5 pM of each BglII (5'-GAGTACACTGTCGATCT) and MunI (5'-
GAGAGCTCTTGGAATTG) primers. The reaction mix was incubated for 2 
min at 95ºC, and subjected to 20 cycles of PCR (30 s at 95ºC, 30 s at 56ºC 
and 2 min at 72ºC). Four µl of 1:20-diluted pre-selective products were 
used as template for selective reaction with Mun-0/Bgl-A selective primer 
combination (in which the Mun primer was fluorescently labelled). The PCR 
program was essentially the same as for pre-selective amplification, except 
that the last cycling step was followed by 30-min incubation at 60ºC. The 
final products were diluted 1:1 with TE, and Genescan-500 internal lane 
standard (PE Applied Biosystems) was added. One µl of the mix was 
resolved in a 7.3% denaturing sequencing gel using a model ABI 373A 
automated DNA sequencer.  
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Gels were routinely prepared by using ABI protocols and electrophoresed 
for 5 h. Gel patterns were collected with GenScan software (PE Applied 
Biosystems) and sample files were transferred to GelCompar II software 
(Applied Maths, Kortrijk, Belgium). 
 
7.3.5. Cluster analysis 
The GelCompar II program was used for cluster analysis of RAPD and 
MEGA fingerpint profiles by Unweighted Pair Group Method with Arithmetic 
Mean (UPGMA) based on the Dice coefficient. With the obtained data 
matrices, Wagner Parsimony analysis was performed on bootstrapped data 
using the Seqboot, Mix and Consense programs from the PHYLIP software 
(Felsenstein, 1989). 
  
 
Fi
g.
 1
. U
PG
M
A 
C
lu
st
er
 a
na
ly
si
s 
ba
se
d 
on
 th
e 
R
AP
D
 re
su
lts
 w
ith
 p
rim
er
 6
06
. 
  Fi
g.
 2
. U
PG
M
A 
C
lu
st
er
 a
na
ly
si
s 
ba
se
d 
on
 th
e 
R
AP
D
 re
su
lts
 w
ith
 p
rim
er
 IL
O
 5
25
. 
 
 Defining the fit of T. equiperdum in the Trypanozoon group 
 
 157  
7.4. Results 
 
RAPD and MEGA reactions were performed with the same set of samples 
on different days and by different persons. The DNA banding patterns 
obtained confirmed the repeatability of both techniques in our laboratory 
(data not shown). Dendrograms from the RAPD results, analysed by 
pairwise fragment comparison using the Dice coefficient and by data 
clustering using UPGMA, are shown in Figures 1 and 2. In RAPD 606, all T. 
evansi strains cluster out in one homogenous group with a 95-100 % 
similarity level. Also, in this cluster eight out of the ten tested T. equiperdum 
strains are found. All T. b. brucei and the two remaining T. equiperdum 
isolates (BoTat 1.1 and OVI) cluster out in a more hetereogenous way (with 
72-88% similarity coefficiënt). The similarity level between these two T. 
equiperdum strains is 75% and they have respectively a 76 and 74% 
similarity coefficient with the T. evansi/T. equiperdum cluster. T. 
equiperdum BoTat 1.1 shares the highest similarity with T. b. brucei AnTat 
2.2, while the OVI strain is distinct from the rest of the group. In RAPD ILO 
525, the T. evansi strains are grouped in one cluster with 90-100% 
similarity. This cluster harbours the same eight out of ten T. equiperdum 
strain. T. b. brucei forms a more heterogenous groups (Dice coefficients 
ranging from 74 to 83%) including the T. equiperdum Botat 1.1 and OVI. 
With this RAPD T. equiperdum BoTat 1.1 relates most to T. equiperdum 
OVI and T. b. brucei KETRI 2494 and AnTat 2.2; OVI is highly similar to 
KETRI 2494. 
 
In the UPGMA clustering data obtained from the MEGA branches of the 
homology tree are longer, indicating the higher resolution power of this 
technique (Fig. 3). All T. evansi are grouped in one cluster with a similarity 
of 85-95 %, together with the same eight T. equiperdum strains. Also with 
this technique the T. b. brucei group appeared as a heterogenous cluster, 
including the BoTat 1.1 and OVI strains. Based on the MEGA data, the 
level of similarity of these two latter strains was calculated at 74 %. In this 
analysis, OVI seems closely related to T. b. brucei KETRI 2494, while 
BoTat 1.1 shares more homology with T. b. brucei AnTat 2.2.  
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In the RAPD and multiplex-endonuclease genotyping analyses, the 
clustering of the strains did not seem to be correlated to their respective 
geographical origin, original host species or the year of isolation. In RAPD 
606, T. evansi and T. equiperdum from different regions and hosts (RoTat 
1.2, AnTat 3.1, CAN 86K, stock Vietnam, STIB 818, American stabilate, 
ATCC 30019 and ATCC 30023) gave a 100% similarity coefficiënt (Fig. 1). 
On the other hand, with RAPD ILO 525 (Fig. 2), T. evansi stocks from 
different origins (RoTat 1.2, stock Colombia, Zagora I.17) showed exactly 
the same pattern. When mixed parsimony analysis was performed on 
bootstrapped data from both RAPD's and the modified AFLP, the 
homogenous T. evansi/T. equiperdum cluster differed from the more 
heterogenous group with a 80% and 100% probability coëfficient, 
respectively for the MEGA and both RAPD's (data not shown). 
 
 
7.5. Discussion 
 
Comparison of the RAPD 606 results in the present study with those from 
Ventura et al. (2001), reveals a similar close genetic relationship between 
T. evansi populations from different origins, and approximately the same 
distance between T. equiperdum BoTat 1.1 and the T. evansi cluster (76% 
similarity versus 60%, respectively). With RAPD ILO 525, Waitumbi and 
Murphy (1993) were able to divide the Trypanozoon subgenus into three 
groups: (1) T. b. brucei and T. b. rhodesiense, (2) T. b. gambiense and (3) 
T. evansi. No T. equiperdum was included in their analysis. 
 
Other previous characterisation studies mainly focused on the T. brucei 
subspecies or on T. evansi and only few T. equiperdum were included. 
Hide et al. (1990), analysed 42 T. brucei by repetitive DNA probes, together 
with only one T. equiperdum and one T. evansi. A separate T. b. 
gambiense type I cluster was found while T. b. brucei and T. b. rhodesiense 
were more heterogenous. The T. equiperdum and T. evansi appeared to 
have a dissimilarity level of 56% with the T. brucei group and a dissimilarity
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level of 45% between each other. Unfortunately from their paper, it is not 
clear which T. equiperdum and T. evansi strains were used. By both kDNA 
and isoenzyme analysis, Lun et al. (1992a, 1992b) could not find 
differences which would distinguish 12 stocks of T. evansi from one T. 
equiperdum (STIB 818). Agbo et al. (2002) included two T. evansi (AnTat 
3.1 and RoTat 1.2) and two T. equiperdum (AnTat 4.1 and STIB 818) in 
their AFLP analysis of Trypanosoma spp., again without conclusive results 
on the differentiation between T. evansi and T. equiperdum. Using 
microsatellite markers on three T. equiperdum (BoTat 1.1, STIB 818 and a 
South African strain), Biteau et al. (2000) observed heterogenous patterns 
amongst them and conclude that previous interpretation of the close 
relationship of T. evansi and T. equiperdum by isoenzyme and RFLP 
analysis might have been simplisitic. Only Zhang and Baltz (1994) found 
some differences between T. equiperdum and T. evansi stocks using 
repetitive DNA probes. BoTat 1.1 and a South African strain were 
separated from the T. evansi group. They were more similar to T. b. brucei 
than to the T. evansi cluster which contained a third T. equiperdum (STIB 
818). Zhang and Baltz concluded that this outlier T. equiperdum STIB 818 
could reflect the limit of sensitivity of the used RFLP technique or could be 
due to the misclassification of this strain. To our knowledge, the South 
African strain is the Onderstepoort Veterinary Institute (OVI) strain (T. De 
Waal, personal communication). Taken together, our results correspond 
well with the present studies that were based on a larger collection of T. 
evansi and T. equiperdum strains. Irrespective of the DNA amplification 
method, two major groups can be formed: one homogenous group 
including all T. evansi and most of the T. equiperdum strains and one 
heterogenous group including all T. b. brucei and two T. equiperdum, the 
BoTat 1.1 clone and the OVI strain. Previous serological and molecular 
studies on the same collection yielded similar results: all hitherto tested T. 
evansi share the presence and expression of the RoTat 1.2 VSG gene, 
while for the screened populations of T. equiperdum only BoTat 1.1 and 
OVI, as well as all tested T. b. brucei, do not express nor contain this VSG 
gene (Claes et al., unpublished observations). 
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Combining these data, two hypotheses can be formulated. Firstly, BoTat 
1.1 and the OVI strain are the only genuine T. equiperdum while all other T. 
equiperdum actually are misclassified T. evansi, thus extending the view of 
Zhang and Baltz (1994). Indeed, in experimental infections with the OVI 
strain by Barrowman (1976), clinical signs of dourine signs were observed 
in the infected horses, while in experimental infections with the American 
and Canadian stabilates, which in our study are both found in the T. evansi 
cluster, only general signs of trypanosomiasis were observed (Hagebock et 
al., 1993). Unfortunately, for most T. equiperdum strains, including BoTat 
1.1, similar clinical experiments have not been performed. The question 
whether BoTat 1.1 and OVI are "real" T. equiperdum strains could be 
solved by following the clinical outcome of horses experimentally infected 
with both strains and by comparing the result with infections with T. evansi-
like T. equiperdum strains. However, one should keep in mind that strains 
that have undergone multiple passages in laboratory animals might have 
lost or changed their pathogenicity and virulence. Alternatively, specific 
serological or molecular markers could be identified which can differentiate 
T. equiperdum from T. b. brucei. In the absence of a conclusive T. b. brucei 
marker this remains a challenging issue. An alternative hypothesis is that 
the species T. equiperdum actually does not exist but that dourine is 
caused by particular strains of T. evansi and/or T. b. brucei. Then the 
clinical outcome of the infection would merely depend on the virulence or 
the tissue tropism of the infective strains or the immunological response of 
the individual host to the trypanosome infection. 
 
Indeed, in horses acute, subacute and chronic forms of nagana (T. b. 
brucei) have been described, sometimes with clinical signs such as 
oedema of prepuce and legs, and sporadically the appearance of urticarial 
plaques. Also for surra (T. evansi) in horses, both acute and chronic 
infections have been mentioned. Here also, oedema is evident as plaques 
on the ventral surface of the body or as swelling of the sheath or prepuce 
(Stephen, 1986). All together, some clinical signs of nagana and surra are 
shared with dourine, i.e. urticarial plaques and genital swellings.  
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Therefore, it might be that differential diagnosis based only on clinical signs 
is not conclusive for the infecting trypanosome species and certain chronic 
cases of nagana or surra might have been considered as dourine or vice 
versa. This enigma would be solved if one considers dourine as the chronic 
form of both diseases. Both hypotheses should be checked against the 
other biological characteristics of the three trypanosome species. Until now, 
T. b. brucei is considered to be only cyclically-transmitted by tsetse flies, 
while T. evansi and T. equiperdum are transmitted mechanically and 
sexually, respectively. However, we have no evidence to exclude sexual or 
mechanical transmission of T. b. brucei. The transmission route could even 
be linked to host specificity and virulence or tissue tropism, and for T. 
evansi, sexual transmission might also occur. Hagebock et al. (1993) were 
indeed able to infect horses by urogenital inoculation with the American 
and Canadian T. equiperdum strains, which in our study clustered together 
with T. evansi. Thus, if these strains are considered to be T. evansi, a first 
proof of sexual transmission of T. evansi in horses has been shown. 
Nevertheless, to prove the possibility of sexual transmission of T. b. brucei 
and T. evansi, more experimental infections with both species should be 
conducted. Based on the available clinical, serological and molecular data, 
we propose that there is not sufficient evidence for the existence of T. 
equiperdum as a separate species. To clarify the confusion about T. 
equiperdum taxonomy, we propose to isolate new trypanosome strains 
from well-defined dourine, surra and nagana cases in horses, to analyse 
them with the most performant serological and molecular techniques and to 
study their pathogenicity and transmission routes in horses. 
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CHAPTER 8 
 
 
General Discussion 
 
 
8.1. Control of African trypanosomosis 
 
Control of tsetse-transmitted trypanosomosis in humans, livestock and 
wildlife has involved, to varying degrees, interventions directed at the vector 
(tsetse fly), the infectious organism (trypanosomes), the disease 
(trypanosomosis), reservoirs (wild and domestic animals) and the hosts 
(humans and livestock). The ideal control will comprise of an effective 
vaccine, complemented by a durable therapeutic agent, and a robust and 
rapid diagnostic tool for molecular epidemiology. No vaccine has yet 
reached clinical stage of development, and peculiarities of the parasite 
suggest that classical approaches to vaccine development will be 
unsuccessful (Chapter 1). The use of trypanocidal drugs to control the 
disease is well established and represents the most widely used approach. 
However, increasing trends in drug resistance (reviewed by Anene et al., 
2001) represent the most serious setback in the use of chemotherapeutic 
agents, and motivate search for new agents and drug targets. In addition, 
the development of a universal molecular diagnostic system, an important 
complementary tool for molecular epidemiology, is currently being actively 
pursued. The possibilities of discovering newer effective drugs and the 
development of a vaccine will constitute a potential breakthrough in the 
quest for reducing trypanosomosis. Current advances in genome analysis 
are offering new tools required for identifying, developing and validating 
candidate targets. 
 
The thesis began with a general review of our current understanding of 
African trypanosome genetics and the available tools for molecular 
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diagnosis and therapy. It linked the impact of genomics-based technologies 
to their potential impact on developing new tools for specific diagnostics 
and the identification of new drug targets, and the prospects for a vaccine 
(Chapter 1).  
8.2. The importance of genetic characterisation 
 
Genetic characterisation of trypanosomes allows their identification at the 
strain (epidemiological tracking) and (sub)species (taxonomic) levels. A 
correlation of such genotypic information may also permit the study of the 
impact of genetic diversity on specific biomedical parameters such as 
virulence or resistance to drugs. The accurate identification of T. brucei 
strains has been a challenging problem in the epidemiology of African 
trypanosomosis, both human and animal. Genotypic variation of the 
ribosomal RNA (rRNA) genes was used to elucidate the phylogenetic 
relatedness of Trypanosoma brucei brucei and T. b. gambiense with the 
aim to derive species-specific DNA probes (Chapter 2). Restriction 
fragment length polymorphisms (RFLP)-based variations in the rRNA gene 
region helped us to show that T. b. gambiense may indeed be a host 
variant of T. b. brucei. According to the molecular signatures, the 
subspecies were clearly separated in different clades in the phylogenetic 
analysis. This approach can be used to rapidly determine the taxonomic 
position of unidentified species or to give an objective and invariable 
criterion to characterise T. brucei, for example, to develop a molecular 
phylogeny of these subgroups in relation to their human serum response 
phenotypes. Similar DNA fingerprinting based on single-locus RFLP 
analysis has allowed a determination of identity of genotypes (Paindovoine 
et al., 1989; Hide et al., 2000). However, genotypic analysis in these 
approaches tends to be laborious if many loci need to be sampled. 
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8.3. Assessing genetic diversity using random molecular 
markers 
 
DNA polymorphisms can provide a set of markers that has to be sufficiently 
numerous and spaced across the genome to be informative. Such markers 
have the additional advantages that they can all be typed by the same 
technique, and their chromosomal location can be found easily by physical 
mapping. The polymorphism information content, which measures how 
informative a marker is, is increased when more polymorphisms are 
detected in an analysis. We applied the Amplified Fragment Length 
Polymorphisms (AFLP) method (Vos et al., 1995) to genotype isolates of 
the three T. brucei subspecies (Chapter 3) for several reasons. First, the 
approach of RFLP analysis of the rRNA gene region detects only a single 
genomic locus in which recombination is known to occur in other taxa. 
Trypanosome genome is known to be highly plastic and reflect a high rate 
of recombination and point mutation, and any genotype based on a single 
locus may provide inadequate results. AFLP markers are PCR-based RFLP 
analysis that can screen over 50 independent loci per PCR. This provides 
the opportunity of detecting a large number of genome-wide molecular 
markers that can be characterised to generate information on their 
arrangement in the genome. Also, AFLP markers are useful for assessing 
genetic differences among populations, individuals, strains or clonally-
related species. For a wide range of taxa, AFLP markers have been used 
to uncover cryptic genetic variation of strains, or related species (Janssen 
et al., 1996; Heun et al., 1997; Ajmone-Marsan et al., 1997).  
 
AFLP-based genomic differences can be detected if they resulted in 
acquisition or loss of a restriction fragment, a marked size difference 
between allelic restriction fragments in two DNA samples, or as mutations 
at primer extension sites. Such size differences could be the result of 
insertion or deletion events within a restriction fragment. Nonetheless, with 
the conventional AFLP method only limited genotypic differences were
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observed among trypanosome subspecies, due to close genetic 
relatedness at the intraspecific level (Chapter 3). Therefore, in resolving 
extremely low genetic variability, e.g. subspecific or intraspecific 
differences, or a confirmation of a lack of differences for clonality of 
individuals, a genetic fingerprinting approach will have to meet a few 
general criteria. It must generate multiple independent markers, provide 
adequate resolution of genetic differences, be reliable (repeatable) and 
require no prior sequence information.  
 
Using multiple independently-accessing restriction enzymes, the number of 
polymorphic sites that can be exploited in a single experiment by PCR-
based RFLPs were expanded and the resulting heterosite fragments 
detected in a robust way (Chapter 4). Amplified restriction products, or 
amplicons, were size-fractionated by polyacrylamide gel electrophoresis, 
but capillary electrophoresis can now be used to maximise fragment 
separation and sensitivity of the method. This multiplex endonuclease 
genotyping approach (MEGA) provides the opportunity of saturating and 
detecting unlinked markers at much higher density within the genome than 
the conventional AFLP. The cloning of polymorphic DNA markers and their 
subsequent conversion into sequence tagged site (STS) assays could 
permit quick and reliable analysis. Restriction endonuclease-based markers 
suffer from their general dominant nature and the limited genetic 
interpretation of the alleles and loci involved. However, detailed pedigree 
information allows the identification of co-dominant markers, which permit 
precise estimation of allelic frequencies and more powerful population 
genetic studies. The development of a genetic linkage map for T. brucei 
based on conventional AFLP is currently being pursued (Tait et al., 2002) 
and will make it possible to perform classicial genetic studies to search for 
genes that determine specific traits. Besides the assessment of genetic 
diversity, the MEGA approach is especially suited to enrich for high 
resolution of T. brucei genetic map and as a resource in marker-enrichment 
strategies for target loci, based on specific intervals of restriction enzyme 
recognition sites.  
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The key questions in trypanosome population genetics are concerned with 
gene flow within and between populations (MacLeod et al., 2001). Several 
marker-based systems have been used to study the population structures 
of trypanosome populations (Paindovoine et al., 1989; Hide et al., 1994), 
and the plausible and limiting attributes of each system have been 
highlighted (MacLeod et al., 2001). Genomic fingerprinting may become 
problematic because the high variability of genetic markers reduces 
similarity between distant taxa to the level of chance. Thus, the usefulness 
of multiplex genotyping markers for systematics rests more in the rapid 
grouping of closely-related populations, which is crucial for epidemiological 
studies. In Chapter 5, the MEGA approach was used to study the 
population genetic structure of T. brucei subspecies and to perform a 
cladistic analysis of these trypanosomes from geographically and 
temporally matched hosts in order to determine stock relationships and 
evolution. This analysis groups organisms that share derived characters 
more closely than those that do not. Important information on the genetic 
background of individual stocks and populations were derived from 
genotype relationships that were observed between marker profiles.  
 
A major advantage of fine-scale genetic fingerpinting is that it gives a direct 
access to genotypic information rather than requiring inference from the 
phenotype. However, a major challenge is determining the contribution of 
sequence variants (both within and between trypanosome species) to 
phenotypes and diseases. The analysis of inheritance of specific 
trypanosome phenotypes has been undertaken only rarely (Gibson and 
Mizen, 1997), although sufficient pedigree clones are currently available 
(Tait et al., 2002). Fine genotyping of human serum-resistant and sensitive 
T. b. rhodesiense clones characterised on the basis of maximum and 
minimum variances between and within groups revealed clear genomic 
differences (Chapter 6). Multilocus genotyping based on methylation-
sensitive endonuclease polymorphisms and a classification strategy of 
combining genotype information with human serum response (HSR) trait
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produced compact well-differentiated groups of genotypes (Chapter 6). 
These results indicate that genotype-HSR phenotype correlation exists 
among T. brucei clones. However, some of these genetic variations may be 
silent, synonymous polymorphisms and thus not accompanied  by 
significant variations in the proteome. Still, it is conceivable that these 
variations can give rise to differences in T. brucei phenotype, which might 
influence the outcome of infection. Furthermore, epigenetic status of 
genomic DNA and its variation in disease is well-known, recently reviewed 
by Fraga and Esteller (2002). For example, the role of DNA methylation in 
modulating cellular activities in eukaryotes, such as differential gene 
expression, is well-established (Busslinger et al., 1983; Razin and Cedar, 
1991; Razin and Cedar, 1994). An adapter-mediated AFLP method with 
two endonucleases has been used to correlate differential methylation 
pattern differences and fungal growth properties (Reyna-Lopez et al., 
1997). Genotyping based on multilocus methylation-sensitive endonuclease 
suggest limited role for differential DNA methylation patterns in 
trypanosome HSR traits. 
 
A most valuable approach for establishing linkage between DNA markers 
and specific trypanosome traits would be to determine the functions of 
known genes in relation to the traits of interest. Such traits should include 
parasite resistance/sensitivity to normal human serum, drug resistance, 
virulence, infectivity for the tsetse midgut and ability to produce salivary 
gland infection. The assessment of DNA markers for specific genetic traits 
is technologically feasible. Unfortunately, our knowledge of potential 
candidate genes for the traits is still very limited, with the serum-resistance-
associated (SRA) gene being the best characterised (de Greef et al., 1989). 
It should be emphasised that not all T. b. rhodesiense appear to express 
the SRA mRNA (Rifkin et al., 1994). Furthermore, the SRA gene is present 
only in the T. b. rhodesiense and not in the T. b. gambiense, which is also 
resistant to normal human serum. This implies that serum resistance in 
human-infective trypanosomes may be regulated by more than one gene 
and/or genome-wide accumulations of polymorphisms.  
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The analysis of the molecular basis of human serum resistance in 
trypanosomes provides an opportunity to define genotype-phenotype 
variations. The most informative way to define gene effects associated with 
specific traits is by genetic mapping, which requires the construction of a 
detailed genetic map. In trypanosomes, the process of genetic 
recombination is unclear, and gametes have not been demonstrated. As a 
result, establishing populations with segregating genetic loci is impossible. 
For this reason, DNA markers are evolving as useful tools for genetic 
mapping. Genetic markers are Mendelian characters, which if sufficiently 
polymorphic, give a reasonable chance that a randomly selected isolate will 
be heterozygous. For linkage analysis we need informative meiosis, which 
has not been observed in trypanosomes. However, when a polymorphic 
marker is used on a large population, linkage analysis may give statistically 
significant data for a specific trait. Therefore, the use of random markers 
(e.g. MEGA, AFLP or RFLP) offers ready tools for diversity assessment in 
order to rapidly discover new candidate genes. However, it should be 
pointed out that the association between a marker and the phenotypic 
expression tagged by that marker will depend on the age of the mutation 
causing the effect, the frequency of recombination and presence of 
recombinational hotspots, as well as the population structure. This is 
especially relevant for T. brucei genome, which is highly plastic. A dense 
map of random markers developed with the help of a fine-scale tool, 
especially the MEGA approach described in Chapter 4 of this thesis, would 
be valuable to rapidly pick up association with a focal trait.  
 
The plasticity of trypanosome genomes could promote divergence of the 
population and the development of subclones, which presumably enhances 
adaptation to host niches. We investigated the genotypic and phenotypic 
characteristics of T. b. rhodesiense clones and strains using the MEGA to 
exploit an expanded assessment of more independent methylation-
sensitive genomic sites. The aim was a detailed analysis of the initial 
methylation-dependent regulative factors of the parasites for better
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understanding of the possible correlation with phenotypic characteristics 
and development of host niches. The contribution of DNA methylation was 
shown to be limited in regulating human serum response traits (Chapter 6).   
 
The genus Trypanozoon is currently separated into three species, namely 
T. brucei, T. evansi and T. equiperdum, based on host niches, development 
cycles and transmission characteristics. However, the validity of this 
classification system, specifically the separation of T. evansi and T. 
equiperdum, is questionable. Trypanosoma evansi and T. equiperdum have 
various overlapping properties, and definitive proof that only T. equiperdum 
causes dourine in horses has not been achieved. We applied multiplex 
molecular markers in a phenetic examination of relationships between T. 
evansi and T. equiperdum. This correlation coefficient measured the 
agreement between the similarity values implied by the dendogram and 
those of the original similarity matrix. Finally, we used molecular markers to 
clarify whether their genetic differences justify their distinction into separate 
species. These genotype analyses allowed us to formulate two hypothesis: 
first, that host immune responses modulate the clinical outcomes of horse 
infections with T. evansi, T. brucei and T. equiperdum, in which case T. 
equiperdum is not distinct from T. evansi and thus does not exist as a 
distinct species; second, that if T. equiperdum truly exists, the genuineness 
of eight of the ten identified strains is questionable. Our conclusions favour 
the first hypothesis (Chapter 7). 
 
8.4. Perspectives on potential and limits of neutral markers, and 
future directions 
 
Genetic diversity within Trypanosoma species can be assessed using 
variation in neutral markers (including AFLP and MEGA), gene-targeted 
markers (e.g. Single Nucleotide Polymorphisms, SNP’s) or gene 
expression (Expressed Sequence Tags, EST’s). The initial investment in 
marker development is generally higher for the gene-targeted approach 
than for the neutral markers. However, it should be emphasised that some 
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neutral markers, such as microsatellites, also need to be developed 
specifically for the species under study. This is circumvented in the 
universality of the AFLP and MEGA approaches. EST profiling requires a 
cDNA library on a microarray against which fragments from different 
genotypes can be hybridised. For trypanosomes, this is currently being 
developed de novo for the T. brucei (El-Sayed et al., 2000). Once 
developed, neutral markers as well as functional markers can often be 
converted to a (semi-)high throughput system for characterisation of the 
trypanosomes. 
 
The genome coverage of a specific DNA marker system indicates whether 
a large part of the relevant variation is covered. For random markers, this is 
debatable. With respect to gene-targeted markers, SNP markers rely on the 
availability of sequence data of candidate genes. As long as our knowledge 
of candidate genes is limited, genome coverage will remain low. For EST’s, 
the coverage can be very high but this depends on the specific 
developmental stages of the parasite used in synthesising the cDNA library. 
Genotypes that differ in phenotype under the tested conditions will be 
picked up, regardless of how many genes affect the phenotype or where 
the genes are located in the genome. However, it could be that different 
species at the same developmental stage have different genotypes. 
 
Neutral DNA markers give the most valuable information on historical and 
demographic processes such as the evolutionary history and population 
structure (Sunnucks, 2000). This will be especially valuable if one could 
statistically test whether the divergence among populations is different from 
profiles of genotypes that are based on target genes. For distribution of 
allelic differences, it could be valuable to have information about variation in 
specific genes, for example, using microsatellites (Biteau et al., 2001; 
MacLeod et al., 1999, 2000, 2001). However, for the assessment of genetic 
basis of trypanosome complex phenotypic traits, it seems risky to replace 
random markers that cover a large part of the genome with markers 
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targeted in a small subset of genes. For a trait that is controlled by genome-
wide accumulations of single nucleotide or sequence polymorphisms rather 
than a loss of particular gene fragment, assessment of diversity by random 
markers could be preferable. 
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The advances in genomics technologies and genome analysis methods 
that offer new leads for accelerating discovery of putative targets for 
developing overall control tools are reviewed in Chapter 1. In Chapter 2, a 
PCR typing method based on restriction fragment length polymorphism 
analysis of the internal transcribed sequence (ITS) rDNA region was used 
to reveal distinct fingerprinting patterns that characterise human- and 
animal-derived Trypanosoma brucei gambiense and T. b. brucei isolates. 
Although these results also highlighted doubts about the uniformity of T. 
brucei subspecies, the limitation of such a typing technique that is based on 
a single genetic locus is obvious. As a result, the studies were extended to 
include all T. brucei subspecies in a more global amplified fragment length 
polymorphism (AFLP) genotyping (Chapter 3). This approach permitted an 
unbiased estimate of the total genome variance and revealed closer 
genetic relatedness between, and higher variability within, T. b. brucei and 
T. b. rhodesiense subspecies, compared to T. b. gambiense strains. 
However, it was clear from these studies that a finer-scale genotyping tool 
with enhanced resolution power was required. Chapter 4 describes such an 
advanced tool, a multiplex-endonuclease genotyping analysis (MEGA) 
approach that simultaneously accesses multiple independent restriction 
enzyme-based polymorphisms within the genome. It offered a robust and 
detailed genotyping tool and was, therefore, used to study the population 
genetic structure of T. brucei isolates, for epidemiological and cladistic 
analysis (Chapter 5).  
 
The MEGA approach envisages the application of genotyping to identify 
genetic profiles that are associated with specific (parasite) traits. Therefore, 
in Chapter 6, genotypes were constructed and correlated with human 
serum response traits of T. brucei rhodesiense clones and strains, to 
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further provide a general method for measuring differential phenotypes and 
an objective assessment of such differences. Also, such fine-scale 
approach can be used to rapidly enrich for identifiable polymorphisms in a 
set of known DNA sequences known to be associated with a phenotypic 
trait of interest. Using sets of four endonucleases selected on the basis of 
the concept defined by the MEGA approach, the role of differential DNA 
methylation patterns in the human serum response properties of 
trypanosomes was evaluated (Chapter 6), which proved to be insignificant. 
Furthermore, we clarified the genetic relationships between T. equiperdum 
and other Trypanozoon species (Chapter 7). In Chapter 8, a general 
discussion of the data is presented.  
 
In summary, three main applications of molecular marker systems in 
trypanosomes were described in this thesis. These involve genomic studies 
for (1) generating sensitive tools for molecular typing of strains, (2) 
elucidating taxonomy of Trypanozoon, and (3) the analysis of the 
relationships between genetic variations and their consequent functional 
effects that may enhance our understanding of important traits. These 
applications have permitted fine-scale genotypic characterisation of the 
parasites, and offered a template for phenotypic correlations of the 
genotype data. 
 
 Samenvatting 
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Hoofdstuk 1 bestaat uit een beschouwing van de vooruitgangen in 
genetische technologieën en genoom analyse methoden en de daar uit 
voortkomende indicaties om het ontdekken van mogelijk nieuwe 
aangrijpingspunten te bespoedigen. Allereerst werd een PCR (polymerase 
chain reaction) typeringstechniek gebruikt (hoofdstuk 2). Deze techniek is 
gebaseerd op Restrictie Fragment Lengte Polymorfisme (RFLP) analyse 
van een intern getranscribeerde rDNA sequentie regio (ITS). Deze techniek 
onthulde verschillende ‘fingerprint’ patronen die specifiek voor  humaan -of 
diergerelateerde Trypanosoma brucei gambiense en T. b. brucei isolaten 
zijn. Ondanks dat deze techniek twijfels aan de uniformiteit van T. brucei 
subspecies versterkte, is het limiterend oplossend vermogen van een 
techniek gebaseerd op één enkel genetisch locus overduidelijk. Om deze 
reden werd het onderzoek uitgebreid met een meer algemene genotypering 
techniek, amplified fragment length polymorfism (AFLP), en werden alle T. 
brucei subspecies onderzocht (hoofdstuk 3). Deze aanpak resulteerde in 
een onbevooroordeelde schatting van de variatie van het gehele genoom 
en onthulde een grotere genetische overeenkomsten binnen T. b. brucei en 
T. b. rhodesiense subspecies en hogere variabiliteit in vergelijking tot T. b. 
gambiense subspecies. Deze aanpak maakte echter ook duidelijk dat een 
gevoeligere genotypering techniek met een hoger oplossend vermogen 
nodig was.  
 
Hoofdstuk 4 beschrijft zo een geavanceerde techniek, de multiplex-
endonuclease genotypering analyse (MEGA). Met behulp van deze aanpak 
wordt tegelijkertijd gebruik gemaakt van meerdere onafhankelijke, op 
restrictie-enzym gebaseerde polymorfismen binnen het genoom. Het 
resultaat is een robuuste en gedetailleerde genotypering techniek die 
daarom gebruikt kon worden om de genetische structuur van de T. brucei 
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populatie te bepalen alsmede voor epidemiologische en ‘cladistic’ analyse 
(hoofdstuk 5). 
 
De MEGA aanpak laat zien hoe genotypering gebruikt kan worden om 
genetische profielen te bepalen die zijn geassocieerd met specifieke 
(parasitaire) kenmerken. Derhalve beschrijft hoofdstuk 6 het construeren 
van genotypen van T. brucei rhodesiense klonen en stammen, het 
correleren van genotypen aan humaan serum reactie kenmerken. 
Zodoende is een algemene methode ontwikkeld om onderscheidende 
fenotypes te bepalen en deze verschillen objectief  te beoordelen. Verder 
kan een gevoeligere techniek als deze gebruikt worden om snel, uit een set 
van bekende DNA sequenties, polymorfismen te identificeren die 
gekoppeld zijn aan interessante kenmerken. Door gebruik te maken van 
sets van 4 endonucleases geselecteerd aan de hand van het concept 
gedefinieerd door de MEGA aanpak, is de rol van differentiële DNA 
methylering patronen ten opzichte van humaan serum reactie kenmerken 
geëvalueerd, welke niet significant bleek. Bovendien konden de genetische 
verwantschappen  tussen T. equiperdum en andere Trypanozoon species 
verklaard worden (hoofdstuk 7). In hoofdstuk 8 wordt een algemene 
discussie van de data gepresenteerd.  
 
Kort samengevat wordt in dit proefschrift een moleculaire marker systeem 
voor trypanosomen beschreven, met drie voorname applicaties. De 
applicaties bevatten genomische toepassingen om (1) een gevoelige 
methode opzetten voor moleculaire typering van stammen, (2) het 
ophelderen van de Trypanozoon taxonomie, (3) het analyseren van de 
verwantschappen tussen genetische variaties en de daaruit volgende 
functionele effecten die mogelijk het inzicht in belangrijke kenmerken 
verbetert. Deze toepassingen hebben gevoelige genotypische 
karakterisering van de parasieten mogelijk gemaakt en een model voor 
fenotypische correlaties van de genotypering data opgeleverd. 
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